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Abstract
DRASTIC (Database Resource for the Analysis of Signal Transduction in Cells) and the 
INSIGHTS (INference of cell Signalling HypoTheseS) web-based suite of tools bring 
together data on plant responses to pathogens, environmental stresses and chemicals from 
refereed journal publications. Presenting these data in a unified, searchable format allows the 
user to extract information beyond that obtained by the authors’ single genes, or clusters of 
similar expression patterns by browsing multiple treatments at once, identifying potential 
regulatory relationships between multiple treatments and genes. DRASTIC-INSIGHTS 
overcomes the limitations of other plant expression databases by allowing for updating of 
information from previous publications, by directly linking to publications and through the 
tracking of genes with unknown function that have the same accession or AGI (Arabidopsis 
genome initiative) number, which would otherwise be difficult to link between publications. 
Additionally, genomic, EST, Northern data and information derived from microarrays from 
multiple plant species are included, after human curation, to ensure accuracy and to 
standardize the nomenclature of data. The INSIGHTS tools encourage comparison of gene 
expression patterns, intelligent mining of information, testing and formulation of novel 
hypotheses on the complex signal transduction and response pathways used by plants. 
Identifying common elements in pathways affected by different treatments permits the 
formation of hypotheses previously opaque to the user.
Genes for proteins involved in the same signal transduction pathway are likely to be co­
regulated and show the same response to a range of treatments. Thus, to find for example 
kinases, transcription factors and calcium-binding proteins that are in the same signal 
transduction pathway, expression patterns should be compared. Verification that identified 
genes are truly associated within signal transduction or metabolic pathways requires 
experimental confirmation, but the database and associated diagrams promote more targeted 
hypothesis formation. This type of analysis is useful in providing a framework for 
understanding signal transduction responses and to assist with identifying regulatory gene 
networks. It is also useful for finding genes associated with plant pathogen infection that are 
also affected by environmental stresses such as drought and cold in differing ways.
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Chapter 1 Introduction
1.1. Overview
Plants are vitally important to our global economy and make a large contribution to the food 
chain. Climate change and disease are causing increasing problems to the yields of food crops 
which is adding further pressure on the demands placed for food by an ever increasing global 
population.
It has been estimated by Agrios (2005) that approx 35% of the world's crop production is lost 
to disease, weeds and insects causing estimated losses of $550,000,000,000 per annum. Even 
with advanced crop protection, pesticides and highly advanced breeding programmes 
scientists have been unable to eradicate the hunger caused by crop diseases. Climate change 
is also having a negative impact on crop yield particularly in the poorest regions of the world. 
It has already caused a decrease in yields of most major food crops due to droughts, floods, 
increasingly salty soils and higher temperatures (Burness Communications, 2008).
One approach to finding solutions to these problems, and the focus of this thesis, is to 
develop a system to help scientists obtain a better understanding to how plants respond to 
biotic and abiotic threats by learning more about the signal transduction pathways and how 
biologists investigate and express them.
The biochemistry of what happens between a stimulus, for example a pathogen or cold 
(referred to here as a treatment), arriving at the outside of the plant cell, and the change in 
gene expression it brings about, is only just beginning to be explored. Difficulties in working 
with signalling mechanisms in plants include the complexity of the responses evoked by a 
single treatment and the number of different treatments that plants respond to (Dey and 
Harborne, 1998). In order to respond to a treatment, the plant cell must first be able to 
perceive it by use of receptors and then transduction of the signal is necessary to have effect 
on the gene expression. The signal transduction pathway compounds already exist in small 
amounts in the cell. When the pathway is triggered by a treatment(s), this causes a change to 
the gene expression in the cell. The genes that produce the gene products involved in the 
signalling pathway are up regulated which means that the signal transduction pathway is 
“ reinforced” . Figure 1 shows a very simplified version of cell signalling.
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The majority of genes are expressed as the proteins they encode. The gene expression process 
occurs in two steps:
T r a n s c r i p t i o n  of the information encoded in DNA into a molecule (D N A  —> m R N A ) and 
T r a n s l a t i o n  of the information encoded in the nucleotides of mRNA into a defined sequence 
of amino acids in a protein ( m R N A  —► p r o t e i n ).
The EST is a piece of sequence from the transcribed and expressed mRNA which can be used 
to identify the gene from which the mRNA was most likely expressed. This information can 
also be used to deduce the protein that the mRNA would likely code for. So, because the 
ESTs can be traced back to the genes and the transcripts that encode the related proteins, 
signalling pathways may be constructed from the gene expression data obtained.
1.2 . The Problem
Plant defence responses are extremely complex reactions and scientists are particularly 
interested in defence responses for example to drought or pathogen attacks as these can be 
devastating for crops. Plant signalling response to pathogens produces multiple signals 
triggering many plant response signal cascades that interact with each other in a complex 
pattern. The final response of the plant to infection is a consequence of the combined signals 
from the pathogen and the combined response by the plant. Other biotic and abiotic stresses 
such as environmental variation, nutritional status, fitness, etc., affecting both host and 
pathogen, will further modify the response, therefore it is important to consider the impact of
many types of stresses and not just one in isolation. With such a volume and complexity of 
data on signalling and response in multiple host-pathogen systems to assimilate, a structured 
framework to store information (data) and systematically build hypotheses, which can then be 
tested experimentally, is essential (Lyon e t  a l . ,  2002).
Charts of metabolic pathways in healthy plant cells are freely available 
(http:/www.genome.ad.jp/kegg/metabolism.html) an example of which is shown in Figure 2.
Figure 2: Pentose phosphate pathway for Arabidopsis thaliana from Kegg (www.genome.adjp/kegg) showing 
the types of metabolic mapping available for healthy plants.
Biologists can view many of these pathways, and investigate the enzymes highlighted in 
green by clicking on them to get further details. The problem for plant pathologists is that the 
published charts on metabolic pathways in plants only refer to healthy cells and do not 
include any data on signal transduction pathways. To add to the complexity, not all processes 
are common between plants belonging to different families and therefore it is not possible to 
create a single metabolic chart although it is possible to present information on secondary 
metabolism for a single plant species. Depicting the molecular networks involved in 
signalling pathways that regulate cell function has proven challenging, due to the enormous 
amount of information that needs to be conveyed for each participant in the network and the 
cross-connections between pathways (Kohn and Aladjem, 2006).
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The concept for the thesis originated from work at the Scottish Crop Research Institute 
(SCRI) on resistance mechanisms in plants, particularly potatoes. A  research project at SCRI 
had focused on discovery of plant genes up-regulated during resistant and susceptible 
interactions between potato and the foliar pathogen Phytophthora infestans, the stem and 
tuber pathogen Erwinia carotovora and the root pathogens Globodera pallida and G. 
rostochiensis. These pathogens are amongst the most economically devastating for potato, the 
world’ s fourth major crop (Birch, 2003). Little is known about the biochemical or signalling 
pathways in potato that are involved in resistance to pathogens. Moreover, there is even less 
information comparing resistance in leaf tissue with that in root. Knowledge from such 
comparisons could be crucial in developing broad-range plant disease resistance strategies.
It is the notion of a broad-range approach that is of relevance here. Because of the specialist 
nature of the research into various aspects of plant signalling, research groups will often 
focus on one treatment or a small aspect of signalling. Take for example research into the 
ethylene pathway in Figure 3 which is very specific. There is little in the way of tools that can 
curate and evaluate this data as a whole which is a problem as many research papers will 
often contain similar, very specialised results.Receptor ETR1iCTR1MAPKKK 1MAPKK SIMKK
iMAPK SIMK, MMK3 MPK6, (MPK13)1EIN21EIN3
ERF I, PDF1.2, GST2, CH1-BGene expression E
Figure 3: A proposed model of the MAPK pathway mediating ethylene signalling in plants. The histidine kinase 
ETR1 functions as an ethylene receptor and activates CTR1 in the absence of ethylene. CTR1 is a negative 
regulator of the MAPKK SIMKK and the MAPKs SIMK/MMK3 in Medicago, and MPK6/13 in Arabidopsis. In 
the presence of ethylene, ETR1 and CTR1 become inactivated, relieving SIMKK from inhibition. Subsequent 
activation of the MAPKs activates gene expression of ethylene-responsive genes via direct activation of EIN2 
and EIN3 or through other factors.
During the research into disease resistance at SCRI gene expression data was collated from 
journals that were identified as relevant to defence signalling in plants of all species. While
15
the data collected was useful for the specific research projects at hand it became apparent that 
there was no database source available that contained this type of data (Newton et al., 2002) 
and that the data could potentially be used as a start to create new hypotheses for plant 
signalling. This thesis investigates whether this data could be used to take a system biology 
overview. It provides researchers with a generic platform which incorporates gene expression 
data from multiple experiment types to enable the investigation of the overall signalling 
pathways rather that investigating niche, specific areas. This enables researchers to identify 
new areas of interest that would have previously been opaque.
1.3. Challenges
There are two separate challenges that must be addressed. The first is determining how to 
appropriately store and organise biochemical information to allow for future classification 
and reasoning requirements. This will be particularly important in the areas of biochemical 
pathways and signal transduction in cells, where the pace of data accumulation has been 
greatest. The beginning of this study coincided with the rise in use of microarray data and the 
move away from specialist one gene experiments as discussed in Chapter 4 along with the 
completion of sequencing projects for several plant species such as Arabidopsis and Tomato. 
For plant pathologists it is an exciting time but with the new knowledge comes a huge rise in 
the amount of available data. Plant diseases and defences have become extensively studied 
and a wealth of data already exists but there has been a slow pace of progress to store, 
categorise and mine value from the increasing data mountains on the responses of plants to 
pathogens and other environmental stresses. New data is also continually emerging at a rate 
much faster that existing data can comprehensively be studied.
The second challenge is to examine the structure of the stored data that will be specific to 
gene expression results for early defence signal transduction mechanisms in plants and 
identify ways to synthesise knowledge from this data.
1.4. Potential Benefits
The wealth of genomic and microarray data accumulated in the last decade holds enormous 
promise for understanding the molecular basis for the control of gene expression in all 
organisms and the functioning of biochemical pathways in all cell types. Understanding and 
controlling cellular responses to pathogens, disease and environmental stresses is probably
16
the most significant challenge and opportunity presented by the availability of this data. 
Important progress has been made through the completion of successive genome sequencing 
projects, most notably for the human, Caenorhabditis elegans, Escherichia coli and 
Arabidopsis thaliana genomes. Genomics together with advances in microarray technology 
provide powerful methods for the global analysis of gene expression and protein content 
(Forster et al., 2003). There has, however, been much less progress made towards a more 
unified understanding of biochemical processes across species groups and between 
kingdoms. This has been due to the volume and complexity of the accumulated data, 
especially where elements of temporal or ontogenetic control are concerned, which require 
more sophisticated bioinformatics tools to enable molecular bioscientists and clinicians to 
integrate biological intuition with rigorous computational data analysis (Quackenbush, 2001). 
These data suggest significant commonality in key signalling pathways and regulatory 
networks between plant species and between plants, animals and microbes (Hammond- 
Kosack and Parker, 2003). Potentially generic solutions to some of the most important food- 
crop diseases could be found from these networks and pathways, if  suitable tools to mine 
value from them, able to cope with large and diverse datasets, were widely available.
1.5. Proposed Solution
An approach to making sense of the volume of genomic data coupled with the complex 
datasets is to design a knowledge based framework to store information and systematically 
build hypotheses for signalling in a multiple plant host-pathogen system. This thesis looks at 
the design of a unique system which will provide a platform for plant pathologists to 
interrogate early defense gene expression results in a novel way (Button et al., 2005). This is 
the first database to enable the searching of such data and the focus has been from a system 
engineering view with the main aims for the study being:
1. Automate and enhance the process of information discovery for the biologist (Chapter 2)
2. Identify suitable data from different sources and different experiments (Chapter 3)
3. Examine the structure of data particularly from journals and make this more accessible 
(Chapter 4)
4. Provide a method to enable results from different types of experiments to be compared 
against each other (Chapter 4)
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5. D esign a data m odel that takes account o f the various data and database standards that 
exist in the plant b iology community (Chapter 5)
6. Improve the speed, efficiency and ability o f the biologist to search for information from  
the gene expression results collected (Chapter 6)
Chapter 2 describes how scientists currently approach the problem o f investigating gene 
expression results and hypotheses for signalling pathways. Chapter 3 exam ines the 
possibilities o f automation and evaluates what data is currently available to mine for gene 
expression defence responses. Chapter 4 assesses the quality o f the data and looks at how  
data from a variety o f  experiments and sources such as online journals, paper-based journals 
and microarray databases can be integrated to enable searches to be carried out across varying 
types o f data. Chapter 5 builds on the results from the data evaluation and describes the 
development o f a generic model that can hold data from multiple species and experiments. 
Chapter 6 describes the development o f a toolset by building an intelligent and generic 
system  for increased understanding o f metabolic and signal transduction pathways based on 
requirements identified in Chapter 2. Chapter 7 tests and evaluates the toolset and looks at 
future work.
The DRASTIC-INSIGHTS enabling technology described in this thesis stimulates new  
interpretations o f existing and emerging data, mining value through the identification o f  
elements o f commonality between different pathways and diverse organisms, whilst allowing  
new hypotheses for these pathways to be postulated and tested.
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Chapter 2 Background
2.1 Introduction
This chapter provides an overview o f the existing work that is being carried out in the plant 
defence signal transduction pathway domain. Effects o f certain treatments and environmental 
conditions start early signalling events which then trigger gene expression changes within the 
plant. Understanding signal transduction may help with problems such as disease and 
drought. There are several current methods used to investigate signalling in plants which are 
evaluated, but the main focus is on the current methods em ployed by biologists at SCRI and 
the strengths and weaknesses o f these techniques. These are examined in order to meet the 
first aim o f identifying the best way o f automating and enhancing the process o f information 
discovery for the biologist.
2.2. Existing Investigative Methods
2.2.1. Diagrammatic Modelling
M odelling is a key tool with which scientists develop an understanding o f the processes 
involved in cell signalling and their interactions (Lyon et al., 2002). B iologists use 
diagrammatic representations to illustrate and summarize molecular interactions between  
plants and treatments. Gene expression results from experiments where plants are exposed to 
various environmental stresses and pathogens (treatments) are used along with the biologists 
own knowledge and educated guesswork to “map” signal transduction pathways into diagram  
form.
An exam ple o f this type o f approach is used by scientists at SCRI where information from  
their gene discovery programmes has been manually collated into a spatial diagrammatic 
representation o f pathogen recognition in potato displayed below  in Figure 4. The diagram is 
created by analysing curated journal data and gradually adding/m odifying the diagram  
manually as new data is reported.
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Figure 4: Metabolic pathways of the diseased potato G. Lyon, SCRI.
The diseased potato diagram in Figure 4 shows the complexity of the plant’s response to 
infection but it also shows some of the responses which may not be so obvious when reading 
primary publications. Papers will report results to one or two specific treatments. When a 
plant becomes infected by a pathogen for example, it is likely that there will be many defence 
pathways triggered in respect to combination of stimuli such as the pathogen, the 
environment and the health of the plant. All these factors will have an impact on the end 
result of the defence response so it is useful to be able to look at the responses from an 
overall perspective rather than an isolated view. Figure 4 shows mainly the secondary 
metabolic reactions that the biologist has hypothesised to occur in a diseased potato. As the 
level of available data into early signally transduction has increased, this has enabled further 
research into which early signalling pathways are involved in mediating the metabolic 
reactions described in the above model. Figure 5 is the next step that the biologist has taken 
by modelling plant cell signalling in resistance and is the most relevant to this thesis.
The cell signalling diagram in Figure 5 demonstrates the complex defence mechanisms that 
may occur in primary signal transduction pathways when a plant is infected by a pathogen. 
Figure 5 highlights some of the different treatments that may come into play in addition to the 
pathogen as shown in box A and B such as jasmonic acid, arachidonic acid and salycilic acid 
among others. It has been created using the knowledge gleaned from a variety of papers about 
gene expression and then illustrated in an A->B->C pathway form built from hypotheses 
based from the literature along with the specialised knowledge of the biologist.
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Figure 5: Complex cell signalling in resistance diagram. G. Lyon, SCRI. Box A and B are enlarged areas of the 
diagram that show the way in which other “treatments’' may work together to create a signal cascade.
These data have been collated from results published in peer reviewed journals over a period 
of several years. The results of the experiments from various stress and pathogenic treatments 
have been manually examined and results added to the chart to build a potential overview of 
signal transduction cascades taking a systems biology overview. In contrast, many 
researchers are interested in a particular pathway or sub pathway due to the level of 
specialism required to study these areas and will use microarray experiments to identify 
gene(s) that respond to the treatment(s) that they are interested in. The cell signalling diagram 
is focused on signalling in resistance due to the nature of research at SCRI, but the thesis 
aims to broaden the scope of this and enable scientist to hypothesis on the defence 
mechanisms in plants to a wide range of treatments.
Both of these models are a good example of how new knowledge can be obtained by
assembling data from disparate sources visually. They were assembled to assist in
understanding the complex biochemical changes that can take place in diseased plants, but as
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a wall chart they are fixed both spatially and temporally. Whilst the charts themselves are 
useful they still only touch the surface of making the information within them readily 
accessible and more importantly, more easily understood by non-specialists. To exploit the 
power of IT, ideally the information it contains should be stored in a database and drawn on 
demand from a set of queries.
To create these charts, in addition to the curated data, the scientist uses additional personal 
knowledge when sifting through results which is very specific to the specialist area that 
he/she has worked in. It is not possible to replicate this level of data in a database for a 
generic structure and so for a system to be useful it must take advantage of the gene 
expression data and also the processes the scientist uses to piece this data together. For each 
paper, experimental methods and results are well documented but there is no description in 
the literature of the cognitive process that the biologist uses when deciding which genes to 
investigate or where these may be placed in a pathway. In order to better understand this, a 
case study was made by observing and questioning the biologist on the steps they took when 
considering how to search for new data and where the results fit into the hypotheses the 
biologists has or will make.
2.2.2. Gene Expression Profiling Analysis
Gene expression profiling studies followed by functional analysis of genes altered in 
expression has revealed unexpectedly complex interactions between plant signalling 
pathways (Walters e t a l ,  2007). Microarray analysis has enabled biologists to move past the 
limitations of understanding single processes such as examining the behaviour of an 
individual transcription factor in plant defence. Instead researchers are looking at how a 
single component of a pathway interacts with other components of the same or different 
signalling pathways and how this interaction contributes to the plant as a whole taking more 
of a systems biology approach. Two examples of the type of results that microarray 
experiments can provide are described in papers by Seki e t a l  (2002) and Shenk e t a l  (2000). 
Seki e t a l  (2002) investigated the expression pattern of lO O O A.thaliana genes under ABA 
treatments using microarray technology with the aim of identifying genes induced by 
environmental stimuli or stress and to analyse their expression profiles in response to these 
environmental signals. They used microarray experiments to test these genes with no
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treatment, ABA, cold, drought and sodium chloride. They identified that there were genes 
that were induced by several of these treatments and deduced there is crosstalk between these 
treatments within the signal transduction pathways. This was discovered by comparing genes 
that were up or down regulated by more that five fold compared to the control set and then 
identifying genes that were regulated by one or more of these treatments.
Shenk e t al. (2000) investigated changes in the expression patterns of 2,375 selected genes 
from A .th a lia n a  after inoculation with an incompatible fungal pathogen A lte m a r ia  
b ra ss ic ic o la  or treatment with the defence-related signalling molecules salicylic acid, methyl 
jasmonate, or ethylene. They found that disease resistance, associated with a plant defence 
response, involves an integrated set of signal transduction pathways. Data analysis revealed a 
surprising level of coordinated defence responses, including 169 mRNAs regulated by 
multiple treatments/defence pathways. The largest number of genes co-induced (one of four 
induced genes) and co-repressed was found after treatments with salicylic acid and methyl 
jasmonate. In addition, 50% of the genes induced by ethylene treatment were also induced by 
methyl jasmonate treatment. These results indicated the existence of a substantial network of 
regulatory interactions and coordination occurring during plant defence among the different 
defence signalling pathways, notably between the salicylate and jasmonate pathways that 
were previously thought to act in an antagonistic fashion.
Hein e t a l  (2004) investigated regulation of bm i sequences using salicylic acid, methyl 
jasmonate, ethylene, H2O2, abscisic acid, wounding and a glucan elicitor. They found no 
single stimulus up-regulated all genes, suggesting either combinations of these stimuli, or 
additional stimuli, are involved in characterisation of early transcriptional changes involving 
multiple signalling pathways. Whereas H2O2 up- or down-regulated 17 of the transcripts 
detected in Northern analyses, salicylic acid stimulated only down-regulation of 5 transcripts. 
These are examples of the type of deductions that can be made when presented with data 
about multiple treatment stimuli.
There are many papers that present data comparing gene expression data from several 
treatments and hypothesising on signal transduction pathways based on the results. If all the 
data from these experiments could be compiled and tools were available to compare 
treatment sets to identify genes that respond similarly to treatments could this enable 
biologists to generate new hypothesis for plant defence signalling pathways?
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2.2.3. Protein-Protein Reactions in Pathways
An alternative option to com piling gene expression results for investigating plant 
transduction signalling is to track the protein cascades by matching gene protein reactions. In 
the same way as enzym es can be tracked by matching the product -> substrate reactions and 
linking pathways using a backtracking search, if  known, the protein -  protein reactions could  
be constructed using this manner.
2.3. Problems with conventional methods
The diagrammatic m odelling approach was a reasonably successful method until the advent 
o f microarray data. Up until this point, biologists were dealing with papers where only one or 
two gene expression results were reported per paper.
When microarray technologies becam e w idely available, this could yield 22000 results per 
paper. Even if  only 15% o f the results reported are relevant to signalling, this is an im possible 
number o f results to manipulate without the aid o f some computing assistance. Microarrays 
profiling analysis techniques are extrem ely powerful but it is frequently difficult to infer 
which biological pathways are activated given a list o f differentially expressed genes. The 
biological outcome o f a differentially expressed gene is dependant on the simultaneous 
activation o f many more gene products and current knowledge o f these dependences and 
interconnections between biological pathways is incomplete.
Other problems biologists identified with the current m odelling methods are:
1. Up-dating (and adding new information) is slow and laborious.
2. There is no temporal dimension within the diagram - N o account is taken o f time or 
‘dose/amount’ o f response and the dynamics o f the interaction are very poorly 
represented.
3. It is difficult to incorporate information on differential induction o f certain genes in 
different plant tissues (e.g. roots vs. leaves).
4. The importance (and interdependence) o f proteins in different intracellular locations is 
sometimes poorly conceptualized.
5. It is not possible to draw separate diagrams for each agonist/response as it w ould be 
too time consuming.
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6. It is difficult to indicate the source of information i.e. whether it is derived from 
Arabidopsis or another plant, or whether it is from another eukaryote, nor the source 
of the publication.
7. It may include varying degrees of uncertainty (‘informed guesses’) that other 
scientists may find inappropriate or are wrong (by virtue of having not taken into 
account some other published information).
8. It is difficult to add information on ‘unknown’ ESTs.
9. It is not possible to interrogate a diagram.
10. It is not possible to add to the diagram ones own personal or unpublished data.
The process of how biologists deduce pathways is not clear and understanding this will 
provide insights for the development of a new system. A case study was undertaken to 
observe the biologist during the manual curation and assimilation of gene expression results.
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2.3.1. Case Study: A workflow of a typical system is shown in Figure 6:
Observations Outcomes
Figure 6: Workflow for signal transduction analysis
This problem can be split into two models -  Curation of Data and Data Analysis as described  
below:
2.3.2. The Search and Selection of Journal Papers for the inclusion of data to the DRASTIC 
database workflow
Several journal databases are searched in order to find relevant journal papers for research. 
The primary database used is the PubMed database 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed) which is a service provided by the 
U .S. National Library o f M edicine that includes over 18 m illion citations from M EDLINE  
and other life science journals for biom edical articles. PubMed includes links to full text 
articles and other related resources and is used to search for papers that may contain gene
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expression data that can be used. This is searched on a daily basis using the text strings “plant 
microarray”, “Arabidopsis”, “Potato”, and sometimes “Rice” and “Barley”.
Each of these searches produces a list of papers which are further sifted based on the contents 
of the title and abstract of the paper. The papers are only accepted to the next stage if they 
contain data pertaining to gene stress responses and the paper is from a journal with a high
impact factor to ensure high quality data.
Figure 7: Workflow of paper curation
The papers that are not rejected from this preliminary sift are printed out in full. They are 
individually reviewed for suitability of data inclusion. The curator is looking with the “eyes 
of a referee” to ensure that the data is of a high quality. The criteria for this quality check are 
that the paper must contain enough experimental data and must include accession numbers 
for each result. Because the biologist is focussed on stress responses, to be included, the 
results discussed in the paper must relate to early responses (ideally < 1 hour or in the case of 
pathogens 12-24hrs after inoculation) as these would be more likely to yield information 
associated with signalling.
If the paper meets all of the criteria it is accepted for inclusion. All the gene expression 
results that are found to be ‘up’ or ‘down’ regulated in each paper are included; there is no 
selection of genes made by the investigator regardless of their field of interest as this could
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bias the data. Because of the time constraints caused by the manual input of the data, ‘no 
change’ data is not included when looking at microarray results.
Data Analysis of the curated data
The analysis model is much harder to define as it is not a transparent process. The observed 
process workflow from Figure 7 gives no clues as to the type of questions or rules that the 
biologist uses when analysing the data and it is difficult to relate how the actual data from the 
paper is converted to the cell signalling diagram.
Strategic knowledge is related to the process by which scientists use the data to construct 
models and generate hypotheses. In other words, gain new understanding as opposed to 
simply gathering the facts. These processes or strategies are not always immediately obvious, 
even to the scientists themselves, and careful, structured research is required to elicit them.
2.4. Elicitation of Requirements
The requirements that the biologists have for the system were elicited using semi-structured 
interview techniques and observation. Previous work carried out under a Carnegie grant 
demonstrated that by linking these results to a web search page on a simple database, 
knowledge could be elicited that would previously have been opaque to the biologist. A 
database approach would seem to resolve a number of the problems identified with the 
conventional approaches used to tackle the problems of analysing the gene expression data. 
(Lyon e t al., 2002).
In addition to the database, a system is needed to allow the biologist to interrogate the data 
and build on the model building strategies used to date. Such systems must maintain the 
stimulation of exploration and hypothesis formation of the current manual methods, while 
adding the precision and ease necessary for integration across diverse knowledge sources. 
Importantly, they must retain the links to the underlying data so that the source, quality and 
reliability of the data can be checked easily. There are several aspects to consider when 
designing a system that includes scale, scope and complexity of the data, the variability in the 
level of detail available, in the spatial and temporal expression of genes and in the reliability 
of the data, as well as differences in the language used to describe such observations.
A diagram for the requirements of the system is shown in Figure 8 and should incorporate:
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• Structured database with interface to enable easy data input for all types of 
experimental results
• Quality/validation data checks and facility to update the data
• Set of web based tools to enable the biologist to intelligently query the data to 
formulate hypothesis.
Figure 8: System Diagram
In order to identify the actual tools that the toolbox should contain, prototypes of potential 
systems were designed to try and capture the type of questions that the biologists were asking 
of the data. The toolbox should act as a knowledge support tool that will enable them to ask 
questions in an appropriate manner that will facilitate them to access the relevant data in the 
system that could be useful to them.
During the case study, the main questions that the biologist evaluated when interrogating 
their results are listed below and were identified as key elements to be built into the toolbox:
1. Co-regulation of genes - If two or more treatments regulate a gene then the genes may 
share a signalling pathway.
2. Gene regulation patterns - If a gene shares a similar regulation pattern to another gene 
then they may be adjacent to each other in the pathway.
3. Regulation types - Within a pathway, a treatment should either up-regulate or down- 
regulate all genes. If this does not happen, this could indicate a quality control issue or 
crosstalk in a pathway. This type of result is of great interest as if crosstalk is involved 
this may indicate a method of switching on/off a particular pathway. For example in 
Figure 9, if a pathway exists between A->B->C->D where C is up regulated, is C up 
regulated as a result of A->B->C->D, or is there an alternative pathway that involves 
C?
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Figure 9: Crosstalk in pathway example where the letters represent genes in a signal cascade pathway.
4. Determine the number of treatments that regulate each gene - Genes that are only 
regulated by one treatment may be early in the pathway. Genes regulated by many 
treatments may be later in the pathway.
5. Grouping of treatments according to similarity of the expressed genes -  This may 
indicate the total number of pathways.
2.5. Summary
The modelling methods and gene expression studies described in this chapter yield results if 
taken as isolated pieces of research. But, if these gene expression results can be collated into 
one system it will enable researchers to take a systems biology approach by curating data 
across the whole of the plant and may provide new insights into the signal transduction 
mechanisms of plants. At the moment, efforts to collate enough data to be of use are severely 
hampered by the sheer scale and time of the manual task and the lack of format from the 
analysis point of view. There are areas identified in the case studies that may be able to be 
automated and this is an opportunity to develop a data model and analysis tools that would 
assist with the hypotheses formation for signal transduction pathways which is investigated in 
Chapter 3.
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Chapter 3 Opportunities for Automation
3.1. Introduction
Chapter 2 describes how and why the biologist has collected the data. Computing has 
historically been used to automate tasks and there would appear to be an opportunity to do 
this here. Manual curation of the data from journals as described in case study section 2.3.2 is 
extremely time consuming and inefficient. The data is not stored in a uniform manner and 
therefore computational data analysis is near impossible. Database techniques and data 
mining are standard solutions when considering automation of data collection and analysis of 
data. There is currently no database that is specifically designed to collect or enable the 
analysis of plant defence response gene expression, however, databases are commonly used 
as a means to hold gene expression and associated data. This chapter will focus on the second 
aim of reviewing existing databases and software in the public domain that hold data relevant 
to this project or data mining tools. This will establish if there are any other potential sources 
of data that can be used in conjunction with the collated data and will provide an overview of 
how others have tackled the analysis of gene expression data.
3.2. Automation and Databases
A  major problem that biologists are encountering is the overload of data. (Tian et al., 2002). 
With new data being published in journals and databases on a daily basis, and each of these 
data consisting of hundreds of thousands of data points, it is not possible that the biologist 
can manually search and capture this data let alone identify relevancy, quality check the data 
and then manually input it to a data sheet before analysing and maintaining it. The required 
data is not readily available and can be found from different sources, in different formats in a 
non standardised manner and this is a key challenge for automation opportunities. Chapter 3 
will investigate what tasks can be automated and how the power of computing can be applied.
3.3. Data Sources
Technology advances in the last few years have had a significant impact on the techniques 
used in signal pathway analysis for defence mechanisms in plants. Scientists have had to 
adapt from dealing with one or two data points from experiments to thousands of data points.
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The increasing precision with which the spatial and temporal expression of genes can be 
observed concurrently provides vital, additional data. For example, genes that respond in the 
early stages of an experiment may indicate that a gene is primarily associated with signal 
transduction from those that are involved in secondary metabolic responses. The project aims 
to sift through the large amount of data and discover more about signalling pathways with the 
dataset that is generated. Rensink and Buell (2005) reviews plant genomics trends for 
microarray expression profiling resources and identifies that currently, plant gene expression 
data are scattered and stored in multiple databases, often separated between species, which 
inhibits cross-species comparisons and functional discovery.
This project endeavours to develop a data model suitable for collecting gene expression data 
from multiple plant species to investigate signal transduction. Plant diseases and defences 
have been extensively studied and a wealth of data already exists. These data suggest 
significant commonality in key signalling pathways and regulatory networks between plant 
species and between plants, animals and microbes (Hammond-Kosack and Parker, 2003). 
Potentially generic solutions to some of the most important food-crop diseases could be 
found from these networks and pathways, if suitable tools to mine value from them, able to 
cope with large and diverse datasets were widely available.
Before any analysis can be done, the data must be collated into a suitably sized dataset. 
Creating a generic database for the data is not straightforward and this chapter provides a 
review of existing relevant gene expression for both data content and structure.
The pace of technological advancement in this field is rapid and with this in mind, the 
reviews of the databases and tools considered here are reflecting the position that they were at 
the commencement of the project with Chapter six examining the enhancements and 
discoveries during the project and the impact theses have made with regards to knowledge 
discovery for plant signalling pathways.
3.3.1. Journal Data
Chapter two finds that the biologists require the information from journals as well as the data 
set to enable them to gain value from the data. Masys (2001) finds that there is a rich source 
of computer-interpretable information in published literature that describes genes and their
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functions which can assist in the interpretation of gene expression patterns confirms this 
method.
The case study in 2.3.2 shows that the biologist searches for papers that hold new gene 
expression data relevant to this project. If the biologist is interested in a specific stress 
response such as “cold” or a particular plant species, journal databases such as Pubmed, 
science direct and ingenta provide a good selection of journals that are returned from a text 
search. The searches are designed on a text based structure and do not return useful results if 
an accession number or an AGI or other unique identifier is entered. This makes it difficult to 
search for additional gene expression data points using just journals alone.
Text-mining is a huge field in itself and much progress is being made in attempting to 
automate text processing which may facilitate such a search. One very interesting example of 
this is pubgene.org (Aubry e t a l ,  2006). Pubgene is designed to accept a gene name or 
identifier and it searches through Pubmed and finds literature articles where the gene is 
mentioned. It identifies genes that are related in the same article and builds a literature 
network, an example of which is shown in Figure 10. This enables the user to discover links 
in genes that would not be obvious by just looking at one article. The software was developed 
in response to the large amount of literature that is published and aims to enable researchers 
to identify links between genes that they may miss by simply reading through manuscripts. 
Gene and protein names are cross-referenced to each other and to terms that are relevant to 
understanding their biological function, importance in disease and relationship to chemical 
substances. Pubgene holds a number of known versions that the gene name is referred to as 
shown in Figure 10 and it is this non-uniformed manner in which genes and proteins that are 
referred to that is one of the key issues involved in gathering results from the literature.
F igu re 10: E x a m p le  o f  P u b G en e  L iterature N e tw o rk  for A. thaliana g e n e  A t5 G 5 2 3 1 0
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The reason for highlighting this particular tool is while it is much more successful that the 
standard text search provided by pubmed, it is still very difficult to quickly identify 
secondary data such as gene expression results which may be hidden in the journal body 
using text-mining processes and therefore some relevant articles will not be retrieved. In the 
example of gene A t5G 52310, this projects’ database holds over 70 journal papers that include 
gene expression results for this gene whereas Pubgene has identified only 9. Additionally, 
while these tools are capable of returning a good selection of relevant journal articles, there is 
no tool that can strip the gene expression results from the article that this project is interested 
in and the journal articles must still be manually retrieved and examined. The next step to 
investigate the possibility of increasing the amount of data for this project is by reviewing the 
main web resources and investigating if there is any suitable data stored there.
3.3.2. Data Standards
Prior to examining alternative database data sources, it is important to evaluate what 
standards exist for the data content and format as these will be relevant to the development of 
the data model.
3.3.2.I. Microarray Data Content Standards
Minimum Information About a Microarray Experiment (MIAME) is a set of guidelines that 
describes the data and metadata that authors should provide in order to reproduce individual 
microarray experiments. The M IAM E document was first described in 2001 (Brazma et al.,
2001) and is a standard that helps define the level of detail that should exist. M IAM E 
compliance is fast becoming necessary in order to publish or submit microarray data to the 
majority of journals and public repositories.
There are six elements that contribute towards M IAM E and these are listed in Table 1
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1. T h e  raw  data for ea ch  h y b r id isa tio n  e .g . C E L  f ile s
2. T h e  fin a l p ro c e sse d  (n o rm a lise d ) data  for  th e se t  o f  h y b r id isa tio n s  in  the ex p er im e n t (s tu d y ) (e .g .,  
the g e n e  e x p r e ss io n  data m atrix  u sed  to  d raw  the c o n c lu s io n s  fro m  th e stu d y)
3. T h e  e s se n tia l sa m p le  an n o ta tio n  in c lu d in g  ex p er im e n ta l fa cto r s  and th eir v a lu es  (e .g .,  co m p o u n d  
and d o s e  in  a d o s e  re sp o n se  ex p er im e n t)
4 . T h e  ex p er im e n ta l d e s ig n  in c lu d in g  sa m p le  data re la tio n sh ip s  (e .g .,  w h ich  raw  data  f i le  re la tes  to  
w h ic h  sa m p le , w h ich  h y b r id isa tio n s  are tech n ica l, w h ic h  are b io lo g ic a l  rep lica tes)
5 . S u ff ic ie n t  an n o ta tio n  o f  th e  array (e .g ., g e n e  id e n tif ie r s , g e n o m ic  co o rd in a te s , probe  
o lig o n u c le o tid e  se q u e n c e s  or r e fe ren c e  c o m m e rc ia l array c a ta lo g u e  num ber)
6. T h e  e sse n tia l laboratory and data p r o c e ss in g  p r o to c o ls  (e .g .,  w h a t n o rm a lisa tio n  m eth o d  h as b een  
u sed  to  ob ta in  the fin a l p r o c e sse d  data)
T a b le  1: S ix  cr itica l e le m e n ts  that co n tr ib u te  tow a rd s M IA M E
Of the six required M IAM E elements listed in Table 1, points 2, 3 and 5 are very important 
for this project. The gene expression matrix (2) is required as the data may need to be pre- 
processed in order to be analysed. The experimental factors and values (3) are extremely 
important as the focus is on experiments which are treatment vs. control therefore the 
experimental treatment information is vital and sufficient annotation of the array (5) ensures 
that the author provides enough detail to identify the gene(s) the experiment refers to. When 
considering data sources, it would seem prudent to ensure that only M IAM E compliant or 
pre-2001 data is included. Importantly, M IAM E does not specify a particular format for the 
data; it only provides guidelines for the content of the data. This is a weakness as obviously 
the data are more usable if it is encoded in a generic manner to enable the data to be easily 
accessed.
3.3.2.2. Microarray Data Exchange Standards
In response to the lack of format for the data requirements that the M IAM E guidelines 
suggest, The Microarray and Gene Expression Data (MGED, 2007) society began to work on 
the standardization of the representation of gene expression data and relevant annotations 
(http://www.mged.org). M AGE, which consists of three parts, The Microarray Gene 
Expression Object Model (MAGE-OM), an XML-based document exchange format (MAGE- 
ML), which is derived directly from the object model, and the supporting tool kit MAGEstk; 
and MO, or MGED Ontology, which defines sets of common terms and annotation rules for 
microarray experiments, enabling unambiguous annotation and efficient queries, data 
analysis and data exchange without loss of meaning.
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3.3.3. Microarray Data Repositories
There are many public sources of gene expression data from full text journal article resources 
and databases discussed in 3.3.2 such as Pubmed, Ingenta and Science Direct which index 
journal articles to a more direct source of gene expression data found in Microarray 
repositories. These are databases which can be accessed via a website and encourage 
researchers to submit their gene expression experiment results thus enabling all scientists to 
access this pooled data. There are several of these repositories, but the key repositories 
considered here are the Gene Expression Omnibus (GEO) database, European Bioinformatics 
Institute (EBI) ArrayExpress database and species-specific resources, such as NASCArrays 
database. These repositories typically store data for download and later analysis and are 
intended to act as central data distribution hubs, not to replace gene expression databases that 
are constructed to facilitate particular analytic methods or comparisons.
3.3.3.1. National Centre for Biotechnology Information Database
The National Centre for Biotechnology Information (NCBI) hosts the GEO database which is 
a public repository that archives microarray and other forms of high-throughput data 
submitted by the scientific community. In addition to data storage, a collection of web-based 
interfaces and applications are available to help users query and download the experiments 
and gene expression patterns stored in GEO (Barrett et al. 2006). GEO’ s aim is to provide a 
central data distribution hub which acts as a general provider of gene expression for all 
scientists to use. The only restriction for microarray submission to GEO is that the data must 
be M IAM E compliant.
GEO holds data on multiple organisms, but at present there are very few plant data sets. Of 
those that exist, the plant datasets tend to be mutant gene knock out experiments or time 
sequence experiments and these are not suitable for the purpose of this project which requires 
treatment vs. control arrays on wild type plant species. The database contains mathematically 
comparable data but for the treatment vs. control experiments, the data would still have to be 
pre-processed to identify genes that have responded to early signalling events.
3.3.3.2. European Bioinformatics Institution (EBI) -  ArrayExpress
The European Bioinformatics Institution (EBI) host a database called ArrayExpress which is 
a public repository for transcriptomics data aimed at storing M IAM E compliant data in
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accordance with MGED recommendations. The ArrayExpress Warehouse stores gene- 
indexed expression profiles from a curated subset of experiments in the repository, (EBI 
Website).
E B I’ s focus is on creating a database that has strict standards with regards to data content, 
data format and data transfer (submission and download from database).
(1) To serve as an archive for microarray data associated with scientific publications 
and other research,
(2) To provide easy access to microarray data in a standard format for the research 
community, and
(3) To facilitate the sharing of microarray designs and experimental protocols.
The ArrayExpress database is at the centre of a wider microarray informatics system at the 
EBI (Brazma et al., 2003), which also includes the experiment annotation/submission tool 
MLAMExpress, data transfer pipelines from other (external) databases and tools, and the 
online data analysis tool Expression Profiler (Kapushesky et al., 2004). Experiments are 
biologically related logical groupings of raw and processed data together with annotation of 
biological samples, the material treatment and data processing steps. Often an experiment 
corresponds to a particular publication. This initially sounds very promising, but the only 
restriction on the type of microarray data that they will accept is that it must conform to 
M IAM E guidelines. A  lot of the data are unsuitable for this project as again there is very little 
plant data and many different types of experiments for the more sparse plant data that it 
holds.
3.3.3.3. Nottingham Arabidopsis Stock Centre (NASC) - NASCArrays
NASCArrays is the Nottingham Arabidopsis Stock Centre's (NASC) microarray database. 
The majority of the data stored is for A.thaliana experiments run by the N A SC Affymetrix 
Facility. All data from the NASC Affymetrix service is made available to the public via the 
NASCArrays database. The structure of the database is not described in the literature and the 
database schema is not available but it is possible to download all of the experimental data. 
The data is provided by means of a subscription service called Affywatch which can be freely 
downloaded via a web interface or via a paid service whereby the experimental data is sent on
CD. Each of the experiments provide data about the purpose of the experiment, C EL files of
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the absolute experimental values and excel files of the normalised experimental values in 
accordance with M IAM E guidelines.
For the purposes of this project, NASC houses the largest collection of gene expression data 
that is suitable for this project as all the data is all for Arabidopsis thaliana has been 
normalised in a unified manner and contains data that relates defence response in plants that 
is available from one source. Again, there is a large variation in the aims of each experiment 
but the NASC database contains the most data on plant gene expression from treatment vs. 
control experiments.
From the subscription to Affywatch 1, approximately 25 experiments were identified as 
suitable, each which contain either 7000 or 26000 gene expression results. With the 
expectation of continual releases of data along with results from the AtGenExpress Project 
which is a multinational effort designed to uncover the transcriptome of the multicellular 
model organism A. thaliana funded by the German Arabidopsis Functional Genomics 
Network (AFGN), this initially seemed to be a very interesting option for increasing the 
amount of data. Work was carried out to determine the feasibility of automating the 
processing of data to enable the gene expression results to be collected and processed for this 
project.
3.3.4. Data Source Discussion
The databases described above are the main large scale microarray databases. There are many 
smaller databases but these tend to provide very specific data relevant to individual research 
groups and there were none that were suitable for this project. In order to include gene 
expression data to the project there are several requirements:
- The data must be from wild type species.
- It must be a treatment vs. control experiment that would elicit a defence response from a 
plant.
- It must be early from a temporal sense, ideally 0-4 hours after the treatment is applied in 
order to capture early signalling events
There must be evidence to support the quality of the experiment for example peer- 
reviewed results.
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In all of the reviewed databases, the treatment vs. control was the experiment type that 
appeared the least. For the project, there is a requirement to obtain a lot of different treatment 
expressions for each gene in order to build up enough data to make comparisons between 
treatments possible. However, in each repository there is a large quantity of experimental 
data that scientists have carried out to investigate gene function. For gene function 
experiments, scientists tend to examine the results for one experiment and find genes that 
respond in a similar manner. They can, for gene function, consider different experiments in 
isolation whereas, for the results the project is looking for, many experiments need to be 
analysed together and ideally must have all the results for each gene vs. treatment to be able 
to get an overview of signal transduction. Rather that looking for genes that respond in a 
similar manner, we are looking for groups of treatments that make a group of genes respond 
in a similar manner. Due to this, it would be necessary for gene data to be curated from these 
repositories on a regular basis rather that a one-off. To establish the feasibility of this 
curation, the NASCArray Affywatch was used as a sample to investigate the automation of 
curation from NASCArray datasets into meaningful results that would be suitable for 
inclusion to the project dataset.
3.3.4.I. Case Study -  Curating NASCArray data
This case study describes the task of selecting appropriate experiments from the NASCArray 
database and curating them into datasets suitable for this project. The NASCArray database 
enables the user to browse each experiment and all the data content adheres to the M IAM E 
guidelines. The actual microarray value results from each experiment are stored in excel 
spreadsheets that can be downloaded to a local computer and then processed.
The format and content of the Excel Sheets has changed over time. The sheets from 
AffyWatch 1 are more difficult to process as they hold less information about each 
experiment in particular the probe data information is less. Figure 1 1  shows the Excel Sheet 
from one of the experiments from the AffyWatch 1 series. Table 2 describes each column 
heading.
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F ig u re  11: S creen  sh o t o f  e x c e l  sp rea d sh eet resu lts from  o n e  ex p er im en t from  A ffy W a tc h  1
E x c e l  C o lu m n  H e a d in g D e s c r ip t io n
S p o tID T h e A ffy m etr ix  ID  for the p rob e set
P robe N a m e T h e A ffy m etr ix  nam e for the p robe set
G en e  N a m e T h e nam e o f  the g e n e
D e sc r ip tio n D e sc r ip tio n  o f  the p rob e from  N C B I ’s N u c le o t id e  datab ase b ased  on the 
A c c e s s io n  N u m b er
P ro c ess D escr ip tio n  o f  the fu n ctio n  o f  the g e n e
U R L P ro v id es the link to lo o k  up the A c c e s s io n  N u m b er  for ea ch  probe from  
the N C B I ’s N u c le io t id e  d atab ase .
D e te c t io n  C all T h e d etec tio n  ca ll ( l= p r e s e n t ,  - l= a b s e n t ,  0  =  m arg in a l)
P V a lu e A  p -v a lu e  for the d e tec tio n  ca ll
S ig n a l N o rm a lised  s ig n a l v a lu e  for the probe set
S tats Pairs U sed T h e num ber o f  p robe pairs u sed  in the n o rm a lisa tio n
T a b le  2: C o lu m n  h ea d in g s  and d escr ip tio n  for the e x c e l  sp rea d sh eets  resu lts  from  the A ffy W a tc h  1 C D ’s
The change in the data quantity and complexity is demonstrated in Figure 12 which shows 
the excel spreadsheet of a set of results from Affywatch 3 and Table 3 which describes the 
columns from this updated format.
A | B C D E F G H 1 J K L M N 0 P Q R
GENEHAME GENE SYMBOL CHR START END STRAND DESCRIPTION
Heinekamp_1-1_control-shoot_Rep1_ATH1 
JRMA CDSLE NOO INTE GO Signal Detectiont PValue StatPairsUs*SdoHD IpROBENAIME-422664 26756J at A "G 3074C-- AT2G30740-_AIF 2 15-07 15-07 1 ATP binding / king 2238 1452 7 IPROi G0:C 64.93 1 0.01 11-422663 267563_at AT2G30730-’  AT2G30730-7AIF 2 1 E-»-07 1E-07 1 ATP bmding / king 1533 1017 6 IPROi GOT 1.55 -1 0.81 11-422662 267562_at At2g39670-M At2g39670-MinT- 2 2E-07 25-07 1 unknown protein 2664 1287 10 198.86 1 0 11-422661 267561 at AT2G455S0-" AT2G45S90-TAIF 2 2E-Q7 25-07 1 ATP binding / pro 2331 2331 1 IPROI GO:C 162.45 1 0 11-422660 267560 at AT2G45580-’  AT2G45580-TAIF 2 2E^ 07 25-07 -1 CYP76C3: heme I 2018 1667 4 IPRCi GOT 75 38 -1 0.15 11-422659 267559 at AT2G45570-' AT2G4S57Q-7AIF 2 2E-07 25-07 -1 CYP76C2; heme 1 2166. 1717 3 IPROi G0:C 9.S -1 0.53 11-422658 267558. at AT2G32700-" AT2G32700-TAIF 2 15-07 1E-07 1 unknown protein: 5369 2885 19 IPRCi GOT 184.91 1 0 11
-4226S7 267557 at AT2G32710-- AT2G32710-TA.IF 2 15-07 1E-07 1 KRP4 i KIP-RE LAI 2396 1411 3 IPROi GOT 41.29 -1 0.3 11-422656 267S56_at AT2G32810-' AT2G32810-TAIF 2 15-07 15-07 -1 BGALS; beta-gak 7195 3943 19 IPROi GOT 143.42 t 0 11-422655 267555_at AT2G32765- '  AT2G32765-TAIF 2 15-07 1E-07 1 unknown protein; 721 616 2 IPROi GOT 78.35 1 0.01 11-422654 267554 at AT2G32790-' AT2G32790-TAIF 2 15-07 1E-07 -1 ubiquitin ccnjugat 837 748 2 IPROi GOT 3.08 -1 0.7 11-422653 267553 s at Mo g^ne 522.57 1 0 11-422652 267552_at A72G3277C-" AT2G32770-TA* 2 1E*07 15-07 1 acid phosphatase 2440 2104 4 IPROi GOT 10.71 -1 0.33 11-422651 267551 at AT2G32780-" A-2G32780-_AIF 2 15-07 15-07 -1 cysteine-type em 3440 3252 3 IPROi G0:C 21.84 -1 0.43 11-422650 267550 at AT2G32800-’  A72G32800-TA1F 2 IE-07 15-07 1 ATP binding / pro 3101 3101 1 IPROi GOT 61.35 1 0.02 11-422649 267549 at AT2G32640-" AT2G32S40-T A IF 2 1E+07 15-07 -1 unknown protein; 3983 2126 17 G0:C 99.42 1 0 11-422648 267548 at A72G32660-’  AT2G32660-TAIF 2 15-07 15-07 -1 kinase/ protein bii 2354 2354 1 IPROi G0:C 28.12 0 0.05 11-422647 267547 at AT2G32670- ' AT2G32670-TAIF 2 IE-07 15-07 1 ATVAMP725; me 2457 1909 5 IPROi GOT 37.84 -1 0.22 11-422646 267546 at AT2G32680- ' A72G32680--AIF 2 1E+07 15-07 -1 kinase/ protein bii 2846 2846 1 IPROi GOT 11.4 -1 0.1 11-422645 267545 at AT2G32690-" AT2G32690-^AIF 2 15-07 1E-07 -1 unknown protein: 880 856 2 GOT 64.8 1 0.01 11-422644 267544_at At2s32720-I.t At2g32720-kllnT- 2 1E+07 15-07 -1 putative cytochrc 1435 405 3 154.94 1 0 11-422643 267543 at AT2G32730- ' AT2G32730-TA1F 2 15-07 15-07 1 unknown protein: 5677 3416 13 IPRCi GOT 231.77 1 0 11-422642 2€7541_at
— ta-acji -LCTC.ir, __ AT2G32750- ' A72G32750-TAIF 2 15*07 15-07 1 catalytic; exestes 1530 1530 1 IPROi GOT 16.64 -1 0.37 11
F igu re  12: S creen  sh ot o f  e x c e l  sp rea d sh eet resu lts from  o n e  ex p er im en t from  A ffy W a tc h  3
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Excel Column Description
S p o tID T h e  A ffy m e tr ix  ID  for  the p ro b e set
P ro b e N a m e T h e  A ffy m e tr ix  n a m e for the p ro b e set
G e n e N a m e T h e  n a m e o f  the g e n e , u su a lly  the A G I c o d e
G e n e S y m b o l T h e  A G I c o d e  for  th e g e n e
C h ro m o so m e W h ic h  c h r o m o so m e  th e g e n e  is  on
Start T h e  start p o s it io n  o f  the g e n e  on  the ch r o m o so m e
E nd T h e  en d  p o s it io n  o f  the g e n e  on  the c h r o m o so m e
Strand W h ic h  strand o f  D N A  th e g e n e  is  on
D e sc r ip tio n A  d escr ip tio n  o f  th e g e n e
M R N A L e n g th T h e  m R N A  len g th
C D S L e n g th T h e  len g th  o f  the c o d in g  seq u e n c e
N O O F E X O N S N u m b er  o f  e x o n s  in  the g e n e
InterPro T h e  IN T E R P R O  a c c e s s io n  n u m ber for  the p ro te in . T h is  is  a  d a ta b a se  o f  p ro te in  
fa m ilie s , d o m a in s  and fu n ctio n a l s ite s
G O T h e  g e n e  o n to lo g y  n u m b ers fo r  th e g e n e
S ig n a l N o r m a lise d  s ig n a l v a lu e  for the p ro b e set.
D e te c t io n  C a ll T h e  d e te c t io n  c a ll ( l= p r e s e n t ,  - l= a b s e n t ,  0  =  m arg in a l)
p V a lu e A  p -V a lu e  for  the d e te c t io n  ca ll
S tats P air U se d T h e  n u m b er o f  p ro b e pairs u sed  in  th e n o rm a lisa tio n
T a b le  3: C o lu m n  h ea d in g s  and d escr ip tio n  for  the e x c e l  sp rea d sh eets  re su lts  from  the A ffy W a tc h  3 C D ’s
The new format includes several new data types and is much easier to analyse because much 
more of the required data is there so there is no need, for example, to identify the gene AGI 
number as this is now provided.
With the majority of the releases of the Affywatch series, the excel sheets tend to change as 
more data is included or the format modified. This is a problem for developing software to 
automatically gather the excel data, process it and add it to the project database because if the 
underlying structure significantly changes on a regular basis, writing generic software is not 
possible. This highlights the changeability of both the data content and structure.
For the experiments that are suitable for inclusion, the data has to be further processed as 
each experiment is treatment vs. control so it is not the individual value results that are of 
interest but the difference in gene expression between the treatment and the control. In the 
NASCArray database, the results for the treatment and the control are presented in separate 
excel files. Both these files must be processed and once this difference is obtained, the fold 
value increase/decrease for each probe in the experiment needs to be calculated. It is now 
very common for experiments to have three or more replicates for quality purposes and this 
adds further complications for the calculating the fold value. There is no software available 
that automates this so a bespoke piece software has been developed for this case study.
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All NASCArray data is derived using Affymetrix Microarrays and the results from the 
experiment are calculated using M A S5.0 Software which is commercial software from 
Affymetrix. This provides call information, signal values and normalises the data so that it is 
possible to compare values across different microarray experiments.
The call information provides a Present (P), Absent (A) and Marginal (M) call for each of the 
probes on the microarray. A  present call indicates a probe that is considered as expressed, an 
absent call is considered as not expressed and probes with a marginal call are possibly 
expressed. Because there are two experimental results (the treated sample and the control 
sample) it is possible that a probe had a present call in one experiment and an absent call in 
another. To process the NASC data, consideration needs to be given as to how to use the call 
information provided. Table 4 lists the nine possible combinations:
C o n tr o l  C a ll T r e a te d  C a ll “ C o m b in e d ”  C a ll
A b sen t A b se n t A A
P resen t A b se n t P A
M argin a l A b sen t M A
A b sen t P resen t A P
P resen t P resen t P P
M argin a l P resen t M P
A b sen t M arg in a l A M
P resen t M arg in a l P M
M argin a l M arg in a l M M
T a b le  4: P o s s ib le  C a ll C o m b in a tio n s  fro m  N A S C  d ataset
Given the above combinations, the interesting expression data (for the purposes of signalling 
data), would be genes that have a combined call of AP, PA and PP. Genes that go from 
Absent in the control to Present in the treated set and vice versa indicate a definite change in 
gene expression. An increase/decrease in the fold value for a gene expression that has a 
present call in both experiments is also valid. A  gene that is A A  (Absent in both the control 
and the treated set) is not interesting as it simply means that the gene is not expressed in 
either sample so these can either be removed from the data set or treated as a no change 
result. In order to maintain quality, combined calls that have a marginal call in them should 
be regarded as “unsafe results” and removed from the data set.
Once the data rejected from the call result has been removed, the final task is to determine 
whether each probe’ s expression increased, decreased or did not change. This is decided by 
the fold value -  if it has increased or decreased by more than two fold then it is classed as up
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or down respectively with the remaining results are classed as no change. These were the 
final results that were included into a database for analysis.
3.3.4.2. Dataset Comparison
The number of results from this case study that were suitable for inclusion for the project 
were disappointingly low. Many of the experiments were rejected as they did not meet the 
criteria for the temporal or treatment conditions. Of those that were included, many results 
had to be disregarded as the quality of the call was ambiguous and so after much effort, there 
were few experimental conditions to compare and even fewer gene results that had a value 
for more that two of the conditions.
This case study demonstrates the problems that would be encountered when using microarray 
results from any of the databases described here. The software used for collation and 
processing would have to be modified continually and this is simply with results from one 
microarray method. The quality and fold factor decisions are ambiguous and user driven 
rather than peer reviewed which could introduce errors into the database and the final results 
are sparse with very few treatment conditions being available. Using the original method of 
collating journal data which has already had the data outcomes and fold cut-off values 
decided and reviewed would seem a sensible option.
3.1.4.3. Data Structure Comparison
The structure and accessibility of the NASCArray data did hamper the data collation as the 
data was only available via excel spreadsheets and the format was changeable. The structure 
that GEO uses to store the data is unconventional in normal database usage as it uses a 
primary and secondary database to handle the data. This is due to the different formats that 
microarray experiment results are presented in. This flexibility is largely attributed to the fact 
that tabular data are not fully granulated in the core database but instead are treated as plain 
text, tab-delimited tables that may contain any number of rows or columns. The primary 
database has no knowledge of these tab-delimited tables some columns reserve special 
meanings and data from selected fields are extracted to secondary databases and used in 
query and analysis applications, (Barrett et al., 2006). EBI differ again in that they are very 
focused on software interoperability which was very difficult in the case study of NASC and 
they focus on the M GED standards. The EBI ArrayExpress uses the M AGE (Microarray gene
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expression) object model (MAGE-OM) and M AGE markup language (M AGE-ML) to 
encode all M IAM E required information. The MGED ontology (Stoeckert and Parkinson, 
2003) defines sets of common terms and annotation rules for microarray experiments aiming 
to reduce ambiguous annotation and promote efficient queries, data analysis and data 
exchange.
3.1.4.4. Data Source Summary
As the NASC data has demonstrated, gathering data from public repository databases is 
difficult and determining how to calculate the quality of the data and decide if it is possible to 
compare is ambiguous. These problems stem from commercial vs. research data, lack of 
standardisation with format and structure and changeability of the data as technology and 
knowledge advances. This makes it difficult to adopt a current data model or structure. A  
proprietary data model that is built with consideration of the likelihood of future 
changeability must be developed and data for this project should continued to be curated from 
peer-reviewed sources until a uniform method of data collation can be identified.
3.4. Data Analysis Tools
There is a wealth of microarray data in existence and there are many different analysis tools 
available to assist biologists with various aspects of bioinformatics investigation. The number 
of review articles on gene expression technology exceeds the number of primary research 
publications in the field but there are a limited number of efficient publicly available tools for 
data processing and analysing in context of existing knowledge. This is due to the lack of 
consensus on how to compare results using different technologies and the number of different 
questions that biologists wish to ask of the available data (Bassett et al., 1999). This section 
investigates the characteristics and attributes of a selection of these tools that are used to 
examine gene expression data in order to assist in the development of analytical tools for this 
project. There are many software tools available ranging from commercial packages to freely 
available web tools. This section provides an overview of a selection of tools and the types of 
analysis they provide.
4 4
3.4.1. TAIR
Two very key plant resources that can be considered as knowledge bases are The Arabidopsis 
Information Resource (TAIR) and The Institute for Genomics Research (TIGR). TIGR is 
now part of the J. Craig Venter Institute and houses plant genomics databases for several 
plant species.
TAIR provides a comprehensive resource for the scientific community working with
A.thaliana. TAIR is responsible for the annotation of Arabidopsis having taken this over from 
TIGR. TAIR does provide some microarray data but this is available in tab delimited format 
rather than a searchable database. However, the site does provide some very interesting 
generic tools that can be used with expression data. The tools selected for review are
•  Java TreeView: an open source, cross-platform gene expression visualization tool for 
interactive display of clustered microarray data, similar to Eisen's TreeView program. 
This uses hierarchical clustering algorithms to identify similar gene expression 
patterns across a microarray experiment and group these together in a dendogram.
•  AraCyc: Arabidopsis biochemical pathways visualization and querying tool. 
Visualisation tool that demonstrates how a list of genes can be transformed into a 
pathway. Due to the level of data available, this tool focuses on metabolic pathways 
but will be interesting to see how this type of technology advances with a view to 
adding temporal gene expression data to the pathways.
•  Chromosome Map Tool: provides chromosome maps of the Arabidopsis genome 
based on a list of Arabidopsis genes entered by the user. This is a generic visualisation 
tool that does not deal with gene expression, but enables a list of genes to be viewed 
on a chromosome map.
3.4.2. GEO
The GEO database enables users to mine the gene expression profiles using tools described 
by Barrett et al. (2006). The more relevant tools are:
•  Cluster heat maps, which enable the user to select from hierarchical and K-means 
clustering algorithms to investigate microarray experiments
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•  Query Subset A vs. B, which assists with the identification of genes that display 
differences in expression level between two specified sets of gene expression profiles
•  Subset effects is a feature that retrieves all experiments that are flagged as having a 
specific experimental type for example ‘age’ or ‘strain’
•  Profile neighbours: returns a list of genes that show a similar expression pattern 
within a given DataSet.
These tools enable the user to select datasets based on search queries, and allow the user to 
mine through the thousands of pieces of data to home in on experiments that may be of 
interest. These searches are very general in nature and in order to drill deeper into the 
experimental results, the user is required to download the experimental datasets of interest 
and manipulate the data themselves.
3.4.3. NASCArrays
The NASCArrays database that was discussed in section 3.3.3.3 has developed tools that can 
be used to analyse data in the database. The data mining tools consist of
•  Gene Swinger -  finds experiments that show high variability of a chosen gene,
•  Spot History -  Histograms of chosen gene,
•  Two gene scatter plot -  plots the signals of two chosen genes,
•  Bulk gene download -  enter up to 300 AGI codes and download the signal values 
over all experiments,
•  Super bulk gene download -  which is a file containing all genes over all experiments 
suitable for clustering.
The tools are aimed to provide scientists with a general overview of the data and enable the 
user to find information about a set of genes across all experiments, but there is no ability to 
be selective of the experiments included.
3.4.4. Genevestigator
The Genevestigator (Zimmerman e t al. 2004) tool is a data analysis tool rather than a data 
repository although it uses an in-house database of approximately 2260 microarrays to run
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the analysis tools from. It is much more specialised in that it has developed web tools 
specifically aimed to enhance gene function discovery for A.thaliana biologists and so has a 
more targeted audience than GEO or NASCArrays. Genevestigator uses the raw experimental 
Affymetrix microarray data from NASCArrays database and processes it to enable data 
analysis to be carried out in more depth that the NASCArray tools allow. The key tools that 
are provided via a web-browser are:
•  Digital Northern which retrieves the signal intensity values for up to 10 genes input 
by the user across a set of experiments again chosen by the user,
•  Gene Correlator allows the comparison of signal intensity values of two genes across 
chosen experiments and
•  Gene Atlas tool provides the average signal intensity values of a gene of interest 
across chosen experiments.
The output from these tools tends to be visual in the form of graphs or tables. Only data from 
one type of microarray can be compared and there is no linking data from the literature but 
the user can find the original experimental values and M IAM E data from the NASCArray 
database.
3.4.5. ACT
The Arabidopsis Co-expression Tool, ACT, ranks the genes across a microarray dataset 
according to how closely their expression follows the expression of a query gene (Jen et al. 
2006). The main tools used are:
•  Co-expression analysis over available array experiments which shows Pearson 
Correlation Coefficients for a probe selected by the user,
•  Co-correlation scatter plot (2-D Pearson Correlation Coefficients) which shows 
Pearson Correlation Coefficients for two probes and
•  Clique Finder is a tool to find clusters of closely-associated probes within the Pearson 
correlation coefficient ranked list for a given probe
The dataset is created from the same data as Genevestigator but has been processed 
differently and is again a data analysis tool rather that a repository. A  database stores pre­
calculated co-expression results for approximately 21,800 genes based on data from over 300
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arrays. A C T ’ s focus is to provide tools to enable users to analyse how gene expression 
changes with respect to all the other genes on the array and is again based solely on 
Arabidopsis data. The tool aims to demonstrate novel biological relationships underlying the 
observed gene co-expression patterns and enable the testing of hypotheses on gene function.
3.5. Data Analysis Discussion
From the above review it is shown that there are many different types of tools with different 
characteristics -  tools attached to repository databases, generic tools that can be applied to 
any dataset with a specific format, data mining tools, website based tools attached to in-house 
databases and visualisation tools.
3.5.1. Data Analysis History
Modern biology has shifted from "one gene" approaches to methods for genomic-scale 
analysis like microarray technology and in response to this, different analysis techniques have 
been developed in order to handle the new levels of data. Eisen et al. (1998) were 
instrumental in developing clustering methods and software that enable biologists to analyse 
thousands of data points and data mine for similarities. Statistical and data mining techniques 
are now extremely prevalent for the majority of tools including even web-based ones due to 
the increasing server processing power. As the available data increased, repositories and 
knowledge bases began to be created, curating data such as TAIR which offers a wide range 
of data about Arabidopsis with a variety of tools that the user can enter their own data into 
and GEO and NASCArrays which provide tools aimed at a general audience to simply 
provide a way of an overall sift through and download the data. Biologists began to embrace 
the potential of the available data and tailor tools to their own specialism, inducing an 
explosion of small tools that used pre-processed data from these repositories were developed. 
These tend to be very specific tools specialised for a particular biological area or species such 
as Genevestigator and ACT.
3.5.2. Data Analysis Characteristics
From the tools described, there are several common characteristics that are shared by a 
majority of the tools. The tools are web-based and interactive. They attempt to provide the 
biologist with a method of hypothesis testing and data discovery using data mining
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techniques and a large proportion of the tools use visualisation of data to enable the biologist 
to gain further insight to the results of their search.
3.5.3. Data Mining and Hypothesis Testing
The biologists use hypothesis testing to investigate signal pathway transduction where the 
investigator tests an idea against a body of data to confirm or reject its validity. This will 
commonly raise new questions that can be tested against the data. This type of software tool 
can be developed by identifying the common questions that biologists ask of the data and 
modelling these as demonstrated by the ACT tool.
In addition to this, a further goal must be to include exploratory analysis to find patterns in 
the data that are not predicted by the biologist’ s current knowledge or pre-conceptions. Data 
mining tools such as the clustering tools provided by GEO provide a method of achieving this 
by providing tools to facilitate large scale interpretation o f biological data in "batch" mode. 
However, such tools often leave the investigator with large volumes of apparently 
unorganized information and unable to further drill down into the data results. Genevestigator 
and ACT both use clustering methods to find genes that have a similar expression pattern to a 
selected start pool of genes. One key difference from the tools described here for this project 
is the data that the project is using will be binary values of either up or down. This will have a 
large impact on the design of mining tools as a large number of data mining tools work based 
on a numeric distance value which will not exist within this projects dataset.
3.5.4. Visualisation
Traditional formats of information presentation such as text and tables of data force human 
analysts into a harder mode of information processing by forcing humans to rely extensively 
on memory. Visualisation capitalises on cognitive strength as humans excel at processing 
visual data. Figure 13  shows an example of a list of gene expression results in tabular form. 
Figure 14 is a Venn diagram displaying the same data but showing the number of genes 
regulated by each treatment combination. The Venn diagram is much more informative and 
information can be collected at a glance rather than sifting through lists of gene expression 
results. This is one small example of how visulisation can produce an instant impact and it is 
a theme that will be given a high priority when designing tools for this project.
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Nome (Sene Name AccessionNumhei Regulation AGINumber TreatmentName Compatibility Genus and Species (Cultivai i
Refei ence
12-oxophytodienoatereductase AtOPR3 AVB24251; AV785462; AF410322 Up At2g06050
sodiumchloride non pathogen
Arabidopsis thaliana (cv Columbia) 107
12-oxophytodienoatereductase AtOPR3 AV824251;AV785462 Up At2g06050 sodiumchloride non pathogen
Arabidopsis thaliana (cv Columbia) 3341-aminocyclopropane-1- carboxylate (ACC) oxidase putative not known At2g19590 Down At2g 19590
sodiumchloride non pathogen
Arabidopsis thaliana (cv Columbia) 4721-aminocyclopropane-1- carboxylate (ACC) oxidase putative not known AM g12010 Down AM g12010
sodiumchloride non pathogen
Arabidopsis thaliana (cv Columbia) 4721-aminocyclopropane-1- carboxylate (ACC) synthase AtACS2
notavailable Up not available sodiumchloride non pathogen
Arabidopsis thaliana (cv Columbia) 4041-aminocyclopropane-1- carboxylate (ACC) synthase like not known At4g26200 Down At4g26200
sodiumchloride non pathogen
Arabidopsis thaliana (cv Columbia) 4722-isopropylmalate synthase-like; homocitrate synthase likenot available AV821148 Down At5g23010
sodiumchloride non pathogen
Arabidopsis thaliana (cv Columbia) 3342-isopropylmalate synthase-like; homocitrate synthase likenot available AV821148 Down At5g23010
sodiumchloride non pathogen
Arabidopsis thaliana (cv Columbia) 1072-oxoglutarate dehydrogenase, E1 not available BE844998 Up At3g55410 sodiumnhlnrirlo non pathogen Arabidopsis thaliana (cv 15
Figure 13: Sample of the 500+ data points shown in non-visual list format
Treatment 1: Treatment 2:ABA (abscisic aci<b: 202 salicylic ackl: 192
Treatment 3: sodium chloride: 254
Figure 14: Data shown in visual Venn diagram format
There are several creative uses of visualisation techniques from the tools from the powerful 
use of dendograms for hierarchical clustering of microarrays in the Java Treeview from 
TAIR to the simple chromosome mapping tool which converts a simple list of A . t h a l i a n a  
genes into a diagram which places them on a chromosome map. However, some of the web- 
based search tools described do simply produce results as lists of genes. In some cases this is 
due to the limitations that are caused by web technology but as shown, applying visualisation 
tools directly to the data enables the user to gain a deeper, faster understanding of the data 
and is an important consideration when designing tools. There are some new graphing tools
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being developed which aim to provide visulisation of pathway data. One such example of this 
is ArrayXPath (Chung et al., 2004) which takes existing pathways and maps gene expression 
data onto these pathways. While this is limited at present due to the lack of pathway 
templates for defense response signalling, as pathway knowledge develops, this technology 
could be an interesting companion to the DRASTIC database.
3.5.5. Web-based Delivery and Interactivity
Web-based software tools attached to an “ in-house” database is a popular model for delivery 
of software tools as it enables scientists to access the tools with no effort and no download or 
installation requirements. Ideally the data results from one query should be in such a format 
that these can be easily transferred into another query to promote interactivity. In practice this 
is very difficult due to formatting issues. One of the problems with microarray data is that in 
order for it to be analysed for a specific purpose, it tends to require pre-processing into a 
suitable format for purpose. ACT and Genevestigator in fact use data from the same source 
but the toolset is not compatible. Another issue with this type of set up is that the dataset 
tends to remain static and therefore does not reflect updated annotations and from a data 
mining point of view, once a query is run, the result will remain unchanged.
3.5.6. Data Tools Summary
Some of the current web-based services hold similar gene expression data from A.thaliana 
microarray experiments (but not other plant species) and enable the recovery of information 
for individual genes or gene sets such as NASCArrays tools, Genevestigator and ACT but 
they are aimed at different users or have different tools. Genevestigator and NASC focus on 
how expression of selected genes varies with respect to different tissues and experiments. 
ACT provides tools to enable users to analyse how gene expression changes with respect to 
all the other genes on the array.
These tools are interesting in that they provide comparative gene analysis services to detect 
clusters of genes with similar expression patterns across selected or the complete set of 
treatments. The downside to these tools is that they force the user to start with a given gene of 
interest to determine similarities in expression patterns to other genes. They do not enable the 
user to compare treatment selections and there is no capability to select combinations of
51
different treatments to determine all overlapping genes being up- or down- regulated by these 
treatments.
From reviewing the data tools, there are many potentially useful tools available but no 
specific toolset to provide investigators with a toolkit for investigating hypotheses for 
signalling in plants. There are some excellent tools that enable gene co-expression to be 
analysed but none that are multi-species with a specific dataset tailored for early signally 
defence responses, or that enable the user to select treatments or that provide links to 
literature resources and nomenclature.
3.6. Summary
Chapter 3 provides an overview of the type of existing tools and datasets that were current 
when the project began. There is no single direct data source that is suitable although some 
data may be extracted from multiple sources that have been examined in this chapter to 
complement the journal data. Collating and analysing data from multiple sources will entail 
studying the data and seeking to determine a generic model. SCRI scientists have expressed a 
wish to find a way to automate the connectivity between resources to enable data to be 
generically considered by a number of tools while maintaining a close link to the literature 
and the findings from this chapter would support this model. Chapter 4 investigates the data 
types to find a uniform system to enable the data sources in different formats to be analysed.
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Chapter 4 Exploring the Gene Expression Data
4.1. Introduction
Chapter 3 has found that there are no single direct data sources suitable for specific 
investigation of plant defence. There are, however, many results from experiments readily 
available in journal papers and some non-peer reviewed database sources as described but 
these are not provided in a standardised manner and this is a key challenge to the synthesis of 
the database. The first step in examining the data is to determine the type and format of the 
data available from peer reviewed sources, identify the different formats, nomenclature and 
annotations that may be encountered and construct a model that will be suitable to store data 
from a variety of sources and formats. Prior to the start of this project, SCRI had been 
collating journals that contained relevant gene expression data. These journal articles contain 
data from a variety of experiments in a variety of different formats and it is this diversity 
which can cause problems when trying to standardise data into a unified structure. The third 
aim is to examine the structure of data particularly from journals and make this more 
accessible. The fourth aim is to provide a method to enable results from different types of 
experiments to be compared against each other. This chapter investigates the different data 
structures and identifies the key elements that will be required to construct a model that is 
suitable to store the data relating to stress-response in plant genes from these different 
formats and in a configuration that will enable the data to be queried thereby assisting 
knowledge gain in the signal transduction area.
Unfortunately, published gene expression data is not uniformly presented, making truly 
systematic searching impossible. This is especially so for the vast amounts of microarray data 
emerging each month. Typically, unknown or poorly characterised genes cannot be compared 
with prior expression data, rendering up to 15%  of database entries valueless, clouding future 
interpretation and may impede biochemical and technological developments severely. Whilst 
part of this value paucity undoubtedly comes from the complexity of cell biology, changes in 
gene names associated with database accession numbers adds to the fog of confusion.
Gene and protein names are often flawed and misleading when naming conventions are not 
universally adopted and adhered to (Lyon et al., 2002). Value is effectively lost from datasets 
when the same gene is given different accession numbers in databases. A  single A.thaliana
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gene which has been shown to be down-regulated by chitin, drought, ethylene, low oxygen 
tension or sodium chloride environmental treatments and up-regulated by salicylic acid 
treatment has been given five different accession numbers by authors, all ultimately 
corresponding to the gene of unknown function, Arabidopsis Genome Index (AGI) code 
At2g 10940. This was determined after laborious tracking of identities and codes through the 
scientific literature and the virtual world. Since it is most unlikely that scientists will 
systematically search for such similarities for each and every gene studied, the resulting low 
quality classification of expensively acquired data means that elements of commonality or 
uniqueness will frequently fail to be identified. Hence reduced scientific value is being 
realised from complex experiments and potentially important conclusions fail to be drawn 
with respect to the control of growth, development and host/pathogen responses.
4.2. Nomenclature
4.2.1. Concept of a Reaction
The data that will be collected for the project is based on the model shown in Figure 15 which 
captures the basic concept of a reaction.
Reaction 
------------- ►Host + Treatment Gene Expression
Figure 15: Diagram of basic concept of a reaction
The study is aiming to collect stress response results from multiple plant species and 
therefore need to identify the data that will be required and how this will be collected to allow 
for a uniform data model to be built to hold and allow computational investigation of the 
data. In order to record the gene expression result, the gene that the result corresponds to 
needs to be recorded.
4.2.2. Historical Problems with Gene Name Nomenclature
Researchers are hindered by a lack of standard naming conventions for genes and proteins. 
The gene name is the form by which a protein object is referred to and communicated in the 
scientific literature and biological databases. There is a long standing problem of
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nomenclature for proteins where ‘profligate and undisciplined labelling is hampering 
communication as discussed in Nature Opinion (1997). Scientists may name a newly 
discovered or characterised protein based on its function, sequence features, gene name, 
cellular location, molecular weight or other properties as well as their combinations or 
abbreviations. The same protein is often named differently in different databases, and 
occasionally different proteins may share the same name. Only a small fraction of all proteins 
has standard nomenclature, most notably the enzyme nomenclature of the International 
Union of Biochemistry and Molecular Biology (IUBMB) 
www.chem.qmul.ac.uk/iubmb/enzvme.
A later study (Aubourg and Rouze, 2001) found that there is a clear lack of controlled 
vocabulary both in the literature and the databases. This problem is linked to sequence 
redundancy in the databases, which can contain several times the same genes under different 
names. The resulting loss in time for the search and the annotation is very serious. 
Furthermore, the multi-origin of the annotations amplifies the diversity of the nomenclature. 
For example, the American annotators name as ‘putative’ or ‘-like’ a function deduced from 
similarities, whereas the Japanese centre and MIPS use ‘potential’ and ‘similar’ , respectively.
With the advent of large genome sequencing projects, nomenclature has been a main focus in 
recent years. Concerning the problems of nomenclature, important efforts are in progress. 
The Gene Ontology consortium (http://www.geneontology.org) and the Mendel database 
(http://genome-www.stanford.edu/Mendel/) produce a reference vocabulary for the gene 
names and functions and a common basis for genome annotation. The Arabidopsis 
Information Resource (TAIR, http://www.arabidopsis.org/) is a central site for this model 
plant. The web site centralizes all the links towards Arabidopsis databases, research 
laboratories and annotation centres, and also displays regularly updated genetic and physical 
maps.
4.2.3. Standards in Gene Naming Nomenclature
As a result of the problems that non standardised methods of gene naming cause, standards 
for naming genes were introduced (Price et al., 1996) and curated by the Commission on 
Plant Gene Nomenclature. Naming conventions for gene families, gene symbols and gene 
products were standardised in a bid to reduce duplication of names and make them more 
meaningful. Efforts to improve the gene naming nomenclature have continued to improve
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and the biological community is moving towards a universal system for the naming of genes 
as described for a number of plants such as Arabidopsis (Schlueter et al., 2005), Tomato 
(Mueller, 2005), Medicagio (VandenBosch and Frugoli, 2001) and maize (MaizeGDB,
2002). In most plant species databases, a gene is identified by a name, a gene family where 
assigned and a gene symbol or synonym along with the EST and the corresponding 
Accession Number for EST which acts as a unique identifier for the EST. Having this 
standard information about all sequences is a huge step in the right direction, but this does not 
uniquely identify a gene but represents a sequence from a gene of which it is likely that there 
could be more than one for each gene.
In the plant research domain, A.thaliana is the model species of current plant genomic 
research with a genome size of 125M b and approximately 28,000 genes. The function of half 
of these genes is currently unknown (Lan et al., 2007). Arabidopsis was fully sequenced in 
2000 in a collaboration project that was headed by The Institute for Genomic Research 
(TIGR). In order to be able to uniquely identify each of the Arabidopsis genes a naming 
convention was required and thus A G I numbers were introduced (Haas et al., 2005).
4.2.4. Arabidopsis Genome Initiative Nomenclature
The Arabidopsis Genome Initiative (AGI) nomenclature allows for the designation of unique 
locus (gene) identifiers for Arabidopsis. The syntax of the AGI nomenclature is described 
below:
The format of the AG I numbers is in three parts:
Part 1 = The organism, in this case At -A.thaliana
Part 2 = The chromosome that the gene is found on (1-5 for Arabidopsis)
Part 3 = The gene id -  g followed by a five digit number
An example A G I is At4g 10020 which means that it represents a gene from A.thaliana found 
on the 4th chromosome and the gene id 10020. The fact that there is now unique identifiers 
for genes is a boon for bioinformatics as it allows direct comparison without the complication 
and potential errors that the previous systems have introduced. The unique identifier does not 
remove the need for the gene name (as this provides information about the function of the 
gene) or the gene symbol and it is wise to record the accession number of the sequence that 
was used in the experiment as this allows the investigator the opportunity to find the exact 
coding sequence used for each experiment.
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There are rules for adding new genes, deleting genes and editing genes so this means that the 
AG I numbers will not remain static and may change as annotations are updated. Locus 
history for each gene is available from the TAIR website so it will be possible to track 
historical AGI numbers and update these as required.
4.2.5. Gene Ontology (GO) Nomenclature
The Gene Ontology (GO) (http://www.geneontology.org/) project was established to provide 
a common language to describe aspects of a gene product's biology. The use of a consistent 
vocabulary allows genes from different species to be compared based on their GO 
annotations. The GO project started as a collaboration between three model organism 
databases, the Saccharomyces Genome Database (SGD), FlyBase (for Drosophila), and 
Mouse Genome Informatics (MGI). The GO Consortium has expanded considerably to 
include many additional model organism databases and annotation groups including 
Arabidopsis, each of which contributes to the development of the ontologies, generation of 
GO annotation files, or development of software tools to utilize GO depending on the nature 
of its affiliation. The GO annotation can be mapped to the AGI numbers and so can be 
included for any gene where the A G I identifier is known.
4.2.6. Gene Names Nomenclature Discussion
The Arabidopsis genome was the first plant genome to be systematically sequenced and 
annotated and a large proportion of the gene expression data contained in the curated journals 
is from Arabidopsis, but the database must be able to deal with data from multiple species to 
meet the requirements. The sequencing of the rice project was completed after Arabidopsis, 
and it adopted the Arabidopsis project as a model for the annotation of the rice genome 
(Aubourg and Rouze, 2001). The A G I number format transfers over to another species very 
simply. An example is Os03g44290 which is a gene from rice (Oryza sativa). It uses the same 
convention whereby Os represents the organism, the next numbers represent the chromosome 
and it is found on the 3rd chromosome and the gene id is 44290. This naming convention 
enables tools to be designed that are portable from one species to another.
Dealing with plant data from species that have not been fully sequenced or have not adopted 
the AGI format is not as easy. The only way to uniquely capture the gene is to record the 
Accession Number, the gene name and the gene symbol for each result reported. This will
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have an impact on the comparison prospects for these genes as a gene may be represented by 
multiple E ST ’ s and it may not be possible to identify which group of E ST ’ s represent a gene, 
therefore some of the gene expression data may not be fully transparent. For plants that do 
not have a unique gene identifier, maintaining an up-to date standardised gene name is 
imperative as this along with the gene code will be the unique identifier and this will be done 
through the use of Unigene as discussed in Chapter 3.
In summary, the main obstacles that will be encountered with gene name nomenclature are
1. Not all species have got a defined unique gene nomenclature. Arabidopsis has A G I 
numbers and this system does seem to be taken up by rice and possibly by barley. For 
those without gene identifiers, tracking results can be trickier and obtaining an accession 
number and gene name is vitally important in these cases to enable results to be tracked 
from journals.
2. Some genes are identified by an EST but the AGI reference may have been omitted or 
there is no unique identifier for the gene. There can be many E ST ’ s per gene and it can be 
difficult to track the AGI associated with the EST. The database must implement a 
method to track these genes and maintain up-to date data to increase the knowledge base.
3. There are problems when considering comparing data across species. At present the only 
method would be to blast accession numbers to find similar genes in different species. It 
is hoped that with the introduction of unique identifiers that genes which are similar from 
one species to the next can simply be mapped by the ID and this would enable more 
powerful queries to be run. At present, the bulk of data is from A.thaliana but it is likely 
that this will change over time, so considerations must be made as to the changeability of 
the data and the data structures when designing the database and tools.
4.2.7. Plant Name Nomenclature
The host is the plant on which the experiment is centred and there is strict nomenclature for 
cultivated plants (Brickell et al., 2004), which makes modelling the data straightforward. The 
requirements elicited from the biologist were that the family, genus, species and cultivar 
would be required from each experiment as well as the classification of plant-monocot or -  
d icot. The cultivar has been highlighted by the scientists as important as although most o f the 
experimental results that we anticipate collecting will be from wild type plants, some data
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may be obtained from genetically modified plants and it will be important to differentiate 
these. The Plant Ontology Consortium (POC) are involved in developing, curating and 
sharing controlled vocabularies that describe plant structures and growth and developmental 
stages, providing a semantic framework for meaningful cross-species queries across 
databases which may prove useful as results from experiments can often be from different 
parts of a plant and the biologists have expressed a requirement to log this (Ilic et al., 2007).
4.2.8. Treatment Nomenclature
Lastly, the ‘treatment’ referred to in this thesis is the method in which the stress response is 
triggered in the plant. These are classified into type categories of abiotic stress arising from 
an excess or deficit in the physical or chemical environment, such as heat stress or biotic 
stress imposed by other organisms, for instance the pathogen Pseudomonas syringae pv 
maculicola. For pathogens, a further requirement is the compatibility to the host plant. For 
each treatment the name and description are required along with the type classification. The 
gene expression result varies depending on the type of experiment platform used as described 
in the next section.
4.3. Types of Experiments
At present the collection of journal references, which will form the basis of the database data 
relate to approximately 57% Northern blot experiment results, 13%  Microarray results, 8% 
Reverse Transcription Polymerase Chain Reaction (RT-PCR) and 22% others. This 
demonstrates that gene expression results related to plant defence signalling are obtained 
using several types of experimental technique and based on the above findings, this project 
considers the primary methods to be Northern blotting, RT-PCR and Microarrays. The 
quality, type and quantity of results from each experiment category varies dramatically as 
outlined below.
4.3.1. Northern Blot
The Northern blot is the oldest technique and was developed in 1977 by James Alwine et al 
(Jackson et a l , 2002). mRNA fragments are probed with a labeled DNA probe after 
separation by electrophoresis and transfered to nylon membranes. Northern blotting is used to 
detect and quantify mRNA or the levels of gene expression from tissue extracts.
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While Northern blots have been superseded in most areas by RT-PCR and microarray 
approaches it is a widely accepted and straight-forward method and Northern blotting is often 
used as a confirmation or check of results produced by a microarray experiment (Holmes and 
Peck, 1998). This explains why there are such a high percentage of journal references that 
report Northern blot results. The drawback to Northern blotting experiments is that they are 
time consuming to set up, the number of steps involved creates more opportunity for error 
and they are low throughput where only one gene can be examined at a time (Roth 2002).
NaCl 
rRNA 
Mannitol 
rRNA
Figure 16: Example result from a Northern blot Experiment (Zhang e t  a l. 2007)
Figure 16 is a result from a Northern blot experiment that was published in the Plant 
Molecular Biology journal by Zhang e t al. (2007). In this experiment, one gene, namely 
TSRF1 from a tomato, was treated with sodium chloride (NaCl) as shown in the first 
horizontal line, rRNA was used as a control in the second line, TSRF1 was treated with 
Mannitol in the third line and the fourth line is another control experiment. Zhang et al. 
(2007) describe the experiment as “To further investigate the role of TSRF1 in plant abiotic 
stress response, we analyzed the expression of TSRF1 under osmotic stress conditions. 
Results showed that TSRF1 also responds to ionic osmotic stress caused by NaCl or nonionic 
osmotic stress caused by mannitol. As shown in Figure 16 above, the expression of TSRFJ is 
observed at the first hour, and got the peak at 5 hours after treatment with NaCl or mannitol, 
indicating the possible regulation of TSRF1 in plant osmotic stress response.” The results 
from Northern blots are generally reported as an up- or down- regulation of gene expression 
in journals although the quantitative increase or decrease in gene expression can be 
determined using a densitometer to assess the intensity of each result (Roth, 2002). When 
collecting data from a Northern blot experiment for inclusion to the database, the host (in this 
case L yco p ersico n  escu len tum  cv Lichun), gene (TSRF1 name, AF494201 Accession 
number), treatment in this case (Mannitol) and gene expression result (obtained from Figure 
16) must be collected. The temporal time is included in this experiment and should be
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recorded in hours as indicated in section 2.3 of the biologists requirements as this reflects the 
subject domain where the users are only interested in early stress responses. The gene must 
be able to be uniquely identified to be included and so it is important to look for EST 
accession references or a unique identifier such as an AG I where this exists. In this case, the 
gene name T SR F1 was the only identifier mentioned in the 2007 paper and the reader was 
directed to a prior 2004 paper. The later paper provided the Unigene accession number for the 
gene in question and this demonstrates the problems that exist with collation of results from 
journals.
4.3.2. RT-PCR
RT-PCR is an extension of the polymerase chain reaction (PCR) method. mRNA is extracted 
from the cells or tissue, converted to cDNA using the enzyme reverse transcriptase and PCR 
is then carried out.
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Figure 17: Example result from a RT-PCR Experiment (Lee e t al. 2001)
This method is used to detect the expression of specific mRNA sequences in cells or tissues. 
RT-PCR is widely used, quantitatively, in the determination of the abundance of specific 
different RNA molecules within a cell or tissue as a measure of gene expression. This 
technique is more sensitive than the Northern blotting technique and can detect levels of 
mRNA that would be missed using Northern blotting. (Holme and Peck, 1998).
Figure 17 is the result from an RT-PCR experiment (Lee et a l , 2001). The result is described
as “Treatment with harpin of cultured tobacco cells resulted in transcript accumulation of the
PR genes PR1, PR2, acidic chitinase (PR3), and chitinase/lysozyme. Transcripts derived from
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genes considered HR marker genes (HSR203, H SR201,H SR515, and HIN1) also accumulated 
in harpin treated tobacco cells.” In this example, the gene expression result without treatment 
(-) is compared to the gene expression result with treatment (+). If the untreated sample (in 
this case the (-) column) has no visible mark and the treated sample (in this case the (+) 
column) does then the gene expression has been up-regulated. If the (-) column has a mark 
and the (+) column has no mark or a less bold mark then the gene expression is considered to 
be down regulated and if the (-) columns and the (+) column are the same then the gene 
expression is considered unchanged. For the purposes of this database, the collation process 
for these results is identical to the Northern blot process with the same details being required 
from the experiment as the results are also reported in journals as up- or down regulated.
4.3.3. Microarrays
Microarray technology is a relatively recent innovation and is quickly becoming a standard 
tool in molecular biology (Lorkowski and Cullen, 2006). Microarrays differ vastly from the 
previous two techniques discussed as they can provide the gene expression levels of 
thousands of genes simultaneously by doing thousands of experiments in parallel. The 
drawback to microarrays is that the creation of each experiment is more complex with more 
steps than Northern blotting or RT-PCR and this leaves more room for error and an additional 
problem of variance in protocol from array to array and from experiment to experiment.
There are the two types of microarrays used to measure gene expression which are two- 
channel cDNA, or Spotted, arrays and single-channel High-density Oligonucleotide arrays 
and results from both of these types are reported in the papers that are relevant to this project. 
While both types of the arrays measure gene expression, the two arrays require different 
experimental and analytical approaches (Baldi and Hatfield, 2002). In the spotted array 
method, mRNA from two biological samples is copied to cDNA, each cDNA is labeled with 
a different fluorescent label, and a mixture of the two cDNA’ s is hybridized to an array that 
has a single DNA spot for each gene on the array. Each spot is scanned and the ratio of the 
two labels is determined. Commercial manufacturers of the spotted array use genomic DNA 
and oligos and based on the papers used for this study, this type of array is used less 
frequently that the oligonucleotide array. In the oligonucleotide array method, mRNA from a 
single biological sample is copied to labeled cDNAs, and then hybridized to a set of short 25- 
mer matching oligonucleotides for each gene and also to another set of the same
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oligonucleotides. To compare biological samples using this method, two hybridizations to 
two separate arrays are needed (Mount, 2004). Commercial manufacturers of the 
“oligonucleotide” arrays include Affymetrix, Nimblegen and Agilent and they can provide 
almost complete genome microarray chips for fully sequenced organisms including 
Arabidopsis. Affymetrix results are the most prevalent and results from the microarray chips 
for the Arabidopsis A G  chip (which can measure expression values of approximately 8000) 
and its successor the ATH 1 chip (which can measure expression values of approximately 
22000 genes) appear with greatest frequency based on the sample of journal articles relevant 
to this project.
There are different ways that microarrays can be used, for example, some microarray 
experiments are time sequenced where the designer may require the expression results at 
particular time intervals and then examine how the expression results vary over the time 
interval while others with be comparing a normal or untreated DNA against chemically 
treated DNA and the control vs. the treated expression profiles are examined. It is the later 
type of experiment that this project is interested with.
4.3.3.I. Common Microarray Terminology
The main terminology used for describing the calculation of results from microarray 
expressions are the same across both the single and two channel microarray techniques 
although the way in which the samples are processed is different. This section provides a 
reference for the key terminology that is used for measuring gene expression when 
comparing a normal sample against a treated sample. Once the experiment has been carried 
out, the absolute value, which means the numeric value of the level of gene expression, is 
obtained from the control sample and the treated sample. This value is then normalised which 
removes any systematic variation, for example differences in power of two lasers or between 
dyes and therefore brings the data from the different experiments onto a level playing field 
(Bari et al., 2006). This is imperative as it allows comparison of results from different 
microarrays. Once the data is normalised, the two samples are then compared and a relative 
value is calculated. This is simply the ratio of the normalised absolute treated value and the 
normalised absolute control value. This relative value is also referred to as the log ratio or 
fold value. The fold value provides an indication of the change in level of expression and
allows a cut-off value to be determined after which a change call can be given. This cut-off
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value will commonly be set by a software package, and tends to be at least 1.5. For example, 
if a fold value shows a 1.5 increase, the change call will be up-regulation of the gene 
expressed and if the fold value shows a 1.5 decrease the change call will be down-regulation 
of the gene expressed. The majority of all the calculations are done by sophisticated statistical 
packages which provide additional confidence values about the quality of each individual 
result. However, as discussed in section 4.3.4, it is necessary to be aware of how to calculate 
the change call as there are still some papers that only feature absolute values. Relative values 
or fold values are very suitable for this study’ s database approach however, as the cut-off 
value can vary from paper to paper, this study is guided by what the author of the paper 
considers to be an appropriate cut-off value for up- and down- regulation calls.
4.3.3.2. Single Channel Microarray Example
Figure 18 shows a partial table of genes that expressed differently in Arabidopsis plants 
colonized by Pseudomonas fluorescens FPT9601-T5a using a single-channel Affymetrix 
ATH 1 microarray (Wang et al., 2005).
Annotation Fold-change ratio Probe set number ACI numberUp-regulated genesMetabolism (22.11%)Seed imbitition protein 3.14 246114 at At5g20250Putative fatty acid elongase 2.87 263443_at At2g28630Putative glutathione 5-transferase 2.66 266746 s at At2g02930P-Xylosidase 2.52 260914 at At 1g02640Xylosidase 2.45 248622 at At5g49360Invertase inhibitor homolog 245 247246 at At5 g64620Xyloglucan endotransglycosylase 2.38 257203 at At3g23730Putative xyloglucan endotransglycosylase 2.35 255433_at At4g03210Proline oxidase 2.33 257315 at At3g30775P-Galacto$idase 2.33 247954 at At5g56870
Figure 18: Example results showing calculated fold changes from a single-channel array (Wang e t a l., 2005).
The important features to note are the gene name (under the heading annotation) which in this 
case has been allocated based on the Gene Ontology (GO) nomenclature, the probe set 
number which is the reference to the individual spot on the microarray, the AG I number 
which provides the unique ID for the database and the fold-change ratio which allows us to 
calculate the change call (the cut-off value in this paper is 2). Affymetrix have their own well 
regarded software called Microarray Suite software (MAS 5.0). This software tool manages 
both the acquisition and processing of the absolute data and provides fold-change ratio results 
along with p-value and absent/present calls that give a good indication of the accuracy of 
each result and therefore if the fold value is not calculated in the paper, it is reasonably
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straight forward to calculate the necessary data if this system has been used. Affymetrix have 
their own published annotation for mapping the probe ID to an AGI number for both the AG 
and the ATH1 microarray chips. The gene function and description can also be taken from 
this annotation, however, the unigene database is updated more regularly with gene function 
information and so the project will use the function and description from the unigene source 
for all experiments to provide a standard platform unless the primary paper is more up-to- 
date.
4.3.3.3. Two Channel M icroarray Example
Figure 19 is a sample of gene expression results from a two channel microarray (Schenk et 
al., 2000). Here, the change call has been explicitly stated. It shows genes that are 
significantly induced or up- regulated (positive ratios, shaded in light orange) or repressed or 
down- regulated (negative ratios, shaded in light blue).
Genbank A1DB A SA MJ E th
PUTATIVE FUNCTION Accesacn Clone Rato Ratio Ratio Ratio
OXIDATIVE BURST/STRESS, APOPTOSIS
coppertonc »upero*ide Cemutaao M38758 178G17T7 378 197 1.19 1.32
L-oioortm’o porondasa N64977 223L16T? 262 1 68 1.75 1 3
cysto no protease T04773 32C6T7 2.53 229 195 1 55
catalase 3 H76812 203O12T7 5.4 1 48 8 1 36
glutathione S-transfosae PM24 N65700 22903T7 448 1 04 282 1.85
DNA-damage-repair/toleration proton T44979 127N10T7 59 2 13 1 06 7.7
blue coppe' protein T44253 123N22T7 1 27 1 39 559 1.47
SAG 12, cytteineprotease f*SUA CI0010 1 33 0 5.57 274
ANTI-MICROBIAL GENES
germin-tice protein T22353 104020T7 2.1 3.17 -3 93 1.13
major sate* protein type 3 T20653 89M9T7 282 -1.3 -1 15 -122
POf 1 1 antifungal detonam prolein Z27258 PAP065 8.3 •2.1 4 35 2.16
POP 1 2 antifungal defensin prolein T04323 37F1077 289 -22 248 2 41
PR1 #NM CI0014 2 76 776 -1 04 0
thaumstin protein T46212 138H14T7 18 239 255 121
PALI, phenytalaninearnrnoftia-lyase tfN/A C10004 2.12 209 23 -192
Figure 19: Example results showing calculated fold changes from a spotted array by Alternaria (A), salicylic 
acid (SA), methyl jasmonate (MJ), or ethylene (Eth) treatments. (Schenk et al., 2000).
Here the microarray was of bespoke construction consisting of 2375 ESTs chosen by the 
paper authors and they imposed an induction or repression ratio cut-off of at least 2.50 for 
data quality purposes. Of the 9500 results obtained, only 705 of these show up- or down- 
regulation to the treatments, therefore only 7.5% of the results from the microarray
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experiment are suitable for inclusion in the database. This is a very typical figure and as 
discussed in Chapter 5 has implications on the types of analysis that can be performed on the 
collected data. The key results for data collection are the host plant, the type of treatment, the 
gene treated (which is identified in this example by the putative gene name and the Unigene 
accession number reference) and the fold change result for each gene. The accession number 
(EST reference) will provide a unique identifier for the experiment, but it makes comparison 
between different genes impossible as genes can have multiple EST sequences. For inclusion 
to the database, it is preferable, where the nomenclature exists, to have a unique gene 
identifier for each gene expression result. As this is an Arabidopsis experiment, further work 
on the part of the collator would be desirable to obtain the AGI number for each gene as this 
is not available in the original publication (discussed further in section 4.4).
4.3.4. Published Result Formats
There are numerous problems encountered in the curation of the gene expression results from 
papers and some of the primary causes of this are missing or inaccessible data and varying 
formats of data. One example of missing data has already been highlighted in section 4.3.1 
where the accession number for the results from the experiment published could only be 
found by searching for a previously published paper. Missing data in the form of missing 
accession numbers or probe numbers has been a common occurrence in the curation of the 
data for this study. Another commonly occurring problem is inaccessible data, where the 
expression data has been created as a word document table, but then saved as a picture file. 
This makes the data unsearchable and forces manual curation. There seems to be no set 
standard for the publication of gene expression results and selective results are published in 
journals in a variety of different formats (such as excel, cvs, .cel and pdf files) and even the 
supplementary results can be provided in a different levels of depth as well as in different 
software packages. This is being tackled by some journals by mandating that authors must 
submit their results to a public microarray repository where they can be accessed in full and 
enforcing adherence to M IAM E standards. The reference papers that have been collected for 
this project are from over 60 journals. Of this number approximately 50% of the papers come 
from five journals, namely, Plant Physiology, Plant Molecular Biology, The Plant Journal, 
Molecular Plant-Microbe Interactions and Molecular Plant Pathology. A  case study was
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carried out in this study to establish what the journals require from authors that submit papers 
for publication.
4.3.4.1. Case Study of Author Requirements
The Plant Physiology Journal is the most specific of the journals surveyed for manuscript 
submission guidelines. It requires plant names in the form of genus, species, and, when 
appropriate, cultivar. Accession numbers should be provided at the end of the Material and 
Methods for any data or materials available in a public repository. Novel DNA sequences 
must be deposited in Unigene and accession numbers provided. For large scale expression 
data, accession numbers, relevant annotation data, and in the case of Arabidopsis, TAIR locus 
identifiers. At the time of publication, supplemental data must be placed in a permanent 
public repository if one is available, or if none is available, in Plant Physiology Online. As a 
condition of publication in Plant Physiology, submitters of manuscripts that contain gene 
expression profiling data are required to describe the experiments according to MIAME 
guidelines and must include replicate experiments (PP, 2008). The Plant Molecular Biology 
has no requirement to submit data to public repository or no standard format for adding 
expression data to supplementary files. It does state that standard nomenclature procedures 
should be followed, but makes no requirement for accession numbers to be provided or AGI 
or other unique locus ID ’ s. There are no guidelines on how experimental results should be 
submitted and no mention of M IAM E standards (PMB, 2008). The Plant Journal states that 
authors including microarray analysis should refer to the M IAM E recommendations for 
guidance in preparing their manuscripts and makes no other reference to how strictly this is 
enforced. There is no reference to any other experiment type and no indication of how results 
from the experiments should be reported in the paper (PJ, 2008). The journal of Molecular 
Plant-Microbe Interactions has a very specific policy on large-scale data sets and enforces 
strict adherence to the M IAM E guidelines. There is no guidance for the information required 
for smaller scale experiments or for the format that results are to be published in. (MPMI,
2008). The journal of Molecular Plant Pathology has no MIAME requirement or guidelines 
for the information that must be included when reporting experimental results (MPA 2008).
This case study shows that there is a large disparity between journals for author guidelines on 
reporting results. The introduction of M IAM E standards has definitely had a positive impact 
with three of the five journals surveyed making it mandatory to meet this standard for
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acceptance. This means that the data must have unique identifiers and even if the data 
published is incomplete or in a difficult format to curate, the full microarray results will be 
publicly available. The downside of this is it that it is likely that the fold values will not have 
been calculated and it will be absolute data values that are available. With the exception of 
the Plant Physiology journal, none of the other journals surveyed made any specific 
requirements for the reporting of any other type of experiment or how the results were to be 
presented. Until a more unified approach to the reporting of experiments in journals is taken, 
manual or automated curation of results from certain experiments will remain difficult.
4.3.5. Can data from different platforms be compared?
There is much debate in the literature as to whether it is appropriate to compare gene 
expression results across platforms or from different experiments and this section assesses 
how other researchers view this. The first question to consider is “can microarrays made by 
the same manufacturer be compared?” ; for example, can we compare Affymetrix ATH 1 chip 
against the A G  chip? The AG array contains 8297 probe sets and the new ATH 1 array 
contains 22814 probe sets. Based on annotations compiled by TAIR, 7388 transcripts are 
targeted by probe sets on both arrays so can these results be analysed against each other?
Genevestigator is a site that allows for comparison of the fold values (relative values) of the 
results from microarray data (including some Affymetrix A G  and A TH 1 Arabidopsis 
microarrays). They state that “Genevestigator uses the Affymetrix M A S5.0 algorithm for data 
normalization. Provided that scaling factors (SF) are in a similar range and there is no 
significant skew in the data, our hypothesis is that signal intensity values can be compared. 
The Genevesigator tools are based on this assumption, and the results seem to indicate that it 
is a fair assumption. For some tissues (e.g. pollen or embryo) where a large fraction of genes 
are not or weakly expressed and a few are strongly expressed, signal intensity values tend to 
be overestimated (and the corresponding scaling factors may differ significantly). Therefore, 
the results provided by genevestigator reveal trends rather than exact quantitative 
information” (Zimmerman et a l, 2004).
However, the genevestigator tool does not allow the user to compare the ATH 1 results
against the A G  results. Zimmerman et al. (2004) state that the reason data from the ATH1
and A G  arrays are processed separately is because different sets of oligonucletoide sequences
are used to probe identical target genes on the two array types, and thus the efficiencies of the
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target to probe hybridization and non target to probe cross-hybidisation makes a direct 
comparison of signal intensities impossible.
Hennig et al. (2003) analysed the reproducibility of the results of transcript profiling between 
microarrays carrying different probes to a common set of genes and focused on the overlap of 
more than 7300 targets from the A G  array and the ATH 1 affymetrix array. They found that 
the results obtained with ATH1 and A G  arrays are very comparable and hence that the 
analysis is largely independent of probe sets. They summarised by suggesting that analysis 
should be focused only on genes called Present by M AS5.0 regardless of their actual signal 
intensities. A  further, although smaller improvement of data quality, can be achieved by only 
including genes called decreased or increased by M AS5.0. Targets producing a fold change 
of at least 1.5 gave results with the best correlation between array types. Given the fold value 
of genes identified as up- or down- regulated when reported in journals is > than a 1.5 fold 
increase or decrease, this would appear to imply that comparison of these results is acceptable 
but is it suitable to compare results across different microarray platforms by different 
manufacturers?
There have been approximately 40 studies since 2000 which have evaluated the extent to 
which data produced by different microarray technologies correlate. Irizarry et al. (2005) 
conducted a multiple laboratory comparison of microarray platforms and found that precision 
is comparable across platforms and that it is the laboratory that affects the experiments more 
strongly than the microarray platform used. They also found that it is only relative expression 
(fold value) that can be compared. Yauk and Berndt (2007) have reviewed the results of the 
40 studies and concluded that the vast majority of papers published on this subject support a 
high degree of correlation among microarray technologies. Both Irizarry et al. (2005) and 
Yauk and Berndt (2007) state that it is the standards and protocols that make the most impact 
on the correlation of the microarray results. This evidence suggests that it is acceptable to 
compare microarray data from different platforms provided it is relative values (fold values 
or call values) that are being compared. It would also appear that only using data from 
published journals is a sensible approach as it is likely that the required standards will have 
been applied to these experiments as they have been peer reviewed. The final consideration is 
whether it is appropriate to compare data from not only different microarray platforms but 
RT-PCR and Northern blot results as well. Yauk and Berndt, (2007) describe the evaluation
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of the microarray gene expression results discussed as being confirmed using RT-PCR and 
Northern blot techniques. This would imply that it is also suitable to compare these 
experimental results alongside the microarray results.
Based on the above findings, it is appropriate to compare results from the different 
experiment techniques described in this chapter. In order to enhance the data quality, the data 
that we are comparing will only be obtained from a refereed source. It is expected that there 
will be duplicate results from different experiments/papers which will provide an additional 
level of confidence in the data. Further more, it is normal practice for any conclusions that 
researchers may make, while using bioinformatics tools would be presumed ‘unproven’ and 
tested using wet science to confirm the hypothesis. Data will be stored in the database in 
binary form either as up- or down- regulated and for microarray experiments, the actual 
relative values, where reported, will also be included.
4.4. Annotations
From the information obtained about the experiments, it is now important to establish how 
we can update experimental results to ensure that we can compare genes and that the 
historical gene expression results gathered relate to the current genome annotation.
4.4.1. Overview
Annotations are in every part of bioinformatics from database formats to locus id for genes to 
probe mapping for microarrays. It is vital to consider what impact annotations may have on 
historical static results such as those found in journals. To examine this, a case study of the 
implications of one type of annotation has been undertaken during this study.
4.4.2. Microarray Annotation Case Study
This case study will examine the gene to probe mapping annotation of the Affymetrix ATH 1 
microarray. The A TH 1 microarray experiment results are all taken from a probe which has its 
own ID and then this ID is mapped using annotation to correspond to an A G I number. The 
problem is that these probe ID to A G I number look-ups change as more up to date data 
becomes available. There have been five releases of the annotation for the probe to gene 
mapping for A TH 1 microarray chips and Table 5 shows the number of changes that occur 
between four of these mappings. There are no changes made to the probe ID numbers or to
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their extensions, however there is a large variation between the probe ID’ s and the locus that 
they are mapped to as shown in Table 5: (The control probes have been disregarded for this 
purpose so the changes are out of 22746 probe ID’ s).
Annotation Date: 23/12/02 30/5/03 1/6/04 TIGR V5 11/11/05TAIR V6 2/5/07 TAIR V7
23/12/02 264 1406 1713 1862
30/05/03 264 1248 1611 1745
01/06/04 TIGR V5 1406 1248 1748 1891
11/11/05 TAIR V6 1713 1611 1784 263
2/5/07 TAIR V7 1862 1745 1891 263
Table 5: Number of changes between the mapping of the probe ID to the locus in the Arabidopsis files on the 
dates shown in the column and row headings.
Table 5 shows that the probe set to locus mapping is relatively changeable with a 5-8% 
change between most annotations. Table 6 describes the probe name nomenclature used and 
contrary to the definition from Redman et al. (2004) that probes ending in _at are genes that 
are represented by unique probe sets there are a number of examples in the TAIR V7 
mapping that show this is not the case, for example, probe 259435_at is mapped to both 
A T1G 01448 and A T1G 01450. Usadel et al (2005) calculated that there were only 89.5% of 
the _at genes left that were unique in the TIGR V5. B y  counting the number of probes ending 
in _at that had duplicate AGI numbers in the locus fields, the data showed that in the TAIR 
V7 there were 604 of 21685 probes that were labelled _at but did not uniquely identify a 
gene. In TAIR V7 there are also 462 “ no_matches”  for the _at probes which means that 
previous results linked to these probe sets should now be disregarded. The reason for this 
change in annotation is a match may have existed in TIGR5 and disappeared in future 
annotation versions because the gene structure of relevant locus was updated so that the 
region to which the probe maps is no longer included in the new structure (Pers Com. 
Berardini, 2006a).
The TAIR annotation is calculated by “The oligonucleotide sequences of the probes were 
mapped to the Arabidopsis Transcripts dataset from the Arabidopsis genome TAIR7 version. 
The dataset included mitochondria and chloroplast genes, as well as pseudogenes and non­
coding RNAs. The mapping to the TAIR7 Transcripts was performed using the BLA STN  
program with e-value cut-off < 9.9e-6. For the 25-mer oligo probes used on the Affymetrix 
chips, the required match length to achieve this e-value is 23 or more identical nucleotides.
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To assign a probe set to a given locus, at least 9 of the probes included in the probe set were 
required to match a transcript at that locus.” (Readme file from TAIR)
Extension Description
at designates probe sets that uniquely identify a single gene
s a t designates probe sets that share common probes among multiple transcripts from 
different genes.
_a_at designates probe sets that recognize multiple alternative transcripts from the same gene.
x a t designates probe sets where it was not possible to select either a unique probe set or a 
probe set with identical probes among multiple transcripts. Rules for cross-hybridization 
were dropped. Therefore, these probe sets may cross-hybridize in an unpredictable 
manner with other sequences.
_g_at similar genes, also unique probe sets elsewhere on the array.
_f_at similarity rules dropped, probe set will recognize more than one gene.
_ i a t designates sequences for which there are fewer than the required numbers of unique 
probes specified in the design.
b a t all probe selection rules were ignored. Withdrawn from GenBank.
l a t sequence represented by more than 20 probe pairs.
_r_ designates sequences for which it was not possible to pick a full set of unique probes 
using Affymetrix probe selection rules. Probes were picked after dropping some of the 
selection rules.
Table 6: Probe Name Extension Nomenclature for probes that represent more than one gene or EST. Only the 
_at, _s_at and _x_at extensions feature on the ATH1 chip.
TAIR are not alone in providing annotation data for the Affymetrix ATH 1 microarray. 
Affymetrix themselves provide data that maps the probe sets to Arabidopsis A G I’ s and the 
Affymetrix annotation is different to both the TAIR V7 and the TIGR V5. There is no 
definitive standard in the literature as to which annotation should be used and is a continuing 
problem for bioinformatics. TAIRs response to why the Affymetrix data is different to 
TAIR7: “Unfortunately, I cannot tell from the A ffy  website what version of the Arabidopsis 
genome annotation they used to generate their mapping file. Also, there is no mention of the 
parameters they used to call a match 'legitimate'. This makes it difficult to compare our 
results and figure out what the differences arise from.” (Pers Com. Berardini, 2006b).
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To give a direct example, Bari et al. (2006) reported the results shown in Table 7 which are 
genes that displayed 2-fold higher or lower expression in Pi-replete pho2 mutant roots in two 
independent Affymetrix ATH 1 genechip experiments. When using the most up to date 
release 7 ATH 1 annotations to check the probe ID to gene mapping, two are found to be 
ambiguous and one (267456_at) has no match. The implications of this mean that probe set 
Ids must be recorded as part of the database. The facility must also be available to check new 
annotation releases and where necessary remove or update results where the gene mapping
has been amended.
Probe ID
Gene
Identifier
Annotation
pho2 versus 
VVi Id Type 
f+Pi>
258158_at At3g17790 Acid phosphatase 5 (AC.P5) 5.90
246001_at At5g20790 Expressed protein 5.55
2 52414_at At3g47420 Gk-3-P permease 5.45
2 46071 _at At5g20150 SPX domain protein 4.56
256597_at At3g28500 60S ribosomal protein P2 2.45
266184_s_at At 2g38 940 Pi transporter Pht l;4 2.43
2 5885 6_at At3g02 040 Gly cerophosphod iester 
phosphodiesterase (SRG3)
2.41
260097_at At1g73220 Sugar Pi transporter 2.21
2 4877 0_at At5g47740 Expressed protein 2.20
245928_s_at At5g24780 Acid phosphatase (VSP1) 2.08
248970_at At5g45380 Sodium:solute symporter 0.46
•2 6745 6_at At2g33 770 E2 conjugase (PH02) 0.17
Table 7: Published microarray ATH1 results (Bari et al., 2006)
This is relevant for the collated data for this project as not all papers that describe microarray 
results will provide the probeset ID for the AGI number or the annotation version that was 
used and therefore, the data cannot always be updated to reflect the actual AG I that relates to 
the result. While at present this only affects 7% of results, this is still a high number and 
seems to be increasing with each new annotation. Additionally, there is a lack of uniformity 
between public databases as to which version of the annotation is used. NASC has only 
recently updated their website, but the datafiles are still holding TIGR5 annotation and 
genevestigator are still using TIGR5. There are also discrepancies between the commercial 
manufactures as Nimblegen (Nimblegen, 2008), for example, are using probe mapping 
annotation from the TA IR  6 release whereas Affymetrix have their own version of annotation 
which is based TAIR 7 that they implemented in Nov 2007. When mapping the probe ED to 
annotation, Affymetrix use their own method which tracks five levels of relationships
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between IVT Probe sets and the current transcript record (Affymetrix, 2008). This annotation 
example is very typical of the problems that face bioinformatics projects and demonstrates 
that the data and surrounding models are not static and this is an important factor when 
developing the data model for this study.
4.5. Data Quality
The previous sections describes the difficulties that can be encountered when collating gene 
expression results. The lack of standard annotation both in print and in gene expression 
databases is a problem. This will not simply be restricted to microarray data. It is possible 
that a gene from, for example, a Northern blot experiment identified as for example 
A tlg l2 34 5  has been re-annotated as A tlg23456 which would have an impact on any 
Northern blot experiment result. The only way this can be addressed is by looking up the 
locus history of an AG I number (which is available from TAIR) or by checking the current 
annotation of the EST (if available) of the gene. The most important point that has emerged 
from this is that it is not enough to simply rely on the AGI number for the result, but that 
there must be other ways to track the current gene annotation by either recording the version 
of annotation used (which is not readily available from the journals) or recording additional 
data such as probe ID for microarrays and E ST ’ s for Northern and RT-PCR experiments. In 
addition to the above, we need to remember that there is likely to be inaccuracies in the 
experimental results themselves which is why it is recommended that replicates of 
experiments are run. When considering results for the purpose of this project, we are 
assuming that the results from the experiment are correct, but what we are interested in is 
ensuring that we are getting full value from the results. If for example new updates of a 
genome are released, can we ensure that we are still holding results for the correct gene and if 
a gene was of previously unknown function, can we provide more information for this gene? 
The results accuracy will increase if  duplicate references are found. This could be limited as 
journals require novel data and experiments are expensive therefore experiments are not 
likely to be routinely repeated. This is however a persuasive argument for ensuring that we 
keep all the data up to date as some experimental results will not be repeated.
The key reasons for maintaining the data is to ensure that the correct results are being 
attributed to the gene and to mine more valuable information from experiments that would
previously not have been identified. For example, previously unknown function proteins can
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be identified and historical gene expression results allocated to them; ESTs when allocated an 
AGI number can add new data about a gene that was previously unlinked (for example a gene 
that was given 5 different accession numbers by different authors turns out to be the same one 
that is regulated by five treatments) (Button et al., 2004).
4.6. Data Model Requirements Summary
The previous sections of this chapter have examined the types of experiment used for stress 
response gene expression and the results each experiment yields and whether it is suitable to 
compare data across platforms.
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Figure 20: Layers of Gene Expression Data. From the results of the case studies made during this project, the 
process of obtaining and reporting results has been built into this flow chart. The grey boxes highlight the key 
points of the process that must be examined to establish whether the most upto date protocol for nomenclature 
or calculation of fold value have been applied.
It is now necessary to identify the generic elements of the data that will allow for comparison 
across each platform. Figure 20 provides an overview of the main stages for each type of 
experiment from construction to publication and shows the layers of data that will need to be 
considered when defining the data model. The four boxes highlighted in grey are the areas 
that are identified as a priority to be considered when developing the data model for this 
projects’ database. These are the areas that may change or be partially missing from the paper 
or require to be updated as new annotations or nomenclatures evolve.
The first consideration is how to record the gene that the expression result is for. While there 
are many differences between the two-channel and single-channel microarray, for the 
purposes of this project, the main difference is the way in which each platform annotates a 
probe to a gene. As Figure 20 shows, the single-channel microarrays use a probe ID which is 
then mapped to a gene A G I or locus ID whereas the two-channel arrays tend to use longer 
sequences that relate to known E ST ’ s and are identified by an ORF or an accession number. 
For Northern blots and RT-PCR experiments, these tend to be identified by either the gene or 
accession number. This means that it is desirable, where available, to record the probe ID, the 
accession number, the gene function, the gene name and the locus ID.
The second element is the actual gene expression result. The four experiment platforms yield 
different types of result -  two are binary values of up- or down- regulation while the other 
two can provide quantitive values that are either relative or absolute. The only way to 
compare the expression results across experiments is to record all the results as binary up- or 
down-regulation. This potentially could reduce the value of some of the microarray results, so 
an additional requirement for microarray experiments only would be to record the fold 
change value and the authors cut-off call. For all experiments, the temporal data for the gene 
expression result should be included where available. The reference and the experiment type 
should also be recorded. This chapter has described the main areas to consider when 
exploring the gene expression data from the published papers. Section 2.3 described the
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problems that biologists encounter with their current system and Table 8 assesses if  these 
problems can be addressed by the data requirements established by this chapter.
Q. Up-dating (and adding new information) is slow and laborious.
A. Data will be linked to up to date annotation such as TAIR V7 and Unigene so updating should be an 
automated process
Q. There is no temporal dimension within the diagram - No account is taken of time or ‘dose/amount’ of 
response and the dynamics of the interaction are very poorly represented.
A. Temporal time for experiments from all platforms will be recorded and fold value will be recorded for all 
microarray experiments
Q. It is difficult to incorporate information on differential induction of certain genes in different plant tissues 
(e.g. roots vs. leaves).
A. Data will be linked to GO ontology and Plant Ontology Consortium information which can provide this 
information as long as there is a unique identifier for the gene
Q. The importance (and interdependence) of proteins in different intracellular locations is sometimes poorly 
conceptualized.
A. Data will be linked to GO ontology information which can provide this information as long as there is a 
unique identifier for the gene
Q. It is not possible to draw separate diagrams for each agonist/response as it would be too time consuming.
A. To be addressed at the query building stage
Q. It is difficult to indicate the source of information i.e. whether it is derived from Arabidopsis or another plant, 
or whether it is from another eukaryote, or the source of the publication.
A. The database model will be constructed and indexed to allow easy reference to all the specified information 
sources.
Q. It may include varying degrees of uncertainty (‘informed guesses’) that other scientists may find 
inappropriate or are wrong (by virtue of having not taken into account some other published information).
A. To be addressed at the query building stage
Q. It is difficult to add information on ‘unknown’ ESTs.
A. Data will be linked to up to date annotation such as TAIR V7 and Unigene so updating should be an 
automated process
Q. It is not possible to interrogate a diagram.
A. To be addressed at the query building stage
Q. It is not possible to add to the diagram ones own personal or unpublished data.
A. To be addressed at the query building stage
Table 8: Biologist requirements vs. Data Requirements
The next chapter will describe the process of creating and implementing the data model based 
on the findings of this chapter.
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Chapter 5 Building the DRASTIC Database
5.1. Overview
This Chapter describes how the data requirements identified in Chapter 4 are converted into 
database design and implementation. The process used to develop the database has been 
based on an established database application lifecycle model (Connolly and Begg, 2002) and 
Figure 2 1 shows the main activities associated with the database design. The previous 
chapters have described the database planning definition and requirements collection and this 
chapter focuses on the database design, implementation, user interface design and testing.
Figure 21: Software development cycle used for developing database application
78
5.2. Database Design
The key purpose of good database design is to ensure that the data is stored in such a way that 
it will enable the users to retrieve correct information from the data. This section describes 
the data modelling process of converting the identified user and data requirements into an 
efficient database structure.
5.2.1. Data Modelling Technique
The database design was developed using the principles of entity relationship (ER) 
modelling. The ER  model was devised by Chen in 1976 and is a diagrammatic technique that 
provides a generalised approach to the representation of data and which is particularly 
suitable for the design of relational database systems. The key concepts of data modelling 
which are referred to in this section are the application domain which is the real-world 
environment in which this database is to be applied, entities which are a group of objects with 
the same properties which are identified by the application domain as having an independent 
existence, attributes which are a property of an entity and relationships which are an 
association or interaction between two or more entities.
This database is more problematic to design than a standard database due to the changing 
experimental technologies and progression in the subject area. Normally once the data model 
is established it is anticipated that no major change would be made to its structure once the 
data is added (Whitehorn and Marklyn, 2002). When designing this database, the data model 
has to be as flexible and as future proofed as possible due to the different formats and the 
evolution of data. For example, if we were dealing with an address system, it is unlikely that 
the attributes for an address would change but this is not the case with the attributes of this 
system. Due to the changing standards (for example the M IAM E standards for microarray 
experiments) and the advances that are being made in the sequencing of plant data there are 
now more attributes available compared to the past up/down results of the Northern blots and 
there is no reason to expect this to stabilise in the future. The database has been robustly 
designed with this in mind and includes entities such as “protein” , “ requires”  and “produces” 
which will enable the entry for future protein-protein signalling reactions.
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5.2.2. Modelling the data
The Entity Relationship Model was developed in conjunction with biologists to model signal 
transduction. The concept of a Reaction models the data requirements and underpins the 
model. The main entities that are identified for this database are the References, Treatments, 
Hosts, Chemicals and the Reaction itself. Each record represents one report of a reaction 
which consists of the chemical which is uniquely identified by the chemical name, the gene 
name (if applicable) and the accession number (if applicable). The project is focused on data 
pertaining to the effects on gene expression of treatments so all reactions contain details of 
the treatments used and the host for the reaction which is uniquely identified by the genus, 
species and cultivar. The compatibility of the host is included (where appropriate) for 
pathogen experiments. The result of the experiment is recorded by the fold change to the gene 
expression and whether the gene expression was up/down or no change. The reference id is 
also included and the Reference table provides details of the journal and paper that the results 
were obtained from. The ER model is shown below along with a brief description of the 
primary entities and their attributes.
REFERENCE
jefld
authors cites
title ►
11 1 *
journal
pages
year
0..*1..*
HOST
{Mandatory} ^
Family
{Mandatory}
Genus
{Optional}^ 
Species 
{Optional}
Cultivar
has
1..1 1..*
CpMipn.N^m?
ct'I.eiartje
Figure 22: Entity Relationship diagram.
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The entities in Figure 22 are represented by the square boxes, and the main attributes are 
listed in the box. The relationships are represented by the lines that join the boxes and the 
type of relationship is denoted at the end of each line - for example one to many relationship
is represented by 1..1 --------- 1 . . .* .  The tables below describe each of the entities and
attributes represented in the entity relationship model.
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Table Description
ATH_GO Contains the Gene Ontology (GO) terms for all the Arabidopsis 
Gene Index (AGI) numbers
Chemical Details of all genes in the database
GeneDictionary All updates made to the name, geneName or AccessionNumber 
attributes are stored
Host Contains all the plant details including genus, species and cultivar
InThePresenceOf InThePresenceOf, Produces and Requires contain chemicals which 
model a protein-protein
Reaction
ListCommonName Taxonomic records of the common name for each host
ListCompatibilityClassification List table that stores all the compatibility classifications
ListCultivars Taxonomic records of all the host cultivars
ListGenus Taxonomic records of all the host genera
ListHostClassification Taxonomic classification of the host e.g. plant-dicot
ListKnownTreatments List table of all treatments
ListOrganelles List table of all organelles
ListOrgans List table of all organs
ListRegulationClassification List table of all regulation classifications
ListSpecies Taxonomic records of all the host species
ListTreatmentClassification List table of treatment classification
Produces InThePresenceOf, Produces and Requires contain chemicals which 
model a protein-protein reaction
Reaction This contains all the gene expression records. Each record is 
comprised of expression data for a single gene.
Reference This table contains the full details of each refereed paper that has 
been used to populate the database.
Requires InThePresenceOf, Produces and Requires contain chemicals which 
model a protein-protein reaction
Table 9: Explanatory Table Names
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A ttr ib u te D e s c r ip t io n E x a m p le
A c c e ss io n N u m b e r C o n ta in s  the g e n e  s e q u e n c e  en try n u m ber in  E M B L  form at A Y 2 7 1 6 1 8
A G IN u m b er A r a b id o p sis  G en e  In d ex  (A G I) num ber A t5 g 0 3 6 5 0
co m p a tib ility C erta in  treatm ent x  h o st co m b in a tio n s  ca n  b e  c la s s if ie d  as 
co m p a tib le  or in co m p a tib le  w h ere  the trea tm en t is  a  p a th o g en .
co m p a tib le
c la ss if ic a t io n D e f in e s  th e ta x o n o m ic  c la s s if ic a t io n  o f  the h ost. P la n t-d ico t
c N a m e C u ltiva r  N a m e c v  C o lu m b ia
E C E n z y m e  n o m en cla tu re 2 .4 .1 .1 8
fa m ily D e fin e s  th e ta x o n o m ic  fa m ily  o f  the h ost. B r a ss ic a c e a e
g e n eP ro d u c t S ta tes  w h eth er  a c h e m ic a l is  a g e n e  p rod u ct Y e s /N o
g N a m e G e n u s N a m e A r a b id o p sis
g e n e N a m e P u b lish ed  or preferred  sy m b o lic  nam e o f  a g e n e A L D H 7 B 4
nam e A  d escr ip tio n  o f  th e g e n e  fu n ctio n a ld e h y d e
d eh y d ro g en a se
refid T h e  id en tity  n u m b er o f  the re feren ce  w h ere  the g e n e  
e x p r e ss io n  record is  c ited
A u to  N u m b er
regu la tion In th e c a se  o f  a g e n e  b e in g  ex p r e sse d  th is  attribute in d ica tes  
w h eth er  it is  up or d o w n  reg u la ted .
U p
rid T h e  u n iq u e id en tity  n u m ber o f  the record A u to  N u m b er
sN a m e S p e c ie s  N a m e th alian a
tD escr ip tio n T reatm en t D e sc r ip tio n iso la te  0 - 2 6 4
tN a m e T reatm en t N a m e Alternaria
brassicicola
tim eM a g P ea k P ro v id es  a su m m ary o f  the s c a le  o f  re sp o n se 4  F o ld
tim eR e sP ea k P ro v id es  a su m m ary o f  the tim in g  o f  re sp o n se 3 H ou rs
typ e T reatm en t T y p e A b io tic
ty p eT em p M sm t I f  tem p ora l data is  a v a ila b le  th en  d en o tes  ty p e  o f  data
T a b le  10: E x p la n a to ry  A ttrib u te N a m e s  - T h e  a b o v e  tab le  d o e s  n ot in c lu d e  attributes su ch  as Y ea r  or A u th o r  
th ese  are se lf-e x p la n a to r y
5.2.3. Defining keys for the ER model
Once the entities and their attributes are identified, the next step is to define the relationships 
between the entities. The important part of defining a relationship is to ensure that no two 
rows of an entity are identical. This is met by allocating each entity an identifying attribute(s) 
which is called the primary key. A  primary key must contain unique data for each record and 
not a null value (Whitehorn and Marklyn, 2002). For the majority of the entities in the ER 
model shown in Figure 22, primary keys are easy to choose. For example the Reference 
Entity contains an attribute ReflD which is a unique auto number field. As this field is unique 
and cannot be a null value, this satisfies the requirements for a primary key. However, for the 
chemical entity, the primary key was harder to select. The Chemical entity contains no single 
attribute that is unique, so a composite key of name, geneName and AccessionNumber was 
selected as the primary key. This uniquely identifies each record within the table, but because 
of the nature of the data, it is possible to have missing data or regularly changeable data 
within these attributes and this impact is discussed in Section 5.5.1.2.
5.3. Implementation
Once the ER  model had been designed and agreed with the users, the database needed to be 
constructed. Consideration was given as to which Database Management System (DBMS) to 
use for the implementation of the database.
5.3.1. DBMS Selection
There were several aspects to take into account when deciding which database package to 
use.
1. The database needs to be free or have an existing license for use on both Abertay and 
SCRI systems
2. It needs to be easily transferable from one machine to another. SCRI will be hosting 
the planned website that will provide search tools for the database, but there will be 
no administrative access to the server from Abertay therefore the database will be 
constructed at Abertay and uploaded to the SCRI server. In addition, data input will 
be processed at SCRI so there must be access to the database front-end there.
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3. Needs to have the facility to create a front-end that can be used to input data and 
provide robust validation checks for the data.
Microsoft Access was chosen as the database application as it is easy to use as a stand alone 
product, would be transferable via the servers used and would serve as a good prototyping 
medium. Microsoft Access also has its own programming language called Visual Basic for 
Applications (VBA) which can be used to construct data entry forms and thus enabled the 
database and front-end to be encapsulated as one package making transferring the program 
from machine to machine very simple.
5.3.2. Database Construction
The database structure was created in accordance to the ER  model with empty tables ready 
for the data to be input. Each of the tables was set up with the primary/foreign keys, the 
relationships were created and all the data types set.
5.4. User Interface Design
Good user design is critical to the success of a system (Sommerville, 2001). An interface that 
is difficult to use will, at best, result in a high level of user errors. At worse users will simply 
refuse to use the software system. Because this interface is being built specifically for the task 
of collecting data, it is imperative that the interface design meets the user needs to ensure data 
integrity. The key principles of user interface design are user familiarity, consistency, 
minimal surprise, recoverability and user guidance and these have all been considered in the 
design process of the interfaces along with Human-Computer Interaction (HCI) as discussed 
below (Dix et al., 1998).
5.4.1. Design Rules
Designing a user interface is never a trivial task, but for this database, particular attention had 
to be paid to how the input interface was designed due to the variety of ways that the data to 
be capture was presented as illustrated in Chapter 4. There are therefore two main parts to the 
design considerations: the design appearance and how the information can be most easily 
input irrespective of which method the data is presented.
During the design process of the database, the users were interviewed to assess what their 
user requirements were of the data entry screens. The decision to use a Graphical User
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Interface (GUI) was based on the fact that the users were all familiar with the HCI of 
windows based systems and it would be inappropriate to expect users to be able to enter data 
directly into the database. A sample screen of the input GUI is shown in Figure 23.
Figure 23: Example of the User Interface Design -  the Add New Host form
In order to provide consistency and user familiarity, each of the data entry forms were split 
into blocks that represented the entities that the users of the system were familiar with. A 
yellow label is used to highlight the area that each section represents. The names used are the 
ones allocated by the biologist to assist with quick recognition and help users who are 
unfamiliar with the system. Each of the entry sections is in a 3-D box -  the dark grey box 
indicates mandatory fields and the light grey box indicates optional fields. The fields are all 
labelled using the terminology selected by the user. In order to meet the requirement of 
minimal surprise, all buttons included on the forms use either a standard windows image or 
the same wording throughout the application. There is always a cancel button available and 
all complete records are automatically saved to provide recoverability. Error messages are not 
generalist, but will actually inform the user which of the fields they have not completed or the 
cause of the error giving the user good guidance. The adding of records is hidden to the user 
and even if a form has collected data which needs to be add records to several different 
tables, this is not visible to the user and they only have to press one update button to add their
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entry. This GUI scheme is used on every form in the application for consistency and to make 
using the application easier.
5.4.2. Input Screen Design
The design rules that are described in Section 5.4.1 provide the basis for the appearance of all 
the forms. The next step is to decide how to present the screens to the user in a logical 
sequence that will minimise the chance of user error and to provide the fastest means of user 
entry. With such a richly structured database, data entry is difficult due to the order data is 
required to be input (dependant on the primary/foreign keys). Data input screens were 
designed around these issues. In addition, consideration was given to the different types of 
format the data came in. Chapter 4 describes what data is required for each record and the 
different formats that the user may find the data. Chapter 3 describes some of the ways in 
which data is uploaded into databases, for example, tab delimited files with identifying 
columns. Automatic loading of data is not appropriate here as the data is found in many 
different formats (including diagrams which would be unconvertible) and the time taken to 
convert the files would negate the efforts made to convert them.
Therefore, until there is more uniformity in the way results are published in journals either in 
the article itself or the supplementary material, the data must be manually input. Several 
different types of input process were identified:
1. Journal reports one result
2. Journal reports multiple results from same gene, same species but different treatment
3. Journal reports multiple results from different gene, same species, same treatment
4. Journal reports multiple results from same gene, different species, same treatment
In case 1, there would be no data that would be the same as another records, however in cases 
2-4 there is duplicate data input for multiple records. As cases 2-4 are most likely, the input 
screens needed to be designed to enable the user to reuse data that they had entered from the 
previous record to prevent the need for re-entry.
Because of this requirement it is likely that there will be several elements of each reaction 
that are already in existence in the database and need to be found rather that added to the 
current reaction. As the user placed an extremely high priority on data quality, reducing
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errors introduced to the system during the input had to be a main concern in the design o f the 
forms. Common types of user error are transposition of numerical digits, misspelling of 
names, repetition of characters etc, and if these errors are introduced to the database they are 
very difficult to pick up and will result in searches missing out potentially vital data (Ritchie, 
2002). For example, as previously mentioned, the only way to uniquely identify genes was to 
create a composite primary key comprising of gene description, gene name and gene 
accession number. Given the complex names that are allocated to gene descriptions and the 
likelihood of change to gene name (as shown later through the gene dictionary), it would be 
unwise to allow the user to enter each gene in manually each time.
F ig u re  24 : M ap  o f  form s
In order to satisfy these requirements, the input screen has been designed to have one main 
screen that allows access to all the other input screens and also displays all the current 
information that the user has entered. The main reasons for this choice are:
i. Obvious to the user what information is not input
ii. More robust as the order in which information is input is controlled
88
iii. Enables better typographical error control by enforcing the user to search for existing 
records first
iv. Allows the data entered from the previous record to be kept so data can be re-used 
where applicable for multiple reactions.
v. The database structure requires that a related record exists in the host, chemical, 
reference, organ, organelle and treatment entities before a new reaction can be entered 
and this provides an easy way to enforce this.
There are three types of form that the user will encounter when entering a record: The main 
Add New Reaction form shown in Figure 25 which is the master form (described below), 
there are ‘ sub forms’ which the user can add new records for a specific entity (an example 
Add Chemical is shown in Figure 25 and ‘search forms’ where the user can search to see if 
the entry they are looking for in a sub form already exists (an example Find Host is shown in 
Figure 27). The map of the data entry forms is shown in Figure 24.
Figure 25: Picture of frmAddNewReaction. The form has been designed so that all sections are clearly separated 
and mandatory fields are highlighted in dark grey as described in the design rules section.
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The Add New Reaction form contains some fields that are mandatory but the user cannot 
directly input data into the main form. They must choose to search for an existing record or 
add new both which launch a new sub form. When the data is input to the subform, a record 
is created in a corresponding table and the data is then copied into to the fields on the main 
form. For example, if  a user wanted to add a reference, they would have to use the form Find 
Reference (described below) to find the appropriate reference or form New Reference to add 
the new reference. This ensures that there is no duplication and that a correct record exists. 
Once the user has chosen/entered the reference, the details are passed back to the form Add 
New Reaction to be used in the creation of the new reaction record. This is the same 
procedure used for Genes, Treatments, Chemicals and Host.
The Search command buttons and the Add command buttons open new forms. The Save 
Record command button performs several validation checks before saving a new reaction. It:
•  checks that there is an entry in all mandatory fields or produces an error message
•  checks for any blank optional entries and if found inserts the correct response according 
to the rules for null entries
•  updates the lookup tables that are related to the non mandatory entries for example 
ListOrgans
•  inserts a record to the Reaction table. There will already be a record for Chemical, 
Reference, Treatment and Host as these need have already been entered in the process of 
completing the form.
Validation rules are also built into the form where applicable for example the Magnitude field 
uses the validation rule: txtMagnitude].[Text]-"" Or
IsNumeric([txtMagnitude].[Text])=True to enforce numeric input to this field and all fields 
that require input to be first entered to the sub forms and then copied to the main form are 
disabled.
The Add New Chemical form is shown in Figure 26 and is typical of all the sub forms that 
enable the user to enter details about specific entities. This particular form allows the user to 
add new chemicals to the database. The user simply enters the details and then presses the 
Add command to return to the main form.
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B1 Add New Chemical 0 d ®
Add Chemical |
Name:
Gene Name: 
Accession Number: 
Gene Product:
Enzyme Code: 
AGI Number:
Cancel Add
Figure 26: Picture of form Add New Chemical.
The Add command button performs the following functions:
• It checks that there is an entry in all mandatory fields or produces an error message
• It checks for any blank optional entries and if found inserts “ not available”
•  It inserts a new record to the Chemical Table. If at this point a matching record is found, 
the insert new record command is cancelled and the data is copied across to the Add New 
Reaction form.
The values from the Name, GeneName and Accession Number are passed to textboxes in 
form Add New Reaction. The Cancel command button closes the form.
The Find Host form is shown in Figure 27 and is typical of all the sub forms that enable the 
user to search for details about specific entities. This particular form allows the user to search 
for a Host that is already entered in the database.
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Figure 27: Form Find Host
The search method is very versatile to enable the user to quickly find the record that they are 
looking for in several different ways. The three combo boxes contain all the genus, species 
and cultivars in the database, but if the user selects a genus from the combo box, the 
remaining combo boxes are updated to contain only records relating to the selected genus. 
The user can type in the Host that they are looking for in the combo boxes and then click the 
search button to find the record(s) they are looking for. The system also supports the use of 
wild cards to enhance the search facility. Once the user has found the record they want, they 
simply click the Use Selected Host button and this transfers the data to the main Add 
Reaction Form. If the host cannot be found, the user can click the close button and return to 
the main form to add the host. This is the basis of all the search sub forms to enhance the 
usability and learnability of the system.
5 .4 .3 .  E d i t i n g  S c r e e n  D e s i g n
As described in Chapter 4, it is very common for gene names to evolve over time, and 
unknown or null values be filled (for example gene function) due to new experimental 
discoveries. Part of the requirements of this project is to enable this data which affects 
primarily data in the chemical entity of the ER model to be updated. However, due to the data 
modelling constraints, editing and deleting data are not trivial tasks and screens have been 
developed to automate this. This editing facility provides this database with much richer 
information than data simply published in journals as it allows simple tracking and updating 
of names and experimental results that would be unable to manually be traced.
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53 Edit Chemical SI
Name: Gene Name Accession Number AGI Number:
lM|1 Z  I z z  r ZJ
View all - Sort bv Accession Number | View all - Sort by AGI Number1 View all unmatching Name/Accession Numbers 1 View all unmatching Name/AGI Numbers |
Name: Gene Name: Accession Number Gene Product: Enzyme: AGI Number:
► SBE2-1 At2g3S390 0 not known At2g36390
1,4-alpha glucan (starch) branching enzyme SBE2-1 T20482 0 2.4,1.18 At2g36390
1,4-alpha glucan (starch) branching enzyme SBE2-2 H36370 (178K2T7) 0 not available At5g03650
1O-formyltetrahydrofolale synthetase THFS At1g50480 0 not available At1 g50480
10-formyltetrahydrofolate synthetase THFS not available 0 not available not relevant
12-oxophytodienoate reductase AtOPRI AAC78440 0 not available At1g76680
12-oxophytodienoate reductase AtOPRl At1g76680 0 not known A!1g7SG80
12-oxophytodienoate reductase AtOPRI AV439642 0 not available All g76G80
12-oxophytodienoate reductase AtOPRI AV440G13 0 not available All g76680
12-oxophytodienoate reductase AtOPRI not available 0 not available All g76S80
12-oxophytodienoate reductase AtOPRI T04750 0 not available At1g766S0
12-oxophytodienoate reductase AtOPRI U924G0 0 not available At1 g7G880
12-oxophytodienoate reductase AtOPRI Y10617 0 not available At1g76680
12-oxophytodienoate reductase AtOPR2 At1g76B90 0 not known At1g78G90
12-oxophytodienoate reductase AtOPR3 AF132212 0 not available At2g06050
12-oxophytodienoate reductase AtOPR3 At2g06050 0 not known At2g0G050
12-oxophytodienoate reductase AtOPR3 AV440671 0 not available Al2g06050
12-oxophytodienoate reductase AtOPR3 AV442615 0 not available At2g06050
Edit Selected Record |
1 Record: M | 11 l ► | M | | of 11212
Figure 28:The Edit Chemical Main Form
The Edit Chemical Screen shown in Figure 28 allows the user to view the elements from the 
Chemical table. The screen has been designed using the same design principles as described 
in 5.4.1. The top box allows the user to search using typed or selected items from combo 
boxes to find the chemical they wish to edit. Alternatively they can scroll through the records 
displayed in the bottom part of the screen.
In order to edit a record, the user must click to highlight a field and then click on the Edit 
Selected Record command button. This displays the Edit Chemical sub form shown in Figure 
29 and enables the user to edit all aspects of the selected chemical.
Figure 29: Edit Chemical Sub Form
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When the gene name is altered, a check is made to ensure that this will not cause any errors 
with the keys in other tables. Providing this check is satisfied, an automated process rolls out 
the changes to all applicable tables within the database.
The delete function couples as a view record facility as shown in Figure 30. The user can 
scroll through the records or enter the record number that they are looking for. When the 
delete command is clicked, the current record in view is deleted and where appropriate, any 
associated records from other tables.
Figure 30: View/ Delete Reaction form
5.5. Database Integrity
One of the key reasons for developing this database has been to create a store of gene results 
that are consistent and up-to date in order to search and gain information from this data. As 
the level of accuracy of the information that is retrieved is directly related to the level of 
accuracy of the data that is stored in the database it is imperative that the data is of high 
quality. Database integrity refers to the correctness and consistency of stored data (Connolly
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and Begg, 2004). There are several levels of consistency to consider: domain-level integrity, 
entity integrity, and referential integrity which are discussed in the context of this database in 
Section 5.5.1. Database correctness is addressed in Section 5.5.2 where some of the 
validation tools that enhance the consistency of the database are explained.
5.5.1. Database Consistency
Database consistency implies that the data held in the various tables of the database is 
consistent with the concept of the relational model. The following sections examine how this 
consistency is applied to this database.
5.5.1.1. Domain-level integrity
Domain-level integrity ensures that the structure of each field is sound and the values in each 
field are valid, accurate and consistently defined throughout the database. For example, the 
GeneName attribute is repeated in the database and it is always a text data type. Each 
attribute has a domain or set of values that are legal -  for example the Microarray attribute 
can only contain the values ‘Y es’ , ‘No’ or ‘Not Known’ . This means that the attribute domain 
for Microarray is a Text data type consisting of only the three aforementioned strings. These 
constraints are identified during the design phase where each attribute is examined and 
assigned a domain. To ensure that this integrity is not violated during the input of new data, 
integrity constraints are developed and implemented in both the database and the input 
screens. This reduces the chance of user introduced errors in the system.
In the database itself, fields that are required are tagged, and default values are set for non- 
required fields where it would not be appropriate to have null values. Additional tables have 
been included in the database to act as lookup lists. For example, table ListOrganelles 
contains all known organelles within the database. In the input screens, the user is presented 
with a combo box that contains this list. The user may only select an organelle from this list. 
If a new organelle is found, it must first be added to the table. This technique is used for 
several entities within the database to prevent typographical errors being introduced and also 
ensures that the same object is not defined twice (for example American spelling/ English 
spelling) which assists with future data mining. Validation rules are built into some of the 
input fields to enhance data integrity (for example to prevent users entering letters where 
numbers are required).
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E ntity integrity is dealt w ith  by  the primary k eys and ensures that there are no duplicate  
records held  in tables. Section  5 .2 .3  refers to h ow  the primary k eys w ere assigned  and 
ou tlin ed  the problem  that is caused  by the changeable nature o f  the data. There is a large  
variance w ith respect to the am ount o f  data availab le for each published  experim ent. T his  
m eans that it is very lik e ly  that m any records that the b io lo g ist w ill w ant to include w ill not 
contain  entries for all the attributes. A nother problem  is that som e o f  the data is m issin g  
b ecau se it has not been  d iscovered  exp erim entally  yet. This cau ses problem s w ith  both  
d om ain -level and entity integrity and rules need  to be established  to d ecid e h ow  the m issin g  
data w ill be dealt w ith. M issin g  data cau ses problem s for several reasons:
1. If there is m issin g  data in a primary k ey  it w ill cause an error in the database as null 
entries are not a llow ed
2. If there is m issin g  data in a required fie ld  that is not necessarily  a k ey  fie ld  this w ill again  
cau se an error.
3. If there is m issin g  data in  a non-required fie ld  it needs to be d ecid ed  i f  the fie ld  w ill be  
null or substitute entry m ade as null fie ld s in databases can cause con flic t errors.
T he problem  w ith  null fie ld s is that null represents m issin g  or unknow n va lu es -  null d oes not 
represent zero or a string o f  text or one or m ore blank spaces. T his m eans that nulls do not 
have a data type (for exam p le  they are not c la ssed  as a text or a num ber type) and i f  you w ere  
to u se  a m athem atical sum  w ith  a null e.g . 1 * null, this w ould  create an error.
T he data is such that som e o f  the fie ld s that m ake up the primary k ey  m ay be unknow n at 
present but w ill be a llocated  a nam e or description at a future date, for exam p le in the 
ch em ica l table, the attribute nam e is o ccasion a lly  m issin g  or not yet a llocated . T his is an 
unusual situation in database d esign  as for entity integrity w here no com p on en t o f  a prim ary  
k ey  is  a llow ed  to have a m issin g  value o f  any type (R itch ie, 2002).
C onsideration  then had to be g iven  as to w hat should  be input into the fie ld s w here the 
experim ent had been  accepted  for data in clu sion , but there w as m issin g  data entries in the 
prim ary k ey  fie ld s. A  set o f  rules w as created w h ich  included rules for handling m issin g  data  
in the primary k ey  fie ld s and a lso  the non-m andatory fie ld s. It w as d ecid ed  that it w ou ld  be  
m ore con sisten t to avoid  null attributes. T his is  due in part to the problem s that null fie ld s can
5.5.I.2. Entity Integrity
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cau se in a database, and a lso  b ecau se it w as observed  that the b io lo g ists  already had som e  
ex istin g  unwritten rules o f  usin g  “not ap plicab le” or “unkn ow n” rather than leav in g  em pty  
fie ld s. In order to ensure con sisten cy  o f  data, a list o f  rules w as drawn up to provide  
guidan ce about w hat to enter in fie ld s w here there is the potential for null input e .g . 
description =  “unknow n” and these rules w ere a lso  built into the database design . It is vital 
for the su ccess o f  the database that these rules are adhered to as for the planned searches to be  
su ccessfu l, i f  the user is look in g  for “unkn ow n” but “not applicable” has been  used in  its 
place this w ill cause the search to fail. T his is a lso  im portant as it a llow s us to identify  
records w ith  m issin g  data and query external data sources on a regular basis to find out i f  new  
inform ation is available.
5.5.I.3. Referential Integrity
R eferential integrity ensures that a pair o f  tables are synchronised  w h en ever data is entered, 
updated or deleted  from  either table and should  ensure that the data o f  one table d oes not 
contradict the data o f  another table. S p ecifica lly , every  foreign  k ey  va lue in a table m ust have  
a m atching primary k ey  value in the related table. T he input screen and ed it screen d esign  
ensures that referential integrity is m aintained as they control the order in w h ich  data is added  
to the database tables. T he input screens are set up to prevent attem pts to add duplicate  
records to tables and ensure that a record contain ing the primary k ey  ex ists  before a record is 
added to a ch ild  table. T he edit screen w as m ore problem atic as the user cou ld  potentia lly  be  
altering primary k ey  va lu es w h ich  w ou ld  cau se a referential integrity error in the 
corresponding foreign  key values. T he inbuilt procedure for the ed iting ch em ica l records is:
•  C heck  i f  the change w ill cause a duplicate record entry in the ch em ica l table
•  If not, then add the n ew  record to the ch em ica l table and then am end all related records in  
the reaction table by  running an update query to find all the records that m atch the o ld  
primary key  va lues (the foreign  k eys) and updating them . F inally  delete  the o ld  record  
from  the C hem ical table.
•  If adding the ed ited  record to the ch em ical table w ill cause a duplicate record entry in 
C hem ical sim p ly  ch eck  to ensure that the m ost up to date data is held  in the none k ey  
fie ld s o f  the ch em ical record and update this record, update the reaction table records as 
p reviou sly  described and in both cases, update the G ene D ictionary table.
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5.5.2. Data Correctness
D ata correctness im p lies that the data capture for entry into the database d oes in fact correctly  
represent the ‘real w orld ’ data that it is supposed  to. T his database has to tack le m any quality  
issu es in clu d in g  nam ing con ven tion s, annotation updates, errors in the experim ents  
th em selves and gen e nam e updates and this section  describes som e o f  the to o ls  that have been  
d evelop ed  to provide further validation  and correctness to the captured data.
5.5.2.I. Gene Name Updating
T he n eed  to standardise gen e nom enclature is im portant (L yon et al., 2 0 0 2 ), thus the nam es  
used in the database correspond w ith  current N ational Centre for B io tech n o lo g y  Inform ation  
(N C B I) U n ig en e  c la ssifica tion  rather than those c ited  in  the original publication , u n less a 
m ore recent prim ary publication  indicates otherw ise. S om etim es ch an ges in gen e  
id entification  are sm all but in other cases they can be dramatic and critical i f  signal 
transduction pathw ays are to be correctly understood. Figure 31 sh ow s the un igene form  
w h ich  is a subform  o f  the Edit C hem ical form  described  in section  5 .4 .3 . T he un igen e form  
provides the user w ith  a help fu l ch eck  facility  w h en  they are updating gen e details. If the user  
click s on  one o f  the A ccess io n  N um bers o f  on e o f  the chem icals d isp layed  in the Edit 
C hem ical form , the U n ig en e  form  is displayed. T he U n igen e form  se lec ts  the A ccess io n  
N um ber o f  the particular ch em ical and u sin g  E xten sib le  M arkup L anguage (X M L ) 
tech n o lo g y  con n ects to N C B I’s U n igen e database and retrieves the gen e nam e, U n igen e ID , 
gen e function  and A G I num ber that U n igen e h old s. T his a llow s the user to easily  find out 
com parative data from  a separate source during the ed iting process o f  a gen e and is  
particularly usefu l for gen es that m ay have an unknow n nam e or A G I num ber or gen es that 
have co n flic tin g  data. A s p rev iou sly  m entioned, N C B I’s U n igen e database has been  ch osen  
as the gen e details standard b ecau se it is the on ly  large database that contains gen e  
standardised data for m ultip le plant sp ecies (but not gen e exp ression  data).
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Figure 3 1: Unigene sub form from the Edit Chemical form of the database.
Feedback from the user was very positive for the Unigene search and further investigation 
showed that there are around 12% of genes with unknown function in the database. Knowing 
the function of the genes is very important and can give insight into what role it may play in 
the signalling process. Therefore regularly checking and updating information for these genes 
is vital and is where the database differentiates itself from simply collecting static results 
reported in journals. To enhance this updating process, a routine to select all genes with 
unknown function and batch process these records through NCBTs Unigene database to 
establish if there are any updates has been created. UnigeneSearch is a companion program 
for the database that allows the user to search for all the Accession Numbers that have 
‘unknown’ in the corresponding gene name attribute or ‘not available’ in the AGI attribute. 
The selected Accession Numbers are loaded into a text file and the program accesses NCBI’s 
Unigene and Gene databases to find out if the gene function has been established or an AGI 
number found for each of the Accession Numbers. In order to use the package, the user is 
prompted to select a text file to load. The file name the user selects is used as the name of the 
excel file the results are saved in -  which is saved to the same directory as the 
UnigeneSearch.exe file resides in.
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The results, o f  w hich  a sam ple is show n in Table 11, d isp lay the A ccess io n  num ber, the gen e  
id, the u n igen e nam e, the gene nam e and links to the geo , h om olog , nu cleotid e and gen e  
databases for the particular A ccess io n  N um ber. T he program  is separate to the database as the 
results n eed  to be m anually ch ecked  and not autom atically  updated.
D ata from  database R esults from  N C B I
Accession AGI Gene ID Unieene Name Gene NameNumber
103C7T7 At5g42530 At5g42530 Expressed protein (At5g42530) mRNA, complete
expressed protein [Arabidopsis 
thaliana]
104A7T7 not available Not Found Not Found Not Found
105P15T7 At3g15450 At3g 15460 Expressed protein (At3g 15450) mRNA. complete
brix domain-containing protein 
[Arabidopsis thaliana]
110F10T7 At5g45500 At5g45500 Expressed protein (At5g45500) mRNA, complete
expressed protein [Arabidopsis 
thaliana]
AI618746 At5g51550 At5g51550
Phosphate-responsive 1 family 
protein (At5g51550) mRNA, 
complete cds
phosphate-responsive 1 family protein 
[Arabidopsis thaliana]
AI618753 At3g46540 At3g46540
Epsin N-terminal homology 
(ENTH) domain-containing 
protein /  clathrin assembly 
protein-related (At3g46540) 
mRNA, complete cds
epsin N-terminal homology (ENTH) 
domain-containing protein /  clathrin 
assembly protein-related [Arabidopsis 
thaliana]
AI618755 not available Atlg66860 Expressed protein (Atlg66860) mRNA, complete
expressed protein [Arabidopsis 
thaliana]
Table 11: Sample results from UnigeneSearch.exe program. The first two columns on the left show the data 
from the project database. The three columns on the right shown the results obtained from the NCBI databases.
The reason that the results are quality ch ecked  first and not sim ply uploaded  is  that the  
un igen e results som etim es returns “E xpressed  protein” or sim ilar phrases for the gen e  
function w h ich  is the equivalent o f  ‘not k n ow n ’. G enes w ith  this result m ust be m aintained as 
‘not k n o w n ’ in accordance w ith  the data rules and ch eck ed  again at a later date.
T he results in the last three row s o f  Table 11 w h ich  are h igh ligh ted  in grey dem onstrate the 
u sefu ln ess o f  this search as new  inform ation is uncovered. In tw o exam p les w e n ow  h ave a 
m uch m ore detailed  description for the gen e fu nction  and in  one case , w e  n ow  have an A G I  
num ber for an a ccession  number. For the A rabidopsis data, the database is very u sefu l for  
link ing together reactions based on A ccess io n  N um bers described as gen es o f  unknow n  
function. B y  u sin g  the un igene too l to convert accession  num bers into A G I num bers (as
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dem onstrated in the U n igen e exam p le in T able 11) w e  have estab lished  that that all the 
fo llo w in g  accession  num bers reported in separate journal articles are either dow n-regulated  
by chitin  (H 37231 , R 9 0 1 4 0 , T 4 1 8 0 6 ), drought (A V 8 2 3 7 4 4 ), eth ylen e (R 9 0 1 4 0 ), lo w  ox y g en  
(A t2 g l0 9 4 0 ) , or sodium  chloride (A V 8 2 3 7 4 4 ), or up-regulated b y  sa licy lic  acid (R 90140 , 
H 37 2 3 1 ) are actually the sam e gen e i.e . A t2 g l0 9 4 0 . This provides m uch m ore insight to h ow  
this gen e responds in the signal transduction process and provides a set o f  related data 
(Button et al., 2004).
5.5.2.2. Gene Dictionary
There is a gene dictionary w hich tracks all changes m ade to the nam e or A G I num ber o f  a 
gen e during the ed iting process. T his w as d esign ed  for tw o reasons, one to capture the type o f  
changes that are m ade to the gene data, and tw o so  that w e  can backtrack our gen e expression  
results to show  h ow  w e reached the currently assigned  nam e by providing historical 
term inology, and if  n ecessary  correct an error m ade in the ed iting process.
W hen a chem ical record is  edited  on ly  one record is altered in the C hem ical table. H ow ever, 
because the gene nam e is a foreign  k ey  in the reaction table, i f  this is m od ified  then all ch ild  
records in the reaction table m ust also be am ended w hich  can m ean m od ify in g  hundreds o f  
records. The M icrosoft A ccess  database is designed  so that once a record is  changed it is 
saved  and it can be d ifficu lt or im p ossib le  to return the database to the pre-edited state. 
B ecau se o f  this it seem ed  a w ise  precaution to construct a data trail o f  the alterations to the 
chem ical table as it has been  identified  at the planning stage that it w as lik e ly  there w ou ld  be  
a large num ber o f  changes. A t the tim e o f  w riting there have been  over 7 0 0 0  m od ification s to 
the chem ical nam e or A G I attributes. The contents o f  the G ene D ictionary are interesting as it 
sh ow s that the gene nam e changes vary from  subtle sem antics such as rem oving a com m a or 
m od ify in g  abbreviations to a huge leap for exam p le from  an unknow n gen e nam e to an 
identified  protein. T able 12 sh ow s som e sam ple records from  the gen e dictionary. The  
changes m ade are underlined in b old  and sh ow  the com p lex ity  o f  the gen e nam es. There are 
several exam p les o f  sm all changes to the gen e nam e form at and som e typographical errors 
w hich  dem onstrate the problem s that the lack  o f  nam ing con ven tion s bring and also raises 
issu es that need to be considered w hen  creating SQ L , searches as straight com parison  
searches m ay not su ffice . It is also worth noting that m any o f  the gen e nam es have changed
several tim es in the tim e the database has been  operational and each  change can be a major
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descrip tive change. T his data can also be used as a k n ow led ge base o f  o ld  to n ew  historical 
gen e nam es that has the potential for use in text m ining.
ID Date
Changed
Old Name Old Gene 
Name
Old
Accession
Number
New Name New
Gene
Name
New
Accession
Number
6902 16-Feb-07 adenine
D h o s D h o rib o s v ltra n s fe ra s e .
D u ta tiv e
not known At4g22570 adenine
p h o s p h o r ib o s y lt r a n s f e ra s e
not known At4g22570
6900 16-Feb-07 A C T  d o m a in -c o n ta in in g
protein
ACR1 At5g65890 A C T  d o m a in  c o n ta in in g  Drotein ACR1 At5g65890
6898 16-Feb-07 a a l ic  enzyme/ oxidoreductase not known At5g11670 m a lic  enzvme/ oxidoreductase not known At5g11670
6897 16-Feb-07 4-coumarate-CoA liease not known AU093458,
AU093459
4-coumarate:CoA liease not known AU093458,
AU093459
6895 16-Feb-07 3-deoxy-arabino-heptulosonate- 
7-phosphate (DAHP) s
DHS1 M74819 3-deoxy-arabino-heptulosonate-7- 
phosphate (DAHP) s
AtDHSl M74819
6887 15-Feb-07 lipid-binding serum glycoprotein not known Atlg04970 lipid binding serum glycoprotein not known At 1g04970
6886 15-Feb-07 l io id - t r a n s f e r  protein OsLTP5 AU063656, 
AU172383
l io id  t r a n s f e r  Drotein OsLTP5 AU063656, 
AU 172383
6868 06-Feb-07 fattv acid hvdroxvlase (FAH1) n o t  k n o w n At2g34770 fatty acid hydroxylase FAH1 At2g34770
6862 06-Feb-07 chalcone svnthase tn a r in e e n in -  
c h a lc o n e  s v n th a s e )
n o t  k n o w n At5g13930 chalcone synthase AtCHS At5g13930
6860 01-Feb-07 u n k n o w n not available AV795353 g lu ta m a te -a m m o n ia  lig a se not
available
AV795353
6857 31-Jan-07 xylosidase n o t  k n o w n BAB09906 xylosidase AtBXLl BAB09906
Table 12: Sample of contents from the Gene Dictionary
5.5.2.3. Validation Screen
There are four other u sefu l functions that enable the data to be ch eck ed  and edited as 
appropriate. T h ese  functions are additional fac ilities that are availab le in  the Edit C hem ical 
form  described  in  S ection  5 .4 .3  and are:
1. V iew  all -  Sort by  A ccess io n  num ber
2. V iew  all -  Sort by  A G I num ber
3. V ie w  all unm atching N a m e/A ccessio n  num bers
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4. V iew  all unm atching N am e/A G I num bers
The first tw o functions w ere requested b y  the b io lo g ist to sim ply sort the ch em ica ls by  
accession  num ber or A G I number. T his a llow s the experienced  user to scan through the  
results for interesting or unusual data.
The third and fourth functions are the m ost u sefu l in term s o f  m aintaining the data. T hey  
provide the fac ility  to identify  records that have the sam e A ccess io n  N um ber but a different  
or unknow n N am e or to identify  records that have the sam e A ccess io n  N um ber but a different 
or unidentified  A G I num ber. T able 13 sh ow s a sam ple o f  the results from  the unm atching  
N a m e/A ccessio n  num ber search. The three pairs o f  m atching A ccess io n  num bers are 
high ligh ted  in black outline b o x es. O ne w ou ld  exp ect that as the A ccess io n  num bers are the 
sam e, the nam e w ou ld  b e the sam e so this prom pts further investigation  to estab lish  w hat the 
m ost up-to date nom enclature is  for this gen e u sin g  the unigene form  and then update the 
database. T he sam e procedure is used for the unm atching A G I/A ccessio n  num bers. The  
reason that this is usefu l is that it links reactions in the database and enables us to find m ore  
results that relate to a sp ec ific  gene thereby g iv in g  m ore inform ation about how  each  
individual gene reacts under m ultip le conditions.
Name: Gene Name: Accession Number Gene Product Enzyme: AGI Number
cytochrome P450 DWF4/CYP90B1 AF044216 0 not available At3g506G0
steroid 22-hvdroxvlase CYP90B1 ! DWF4 AF044216 0 not available At3o50GG0
late embryogenesis abundant LEA SAG 21 homo not available AF069298 0 not available At4g02380
oectinesterase Dutative BRU18 AF0G9298 0 not available not available
chitinase (glycosyl hydrolase family 19) not available AF104919 0 not available At4g01700
DNA binding protein not available AF104919 0 not available not available
Table 13: Sample of unmatching Name/ Accession numbers.
For com p leten ess, another ch eck in g  fac ility  availab le to the user is a subform  o f  the Edit 
C hem ical that d isp lays the G ene O n to logy  (G O ) term s for a se lected  A G I number.
5.6. Testing of database
O nce the data structure and interfaces have been  im plem ented, the old  data needs to be  
converted  and loaded  into the n ew  database and the database needs to be tested  to ensure that 
it m eets the requirem ents and d esign  sp ecification s.
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5.6.1. Data Conversion & Loading
T he procedure o f  con vertin g  the data w as particularly d ifficu lt as the gen e  exp ression  data 
had p rev iou sly  been  stored in a sing le table and there w as not data for all the required  
attributes nor w as there any structure. The data had to be backtracked to the original journals  
that it w as captured from , appropriate attributes co llec ted  and then the data restructured and  
validated  before b ein g  load ed  into the new  database. To test the con version  process, a sub-set 
o f  the added records w ere random ly selected  and ch eck ed  against the database to ensure that 
the records w ere stored correctly.
5.6.2. Testing Procedure
C on n elly  and B eg g  (2 0 0 4 ) describe the purpose o f  testing in the con tex t o f  a database 
application  as the process o f  running the database system  w ith  the intent o f  finding errors. 
T estin g  should  analyse the functional and structural aspects o f  the database as w e ll as the 
usability  o f  the interface and the tests for the database w ere d esign ed  to consider:
•  Interface T estin g  - ensure the user interface b eh aves as exp ected , is u seab le and validation  
rules w ork correctly
•  V erification  T esting  -ensure all functional sp ecifica tion s are accurately m et and check  
there are no bugs in the cod e from  either the Structured Q uery L anguage (SQ L ) w h ich  is  
u sed  to search the data or the V B A  w hich  is used  in d esign in g  the interface.
•  V alidation  T esting  - sh ow  that the w h o le  application m eets the original form al 
requirem ent sp ecifica tion s
5.6.3. Testing Results
A  sam ple o f  som e o f  the tests that w ere carried out on the database are sh ow n  b e lo w  in  Table  
14.
Test
No.
Test Description Test Data Expected Output Actual Output
1 Search for all 
treatments
SQL search “Select * 
from Treatments”
All treatments returned Fail - All bar one
treatment
returned.
2 Add new records to 1st Record Both records Fail - Unable to
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chemical table Name: Test
GeneName: not available
AccessionNumber: not 
known
ECNum: unknown 
AGINum: not relevant
2nd Record 
Name: Test
GeneName: not available
AccessionNumber: not 
known
ECNum: not known 
AGINum: Atlgl 1111
added add 2nd record.
3 Enter new reaction 
-  check interface 
operates correctly
Sample data for a full 
gene expression result 
was selected from a 
journal
Reaction Added and all records 
in other entities added
Success - All 
records 
successfully 
added.
4 Leave blank data in 
required fields for 
adding reaction -  
check domain 
integrity
Sample data for a full 
gene expression result 
was selected from a 
journal
Error message to prompt for 
more data entry
Success -  Error 
message prompt 
displayed.
5 Leave blank data in 
non-required fields 
for adding reaction
Sample data for a full 
gene expression result 
was selected from a 
journal
Expect that the rules for 
handling missing data should be 
applied and ‘unknown’ or ‘not 
available’ should be inserted to 
missing attributes where 
appropriate and records added
Success -  
missing data 
correctly filled 
and record added.
6 Edit a Chemical -  
Check referential
Change the Name from 
Test to Testl
Expect that the Chemical record 
should be updated and all
Success -  all data 
updated.
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integrity records in reaction containing 
the foreign key should be 
updated
Table 14: A small selection of some of the tests that were carried out on the database
There w ere a few  errors p icked  up in the testing process o f  the database ranging from  data 
form atting to dom ain sp ec ific  -  tw o are described  below :
1. Square brackets [ ] are accepted as an attribute value by M icrosoft A ccess  but are not 
picked  up during the SQ L  search. O ne treatm ent sodium  nitropruside [an N O  donor] had  
these brackets. It is considered  go o d  practice to avoid  characters such as am persands, 
percentages, asterisks, brackets and quotation marks fie ld s or fie ld  nam es but this is 
d ifficu lt to avoid  w ith  the m ake up o f  the gen e nam es. T he record and all related reaction  
records have been  am ended to sod iu m  nitropruside (an N O  donor) and a n ew  validation  
rule to reject any user entries w ith  square brackets has been  added to the input screens.
2. T he user is unable to create a new  record in the chem ical table: It w as found during the 
testing process in  the m ajority o f  ca ses it w as p ossib le  to add a record to the C hem ical 
table, but if  a gen e from  A rabidopsis has the sam e nam e as a gen e from  another sp ec ies  
and an unknow n a ccession  num ber then a record w ill already ex ist and the user w ill not 
b e able to create a n ew  record to in clu d e the A G I num ber (w hich  is a none k ey  fie ld ). 
T his w ou ld  be a rare occurrence as m ost records have an a ccession  num ber w h ich  w ou ld  
be different for d ifferent species. H ow ever , a new  b usin ess rule had to be created to avoid  
this situation. T his rule stipulates that i f  the A ccess io n  N um ber is unknow n, but the A G I  
num ber is know n, the A G I num ber is input to the A ccess io n  N um ber field .
On com p letion  o f  the testing, the test results sh ow ed  that the database and the input screens  
w ere w orking correctly.
5.7. Summary
A n independent pub lish ed  review  o f  the n ew ly  created database (Sam son, 2 0 0 5 ) included  in  
A p p en d ix  II found “that there are no plant gen om es represented in E nsem bl, and even  
M ed lin e, surely an essen tia l too l for all b io lo g ists , deals, deliberately, w ith  ‘very broadly  
m ed ica lly  related’ journals on ly” . T he rev iew  fin d s that “the plant com m u n ities are, at last, 
setting up som e unique resources. D R A S T IC , a D atabase R esource for S ignal Transduction
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in C ells  is a u sefu l, and relatively n ew , p lant-specific  b io in form atics resource” . W ith  the 
database n ow  su ccessfu lly  constructed and tested to the users and to requirem ents 
sp ecifica tion s standards, the next step in the process is to d eve lop  too ls to enable the user to 
analyse the data.
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Chapter 6 DRASTIC-INSIGHTS: Data Toolset
6.1. Introduction
T his chapter describes and evaluates the D rastic-Insight too lse t as described in the paper 
published  in the N u c le ic  A cid  R esearch Journal (Button et al., 2 0 06 ). A  dow nload able gu ide  
for usin g  D R A S T IC -IN S IG H T S  has been  d evelop ed  to assist users and is availab le in  
A ppendix  VI. T he too ls  w ere d evelop ed  based  on the requirem ents analysis and k ey  
ob jectives from  Chapter 2
6.2. Gene RoadMap
T he requirem ents process identified  several m ethods o f  investigating  data that m ay provide  
insights into signal transduction pathw ays. T h ese  have been  im plem ented  in the RoadMap 
too l w hich  has four types o f  searches (C om m on G enes, U nique G enes, G ene R oadM ap &  
Pathw ay R oadM ap) providing sum m ary representation on all or selected  gen es from  the 
D R A ST IC  database and the ability to drill deeper:
C om m on G enes - T his search enables the user to determ ine gen es that are co-regulated  by the 
treatm ents that they  have selected.
U nique G enes - T his utility  identifies all gen es that are on ly  regulated by one treatment.
G ene R oadM ap - T o operate the G ene R oadM ap (Figure 32), the user m ust se lect the gen es, 
sp ecies and regulation (up, dow n or both) to include in the search. A n  initial ch eck  is run to  
establish  the treatm ents to include in the search and populate the colum n and row  headings, 
after w hich  the too l p rocesses and d isp lays the data. T he m ap itse lf  (show n in F igure 32  Part 
A ) is dynam ic and w ill a llow  the user to v iew  results ranging from  a sm all num ber through to  
results coverin g  all sp ecies w ithin the database. B oth  row  and co lum n headings o f  the G ene  
R oadM ap are the sam e and disp lay each  treatm ent in the current search. T he c e lls  that are 
highligh ted  in red indicate the results that correspond to on ly  one treatment. T he ce lls  
high ligh ted  in y e llo w  indicate potential n ew  d iscoveries o f  interest w h ich  w ou ld  o therw ise  
rem ain opaque.
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The Gene RoadMap can be used as a lookup table. For example if we want to know if there 
are any genes that are regulated by cold and abscisic acid (ABA), we can scan along the cold 
row until we come to the ABA column. The cell shows that there are fifty five genes that are 
regulated by both treatments. This tool provides the facility for the user to mine through 
different layers of data. For example, functionality to display all gene names for any result is 
found if the user double clicks on a cell as shown in Figure 32 Part B where the cold/ABA 
cell has been selected.
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Figure 32: Gene RoadMap screen showing results from a search of all genes from Arabidopsis thaliana which 
are up-regulated. The different Parts (A-D) demonstrate the diverse ways in which the RoadMap tool can be 
used to examine the dataset.
The user can then further investigate individual genes by clicking on the gene name. This 
allows all the references that support the individual gene expression data for each treatment to 
be obtained, thus providing the user with a level of confidence for each result (Figure 32 Part
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C). In addition, the total number of genes in the map along with the number of times each 
gene occurs is displayed. The user can locate every entry for a particular gene by clicking on 
the gene name. The tool will then highlights all cells in which the gene is featured allowing 
for further investigation (Figure 32 Part D). The Gene RoadMap tool demonstrates that it is 
possible to identify groups of treatments that appear to produce similar regulatory results. 
This has yielded both expected and unexpected grouping results.
6.3. Clustering Analysis of Treatments
From the results provided by the Gene RoadMap, the next stage of research focused on 
identifying groups of ‘similar’ treatments. We sought to find a method that could identify any 
groupings that existed between treatments as these could indicate shared signal transduction 
pathways. Narayanan et al. (2002) described the use of Hierarchical Clustering to establish 
the similarity of two bio sequences across all attributes. This data mining technique has been 
applied to the database. The data required preparation in advance of applying the clustering 
technique as follows:
1. Selection of a species and compilation of an array of all treatments that have results for 
the species.
2. Compilation of an array of all genes that have results for the treatments and species.
3. Creation of an array for each treatment which holds the response result for each selected 
gene. The resulting gene expression data is categorical and has four possibilities 
classifications: up, down, same, not known (N/K). Each treatment will have an array of 
results of equal number as shown in Table 15.
Treatment Gene 1 Gene 2 Gene 3 Gene n
A Up Up N/K Up
B Up Up Up Up
C N/K N/K N/K Down
D Up N/K Up Up
Table 15: Example of the results produced from the cluster search. Each treatment can now be compared to 
identify similar treatments.
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The ‘distance’ between treatments is calculated using a matching coefficient for each pair of 
treatments. It is computed by dividing the total number of genes by the number of matching 
genes in each pair of treatments. This produces a 2-D matrix of treatments by treatments with 
the corresponding matching coefficient for each. In order to produce a visual result, the 
treatment matrix is processed using the statistics package plclust method (Ihaka and 
Gentleman, 1996). Initially, each object is assigned to its own cluster and then the algorithm 
proceeds iteratively, at each stage joining the two most similar clusters, continuing until there 
is just a single cluster. At each stage distances between clusters are recomputed by the 
Lance-W illiams dissimilarity update formula according to the particular clustering method 
being used. The complete linkage hierarchical clustering method produced the similarity tree 
for A.thaliana shown in Figure 33. Each branch represents a treatment. The magnified sample 
of the diagram shows the treatment results for one sub-cluster of the tree. The diagram 
illustrates treatment groupings that have been indicated in the literature. For example, 
jasmonates have been implicated in the wounding response and abscisic acid has been 
associated with cold tolerance.
Figure 33: Dendrogram created using A.thaliana data and R Stats Package. As shown in the enhanced portion of 
the diagram, each branch in the cluster represents a treatment.
Thus the results demonstrate that this tool is capable of quickly producing interesting 
clustering output, but to be truly effective a more even distribution of data is required. The 
results from the clustering yielded the requirements for the next tool which provides a method 
of comparing the regulatory patterns of groups of genes.
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6.4. Expression Patterns
Expression Patterns show all relationships between selected genes and the treatments (based 
on the data from the database). The treatments are placed around the circle edges of the 
diagram predominantly alphabetically. This order may in the future be informed by the 
results from the clustering tool. Genes that are found to be regulated by only one treatment 
are noted outside the circle. Genes that are co-regulated are placed inside the circle with lines 
drawn to each treatment to which they respond. The data used in the creation of the diagram 
is obtained through an interactive web tool. This tool enables the user to select a group of 
genes such as ‘all kinases’ or ‘all transcription factors’, a species and a regulation from the 
database. A table is produced for each group of genes selected displaying all the genes and 
treatments that regulate the specified group. The cells on the table that have a result have 
been hyperlinked to allow rapid retrieval of the records from the database. However, in this 
format, the data is very sparsely spread and difficult for the user to interpret. To provide a 
more insightful diagrammatic view, the resulting data has been used to manually create the 
diagrams shown in Figure 34.
Figure 34 is an example of an expression pattern diagram for stress-responsive kinases up- 
regulated in A.thaliana. The magnified Part A shows MAP kinase 3 gene which in this 
diagram is shown to be up-regulated by calyculin, chitin, cold, sodium chloride, 
drought/dehydration/wilt, hydrogen peroxide, jasmonate (methyl), mechanical stimulation, 
salicylic acid, UV and wounding. Part B shows gene MAP kinase kinase kinase up-regulated 
by cold, sodium chloride, jasmonate (methyl), mechanical stimulation, salicylic acid and 
wounding. It can be seen in Figure 34 that some kinases (e.g. MAP kinase 3 (AtMPK3; 
At3g09010) and MAP kinase kinase kinase (AtM EKKl; At4g08500)) are up-regulated by a 
number of treatments whilst others have only been reported to be up-regulated by a single 
treatment. As more information is put into the database, some of the kinases currently shown 
as up-regulated by a single treatment will probably be up-regulated by other treatments. 
Genes for proteins involved in the same signal transduction pathway are likely to be co­
regulated and show the same response to a range of treatments.
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Figure 34: Expression Pattern Diagram for kinases
Figure 35: Expression Pattern Diagram for transcription factors
Thus, to find kinases, transcription factors, and calcium-binding proteins that are in the same 
signal transduction pathway one should compare expression patterns between these diagrams. 
Figure 35 shows the Expression Pattern Diagram for stress-responsive transcription factor 
genes up-regulated in A.thaliana. There are several instances where genes are showing 
similar patterns of regulation one of which is highlighted in Figure 35. Verification that these 
genes are really associated requires experimental confirmation, but the database, and these
diagrams, promote more targeted hypothesis formation. This type of analysis is useful for 
providing a framework for understanding signal transduction responses and to assist with 
identifying regulatory gene networks. This approach is also useful for finding genes which 
are associated with infection by plant pathogens and that are also affected by environmental 
stresses such as drought and cold.
Figure 35 shows an expression diagram for stress-responsive transcription factors up- 
regulated in A.thaliana. The magnified part of the diagram shows the gene for the 
Transcription Factor (TF), DREB2A (At5g05410) which is up-regulated by cold, sodium 
chloride, drought/dehydration/wilt, hydrogen peroxide, UV, harpin and wounding.
6.5. INSIGHTS data tools
Following on from the development of PC based tools, a web interface was developed to 
enable many scientists to use the features of the DRASTIC-INSIGHT tools. At a simple level 
the web interface (software available in attached CD) permits users to find published 
information on expression data for plant genes of interest. More importantly, INSIGHTS 
offers a number of tools to mine further information and create new knowledge and 
formulation of hypotheses. Some mining tools use AGI numbers where expression data 
correctly identify a specific member of a gene family. Through the INSIGHTS integrated 
toolkit users may investigate data in the following ways:
6.5.1. General Database Search
General database search provides a basic query function for the database. The user can select 
the following parameters: treatments, species, gene, regulation and date. The search returns 
the results in tabular format which can be sorted on all parameters and provides links to the 
primary references.
6.5.2. DRASTIC Statistics
DRASTIC statistics provides an up-to-date list of statistics for the database including the total 
number of records, species and treatments. It also provides a breakdown of both records per 
species and records per treatment, which can be ordered alphabetically or numerically. To 
gain a more in-depth view, a table of data providing statistics on the number of records by
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species or treatment can be obtained. These can be further mined to view individual records 
with bibliographic references.
6.5.3. Accession Number Search
Accession number search provides a query function specifically for the accession numbers in 
the DRASTIC database. Selectable parameters include accession number, treatment, 
regulation type and date. The results are displayed in tabular format which can be sorted, 
providing links to references.
6.5.4. AGI Search
Arabidopsis genome initiative search provides a query function specifically for AGI numbers 
in the DRASTIC database. The user can select from AGI number, treatment, regulation and 
date.
6.5.5. Venn Diagram
Venn diagrams enables the creation of Venn diagrams using the A.thaliana data from the 
DRASTIC database. The user can select two or three treatments and the tool will process the 
selections and output the results as a Venn diagram. The Venn diagram tool displays the 
number of genes regulated by each individual treatment or by multiple treatments based on 
the DRASTIC data. Records where genes have been up-regulated, down-regulated or both 
(up or down) can be included. The diagrams can be mined further by clicking on a segment of 
the diagram to view the individual records and relevant bibliographies.
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Figure 36: Web interface for the Pathway tool.
Figure 36 is an example of the web interface for the pathway tool. (A) shows the search page 
for a set of AGI numbers. The pathway result is shown in (B). Up-regulated genes are shown 
in red. Down-regulated genes are shown in blue. Green cells indicate that both up- and down- 
regulation record(s) are held in DRASTIC. The pathway can be further mined by choosing 
any coloured cell which will display all the records for the AGI/treatment combination as 
shown in (C). The references for each record can be selected as shown in (D).
6.5.6. TAIR AGI Search
TAIR AGI search enables the user to search records that include the AGI number and directly 
use them with the TAIR chromosome mapping and functional categorization tools, which are 
specifically designed to analyse AGI data. The user can select a subset of records from
DRASTIC using a search on a treatment, multiple treatment or gene group (such as kinases) 
and regulation type. The selected data are then formatted for use with the TAIR tools.
6.5.7. Pathway Tool
Pathway tool enables the user to extract and visualize knowledge from the database to 
hypothesize potential relationships between signalling elements. It includes a search facility 
to allow selection of a number of A.thaliana genes by AGI numbers. A ‘pathway’ is produced 
to display the regulation of selected genes in response to different treatments (Figure 36). 
Any groups of genes that are always co-regulated are identified, suggesting that they are 
likely to occur in the same signal transduction pathway. The pathway tool can be used to 
indicate the relatedness of induction patterns for selected genes. For instance, it can be shown 
that up-regulation of calreticulin 3 (Atlg08450) in Arabidopsis has been shown to be 
associated with the up-regulation of a number of potential signalling genes (including 
kinases), which does not occur if calreticulin 1 (Atlg56340) and calreticulin 2 (Atlg09210) 
are down-regulated. The pathway tool can also be used in a hypothesis testing manner or as a 
quality control check tool for data in known signal transduction pathways.
6.5.8. RoadMap Tool
Roadmap tool creates lookup tables to find genes that are co-regulated by different 
treatments. The user can ‘drill down’ through the map to investigate individual genes and 
view all references that support each data point providing a level of confidence for each 
result. To operate the roadmap, the user selects an AGI number and a regulation (up-, down- 
or both) to include in the search. The tool establishes which treatments regulate expression of 
the selected gene and then displays in a map all the genes in DRASTIC that are regulated by 
these treatments (Figure 37). This tool demonstrates that it is possible to identify groups of 
treatments that appear to produce similar regulatory results in A.thaliana. Roadmap results 
can be used in conjunction with the Pathway tool.
6.5.9. Unique Genes Tool
Unique genes tool identifies all the A.thaliana genes that are regulated by a single treatment. 
Full details including references for each gene are linked to each record.
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Figure 37: Web interface for the Roadmap tool.
In the example shown in Figure 37, treatments up-regulating At3g45640 (MAP Kinase 3) 
were selected for investigation. (A) The resulting roadmap. From the DRASTIC data, 12 
treatments up-regulate Atg45640. Using these treatments as the ‘lookup co-ordinates’, the 
map displays the total number of unique AGIs up-regulated by these treatments. The red 
squares hold the total number of genes up-regulated by a single treatment, and the numbers in 
the unshaded squares show the number of genes co-regulated by treatments. This map can be 
further mined by clicking on any of the squares to display the supporting records (see (B) 
where the co-ordinates wound and UV have been selected). Each record has a link to the 
reference it was curated from as shown in (C).
6.6. Technical ToolSet In form ation
The Drastic-Insight toolset that is available through the website has been developed using 
ActiveX Data Objects (ADO) and Active Server Pages (ASP) technology to enable the user 
to dynamically interface between the toolset and the database as demonstrated in Figure 38.
Figure 38: Drastic-Insight SiteMap. This figure shows the pages and links that are needed for the website. The 
boxes with the green border are one page template that is used many times and the blue bordered boxes are
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another example o f the use o f dynamically generated content based on user request. The red box is the entry 
page for the Drastic-Insight toolset and provides links to the other tools. This illustration does not include the 
internal links on a page such as sorting functions or clearing results that require the page to be reloaded.
This technology enables the creation of webpages “on the fly  ” as the ASP technology allows 
programmers to use functions, variables and control structures to build a web page 
dynamically at the moment it is requested by the browser. This enables users to “ask” 
different questions of the database and be presented with individual results which will include 
the most up-to-date information from the database.
6.7. Summary
The INSIGHTS tools encourage comparison of gene expression patterns, intelligent mining 
of information, testing and formulation of novel hypotheses on the complex signal 
transduction and response pathways used by plants. Identifying common elements in 
pathways affected by different treatments permits the formation of hypotheses previously 
opaque to the user as demonstrated in Chapter 7
This type of analysis is useful in providing a framework for understanding signal transduction 
responses and to assist with identifying regulatory gene networks. It is also useful for finding 
genes associated with plant pathogen infection that are also affected by environmental 
stresses such as drought and cold in differing ways. Chapter 7 provides details of testing, 
evaluation and analysis of the toolset and results that it produces.
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Chapter 7 Testing and Analysis
7.1. Introduction
This chapter analyses the DRASTIC-INSIGHT toolset and summarises the study findings. 
The toolset is very difficult to benchmark due to the fact that it is an investigative tool and is 
likely to be subjectively assessed based on the experience of the individual user. The toolset 
has been comprehensively tested as detailed in section 7.2. In order to evaluate the tool 
effectiveness, plant pathologists were asked to utilise the database and report back their 
findings. The results from this test are evaluated against the overall objectives of this project.
7.2. Testing Procedure
The testing approach taken for the DRASTIC-INSIGHT toolset incorporated the standard 
software testing protocols of Unit Testing, Integration Testing, System Testing and 
Acceptance Testing (Kappel, 2006). As the majority of the toolset is a web based application, 
the testing was adapted to include content, hypertext structure, design aesthetics, usability 
and page loading.
7.2.1. Testing Results
A sample of some of the tests that were carried out on the database are shown below in Table 
16.
Test
No.
Test Type Test Description Expected Output Actual Output
1 Usability Test the internal and external 
navigational links between the 
webpages.
All links work 
correctly.
Pass
2 Reliability Test the time that pages take to 
load.
Pages load in 
under 15 
seconds.
Fail -  Venn Diagram search is 
extremely slow. Progress bar 
added to page.
3 Functionality Test the pathway software with 
pre-chosen data.
Expect that the 
results will 
match the 
predicted result
Pass -  However, user noted that 
it would be useful for the 
treatment number to be a pre­
allocated number rather than a
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d ifferen t n u m b er for ea ch  search  
as it is  ea s ier  to  co m p a re  
diagram s.
4 L earn ab ility T est i f  the s ite  n a v ig a tio n  and  
d e s ig n  is c o n sis te n t  and e a sy  to  
u se
P a ss P ass
5 D a ta b a se
C o n n ec tiv ity
T est i f  the d atab a se  is 
c o n n e c tin g  and a c c e s s in g  data  
co rrec tly  b y  te s tin g  the return  
o f  th e s ta tis t ic s  p a g e  and  
co m p a rin g  th e  resu lts  a g a in st  
the actu a l d atab a se  resu lts
E x p e c t  that 
s ta tis tics  from  
the w e b s ite  and  
the d atab a se  w ill  
m atch .
F ail -  O n e  S Q L  sta tem en t in  the  
In d iv id u a l R e a c tio n  P a g e  w a s  
in correct and has b ee n  a m en d ed .
T a b le  16: A  sm all se le c tio n  o f  so m e  o f  th e te sts  that w ere  ca rried  ou t on  the D r a stic -In s ig h t to o ls  
7.2.2. System  O bjective Testing
W ith the system  function ing correctly , the n ext test w as to evaluate i f  the system  m et its 
original ob jectives in section  2 .4 . T he requirem ents o f  the m ain com ponents o f  the system  
were:
•  Structured database w ith  interface to enable easy  data input for all types o f  
experim ental results described in Chapter 5.
•  Q uality/validation  data ch eck s and fac ility  to update the data described  in Chapter 4  
and
•  Set o f  w eb based  too ls to enable the b io lo g ist to in telligently  query the data to  
form ulate hypothesis described in Chapter 6.
The original ob jectives w ere then exam in ed  as deta iled  b e lo w  in Table 17.
O bjective 1. Co-regulation o f genes - If two or more treatments regulate a gene then the genes may 
share a signalling pathway
The user can use the Venn Diagram search to identify co-regulation o f genes by up to three treatments 
or they can use the roadmap to search for co-regulation across the whole database.
O bjective 2. Gene regulation patterns - If a gene shares a similar regulation pattern to another gene 
then they may be adjacent to each other in the pathway.
The clustering program enables the biologists to identify genes with a similar regulation pattern and
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groups the results by treatment. The user can alternatively use the pathway tool to view  regulation 
patterns o f selected genes and visually compare the patterns.
O bjective 3. Regulation types - Within a pathway, a treatment should either up-regulate or down- 
regulate all genes. If this does not happen, this could indicate a quality control issue or crosstalk in a 
pathway.
The user can select all the genes within the pathway and use the pathway tool to display the gene 
expression values for all the treatment/gene combinations in the database. The pathway tool uses 
colour to highlight the regulation making it easy to identify any anomalies in the pathway result. 
O bjective 4. Determine the number o f treatments that regulate each gene - Genes that are only 
regulated by one treatment may be early in the pathway. Genes regulated by many treatments may be 
later in the pathway.
The user can go to the statistics page and drill down into the database results to find the number o f  
genes per treatment among many other useful figures. There are sort functions available to enhance 
the usability o f  this tool.
O bjective 5. Grouping o f treatments according to similarity o f the expressed genes -  This may 
indicate the total number o f pathways.
The clustering tool enables the biologist to group treatments according to similarity and produce a 
dendogram o f  results.
T a b le  17: E a ch  o f  the o r ig in a l o b je c tiv e s  are listed  a lo n g  w ith  the to o ls  that m ee t th em .
In addition to the ob jective  testing, the b io lo g ists  at SC R I used  the w eb  too l for a tw o w eek  
period as part o f  the acceptance testing and w ith  the excep tion  o f  som e sm all m od ification s to 
the navigation  m enu to enhance usability , the system  functioned correctly  and m et the 
requirem ents identified  in  Chapter 2.
7.3. Discussion
From  the outset o f  the research the goal for this project w as to d eve lop  a n ovel system  that 
w ou ld  enable the plant p ath ologists to search and co lla te  gene exp ression  data and section  4  
dem onstrates the b en efits  o f  this system . Chapter 1 set out the k ey  aim s o f  this research and 
h ow  these are m et is described  in the preceding Chapters, how ever, som e o f  the m ost relevant 
and interesting results or find ings from  these aim s are d iscu ssed  b elow .
1. A utom ate and enhance the process o f  inform ation d iscovery  for the b io lo g ist
From  the outset it as b een  clear that one o f  the m ain issu es that plant b io lo g ists  are fac in g  is
data overload. A  k ey  aspect o f  this research has been  enabling the b io lo g ists  to q u ick ly
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id en tify  usefu l data, provide a system  to co lla te  the data and lastly  m ake inform ation  
d iscoveries from  the data. O ne o f  the w ays that this study has approached the inform ation  
d iscovery  task is to in terv iew  the b io lo g ists  and m od el the w ay  in w h ich  they currently w ork  
w ith  a v iew  to autom ating tasks and m od elin g  co g n itiv e  responses.
T he system  provides the b io log ist w ith  an easy  data entry system  along w ith  too ls that w ill  
autom ate the process for certain datasets. W hen searching for k ey  papers, this system  qu ick ly  
id en tifies relevant research papers and the results from  the analysis in 7 .4  dem onstrate that 
the inform ation d iscovery  is su ccessfu l. There are also too ls that en ab le  con n ectiv ity  w ith  
public databases such as IN C U B I to autom ate data d iscovery  and id en tify  n ew ly  annotated  
gen e function or A G I num ber updates thus m aintaining the quality and currency o f  the data.
2. Identify suitable data from  different sources and different experim ents
A t the outset o f  the project it w as anticipated that there w ou ld  b e m uch m ore suitable data  
availab le than there in fact is. Scientists w orking in  hum an and anim al equ ivalents o f  this area  
are m uch m ore advanced  and have not on ly  got gene exp ression  results but also protein -  
protein interactions. W h ile  the database is set up to co lla te these type o f  experim ents w hen  
they b eco m e available it w as surprising h ow  few  suitable data sources there w ere for data on  
plant d efen ce sign allin g . This research also found  that there are m any different experim ent 
form ats and types and has explored  how  to id en tify  suitable experim ents and m od eled  w ays  
to store these d iverse types. There w ere no databases or too ls that w ere available for plant 
sign allin g  in d efen ce and very few  suitable sources o f  data in database repositories. In order 
to m aintain quality and to provide additional background on gen e interaction, peer rev iew ed  
results w ere sought for th is project and the on ly  suitable plan for this research w as to create  
and curate a n ovel database source for this n iche d iscip line.
3. E xam ine the structure o f  data particularly from  journals and m ake this m ore a ccessib le  
For this project, a requirem ent w as that the data should  be from  peer rev iew ed  sources, thus 
journals are a natural fo cu s for data acquisition. O nce the data m od el had been  d evelop ed  the  
next ch a llen ge w as h o w  to co llec t the data that is published  in journals. It is relatively  
d ifficu lt to search for publications contain ing results relating to sp ec ific  gen es. In a 
com parison  study described  in Chapter 4 , D R A ST IC  returned far m ore relevant papers than  
P ubm ed or text m in ing  too ls. T his seem s to stem  from  the w ay  in w h ich  the journal data is  
stored. In addition to k ey  w ords, it w ou ld  be u sefu l to have the fac ility  to “tag” relevant 
points in an article in a w ay  sim ilar to the function  that on -lin e forum s use to link  sim ilar
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threads. For exam p le, authors could  tag the unique gen e identifier and gen e function to enable  
th ese  to be searched for. It w ould  also be interesting to see  a fo cu s p laced  on updating journal 
articles - for exam p le  w here a gene is stated as “unknow n”, and this status is subsequ ently  
updated, what im pact d oes this have on  the article? A t present, journal articles rem ain  
untouched, how ever, n ow  that the m ajority o f  these are availab le on -lin e, it is in creasin gly  
p ossib le  to enhance the search fac ilities  and quality o f  the results contained w ith in  them . 
There are constantly  n ew  d iscoveries b ein g  m ade in the b io lo g y  and from  this research, it 
w ou ld  seem  that the data and the p revious con clu sion s detailed  in the papers are v ital for  
b io log ists  to hypothesis further. W ith the excep tion  o f  the Plant P h y sio lo g y  journal, none o f  
the other journals surveyed  m ade any sp ec ific  requirem ents for the reporting o f  any other 
type o f  experim ent or h ow  the results w ere to b e presented. T his m eans that key  results can  
be contained w ith in  an unsearchable im age or a poorly form atted file . U ntil a m ore un ified  
approach to the reporting o f  experim ents in  journals is taken, m anual or autom ated curation  
o f  results from  certain experim ents w ill rem ain difficu lt.
4 . Provide a m ethod to enable results from  different types o f  experim ents to be com pared  
against each other
A s d iscussed  in section  4 .3 .5  there is debate in the literature as to w hether it is appropriate to 
com pare results from  different types o f  experim ents. S o m e database platform s such as 
G enevestigator have taken the d ecision  to not enable users to com pare results from  different 
types o f  experim ent (for exam ple A G  ch ip  versus A TH 1 chip). For this research, I opted to 
a llow  the users to carry out com parison searches betw een  results from  m any experim ents and 
d evelop ed  a schem a to enable this search. T his w as b ecau se the too l w as designed  to enable  
scientists to in vestigate and create h yp oth esis and any fin d in gs w ou ld  be tested u sin g  w et 
scien ce. It also un iqu ely  enabled the b io lo g ist to have a general overv iew  o f  all o f  the results 
from  different treatm ents and sp ecies rather fo cu sin g  in on a sm aller m ore n iche area as tends 
to b e the case  in this d iscip line. T h is provides sc ien tists w ith  a new  w ay to v iew  and 
m anipulate the data. In order to com bat the potential issu es  o f  inaccurate data, m ultip le  
reports o f  gen e exp ression  results for a gen e  and treatment are stored w here p ossib le  and any 
differences are h igh ligh ted  to the user at the results stage.
A t the start o f  this project, there w ere som e differing v iew s  about D R A ST IC  a llow in g
different types o f  experim ental results to b e com pared as it in ev itab ly  m eant reducing the data
to a binary set. T his is  because the o n ly  w a y  to enable com parison  from  experim ents across
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the board w as to sim p ly  consider the results as up and d ow n  rather than use any num eric or 
factor values. T his concern  w as raised as com pressing the data like this p oten tia lly  lo ses  
som e data value. H ow ever, due to the sim pler v iew  o f  up and dow n, it is m uch easier to 
identify  gen es that respond in a sim ilar m anner than i f  a large set o f  num erical va lu es are 
presented to the user. A s  already m entioned , the journal results can be in m any different 
form ats and the o n ly  com m on  denom inator for these results at present is to convert them  to 
up or dow n thus it has a lso  enabled the k ey  principle o f  u sin g  peer rev iew ed  quality data to be 
m aintained. T his approach is increasingly  b ein g  validated w ith  som e o f  the m ain data 
repositories includ in g  E M B L  recently enabling users to search for results that are converted  
to these binary values.
5. D esig n  a data m od el that takes account o f  the various data and database standards that 
ex ist in the plant b io lo g y  com m unity
The data m od el for this research needed  to have the ability  to enable storage o f  d iverse  data  
form ats w h ile  m eetin g  the protocols and data standards and nom enclature o f  the plant 
com m unity. There are tw o w ell docum ented  types o f  standard w h ich  are applied  to plant gene  
exp ression  results (M IA M E ) and protocols for softw are d evelop ers (M A G E ). M A G E  is on ly  
usefu l i f  d ealing w ith  the fu ll M IA M E  data w hich  m ost too l providers w ill not be. There are 
no other standards produced for sm all n ich e database sites w h ich  m ake data and too l sharing  
difficu lt. In addition, th ese  standards do not address h ow  to integrate the data they  describe  
w ith different data and nom enclature. M icroarray tech n ology  is relatively  you n g , but it w ould  
be w rong to assum e that there w ill not be a new  generation o f  tech n ology . Standards such as 
these im plem ented  in this data m odel w ill be required to future p roof the data and enable new  
form ats and standards to be integrated w ith  old.
If w e  consider o n ly  A rabidopsis, there are p u b lic ly  funded sites such as T A IR  and TIG R  that 
release updates on the annotation and nom enclature o f  this species. H ow ever, private 
com panies such as A ffym etrix  have their ow n  annotation w h ich  does d iffer sligh tly  from  the 
T A IR  version  and there is no collaboration  on this. Further m ore, o f  the public  repository  
databases surveyed  here, there w as no updating o f  the results w hen  n ew  annotations w ere  
released so certain gen e expression  results are actually n ow  referring to d ifferent genes. 
W h ile  there is so  m uch  effort in the statistical correctness o f  m icroarray probe ca lls  and 
absolute va lu es, o n ce  th ese  are released  into the database repositories there is  very  little  
ev id en ce  o f  these results being  m aintained. D u e to the nature o f  publication  o n ly  a llow in g
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n ovel findings to be published, there m ay be no up-to-date results for som e gene expression  
values uploaded and these therefore m ay alw ays rem ain out o f  date and incorrect. D R A ST IC  
overcom es these issu es by data quality check s to key database repositories and updating  
annotation as they are released. G O  annotation references are m aintained w here appropriate 
for relevant genes in the database. O nly data that has m et the M IA M E  standard is included. In 
addition, all m odifications are stored in a “gen e dictionary” so any d iscrepancies can be 
checked  and the data and data m odel is available to any developers or b io log ists.
6. Im prove the speed, e ffic ien cy  and ability o f  the b io lo g ist to search for inform ation from  
the gene expression  results co llected
Through the d evelop m en t o f  the data m odel that holds the d iverse data form ats, autom ation  
o f  the sim pler search queries, for exam ple search for one gene, have vastly  im proved the 
speed and e ffic ien cy  o f  these searches com pared to the previous manual curation and 
investigation techniques.
D evelop in g  m ore sophisticated  search functions, such as the pathw ay finder, for the project 
w as a dem anding p rocess due to the structure o f  the data stored. W hile there is data overload  
in terms o f  the hundreds o f  thousands o f  individual gene expression  results that are available, 
w hen each experim ent is stripped dow n, it w as d iscovered  that approxim ately on ly  5% o f  the 
results from  a microarray experim ent that w as identified  as suitable for inclusion  are o f  value  
to the project.
IUiml>ei of Unique Genes Aitl) Expiossion Results |>«i Tie.vtment
Figure 3 9 : Shows the distribution of the number of genes with gene expression results per treatment.
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This along w ith  the inclusion  o f  sin g le  result experim ents causes the data m atrix to be sparse  
and u n even ly  distributed as show n in Figure 39  w h ich  therefore presents a great ch a llen ge  
w hen considering h ow  to search this data.
A t the outset o f  the project, the exp ectation  w as that it w ou ld  be p ossib le  to u se  data m in ing  
too ls such as B ayesian , D ec isio n  T rees and C lustering. T he data is binary so on ly  hierarchical 
clustering w as suitable. E xperim ents w ere undertaken in collaboration w ith  researchers at 
A berdeen U n iversity  (Pers C om m . W iranga, 2 0 0 5 ) to use their algorithm s w hich  w ere  
d evelop ed  sp ec ifica lly  for use w ith  a sparse dataset. T he results from  these experim ents  
show ed  a lim ited  im provem ent but d isapp ointingly  did not enable anym ore sign ificant results  
to be obtained from  that o f  the clustering too l d iscu ssed  in 6 .3 .
B ayesian  m ethods w ere also exp lored  as it w as hoped that these m ay enable linkage o f  
related gen es to be d iscovered , but again  the data sparsity m eant that the results w ere o f  little  
use. Other conventional data m in ing m ethods w ere considered , but the data sparsity and lack  
o f  attributes did not m ake the dataset suitable for these techniques. C onsideration w as g iven  
to utilising  the absolute value o f  the microarray data o f  each result, but the b io lo g ists  focu s  
for this research w as prim arily in w hether the gen e  w as up or dow n regulated and not by h ow  
m uch.
T he D R A S T IC  IN SIG H T S system  overcom es th ese  ch a llen ges b y  providing advanced search  
functionality  for the b io log ists even  w ith  the sparse data set. D uring the research process, the  
focu s has been  to creating a k n ow led ge  d iscovery  too l w hich  w ou ld  enable h yp oth esis  
generation based on the cogn itive  w ay  in w hich  the b io lo g ist processes the inform ation. T he  
process w as m od elled  in Chapter 2 and the search functionality  has been  built based on this. 
A ppendix  V  details som e o f  the su ccessfu l results that have been  d iscovered  u sin g  the search  
protocols d evelop ed  for this system  and sh ow s that this provides the b io lo g ist w ith  the ability  
to quick ly  search through m any data points and d iscover  n ew  k n ow led ge that w as p reviou sly  
opaque.
7.4. Analysis of Results
T he too ls have been  show n to m eet the original sy stem  ob jectives, but to evaluate this study, 
researchers at SC R I w ere asked to u tilise  the database and too lset and report back any  
interesting results. The results w ere then analysed  in order to establish  w hether the database  
w as usefu l and i f  it assisted  w ith the form ation o f  h yp oth esis for signal transduction.
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A ppendix  V  sh ow s som e o f  the sam ple results that the b io log ists  d iscovered  during testing o f  
the system . W hile these data d iscoveries w ould  need to be experim entally  tested, they clearly  
dem onstrate the syn th esis o f  k n ow led ge that w as previously  opaque or hidden in 
unsearchable data journals or disparate microarray databases. The results from  the use o f  the 
too lset sh ow  that it is possib le  for a b io log ist to h ypothesis, test the hyp oth esis using the 
toolset and based on the results re-hypothesis or d ev ise  a w et sc ien ce  experim ent to form ally  
test the results.
The num ber of matching records: 37
G e n e  N a m e  /  T r e a t m e n t 1 2 3  4 5  6  7  8  9  lO 11 1 2 1 3  1 4
A t2 g 4 0 0 0 0  (n e m a to d e  re s is ta nce  p ro te in  p u ta tiv e  /  H s lp ro -1  like) B a g S g a g S  M B S g a g a
A t3 g 5 0 9 3 0  (ATPase fam ily  A A A -ty p e ) [ s a g a  i n m g a
A t4 g  12720 (g ro w th  fa c to r- l ik e ) g a g a
A t4 g 2 0 7 8 0  (ca lc ium -b ind ing  p ro te in  p u ta tiv e ) m D 9 I 9 S g a
A t4 g 3 9 6 4 0  (g lu ta m y ltra n s fe ra s e , gam m a, p u ta tiv e ) B r a g a  i b s g a
A t5 g 2 5 9 3 0  (leu c in e-rich  re p e a t fam ily  p ro te in  /  p ro te in  kinase fam ily  RLK5 like) g a g a g a
A t5 g 5 7 5 6 0  (x y lo g lu c a n  e n d o tra n sg lyco sy la se  re la ted ) ma mama gaga mainaigig ita g a m a m a
Treatm ent Legend
Number Treatment
1 ABA (abscisic acid)
2 brassinosteroid
3 cold
4 cucumber mosaic virus (CMV)
5 drought / dehydration / wilt
5 flagellin 22 (flg22)7 gamma irradiation
B hydrogen peroxide
9 IAA
10 low oxygen
11 malondialdehyde (MDA)
12 methanol
13 wound
14 Yariv phenylglycoside (beta-D-Glc)3
Figure 4 0 : Evaluation Experiment 1.
The result in Figure 40  dem onstrates how  several o f  the D R A ST IC -IN SIG H T  tools can be 
used to find new  inform ation from the data set. T he researchers com m ent from  this test w as 
“Another set of genes possibly in the same pathway. I have just put some information into the 
database on genes regulated by gamma irradiation and noticed that some were also 
regulated by Yariv phenylglycosides. I therefore had a closer look at everything that was 
regulated by both of those treatments and noticed that the following subset of genes are also 
all up-regulated by flagellin. These must therefore be likely candidates for being involved in 
the same pathway, (possibly the last gene i.e. At5g57560 may be regulated by too many 
different treatments arid may therefore not be that close in terms of signalling distance to the 
other genes)”.
Here the researcher has used the V enn D iagram  tool to find gen es that are regulated by both  
Y ariv p h en y lg ly co sid es and gam m a irradiation based on curiosity  from  a research article he
w as interested in. This query has y ielded  a subset o f  gen es w hich  have been put into the
1 2 9
pathw ay tool. The results find that the subset o f  gen es are also all up-regulated by flagellin . 
This m ay indicate that they share the sam e pathw ay and enable the b io log ist to further 
investigate this set o f  genes. G ene A t5 g 5 7 5 6 0  is show n to be regulated by 11 treatm ents and 
this leads the b io log ist to hypothesis that it m ay be further dow n the sign allin g  pathw ay and 
therefore not as sp ecific  to the grouping o f  gen es. T his is new  inform ation that has been  
discovered  because o f  the design  o f  the too lset w hich  enables the b io lo g ists  to “ask” 
questions o f  the data in various w ays.
The result in Figure 41 is an excitin g  result for the researcher w hose com m ent on this result 
w as “This is one to rave about” as it m ay indicate that there is cross talk w ithin the 
pathw ays. In colum n 9, all gen es are dow n regulated excep t gene A t2 g 2 1 6 6 0  and in colum n  
19, all gen es are up regulated excep t gene A t2 g 2 1 6 6 0  again. The reason that this is o f  interest 
is it m ay m ean that this gene can be used as a sw itch  to turn a pathway on or o f f  thereby  
inhibiting or enabling a plant response. T his w ou ld  require further in vestigation  using w et 
science. N either o f  these results cou ld  have been d iscovered  using querying alone or w ithout 
the additional k n ow led ge /  curiosity  o f  the researcher w ho w as operating the system .
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The number of matching records: 15
Gene Name /  T rea tm ent
Atlg20o50 (protease, cysteine, papain-like (CIA-3 family))
At3gl2610 (DNA damage-repair/toleration protein)
At3g53460 (RNA binding protein cp29)
At4g04460 (protease, aspartic, pepsin-like (A 1-4 family))
At4g 13660 (pinoresinol-lariciresinol reductase., putative)
Up I Down
Up I Down
Down I Up I Down I I
Down I Up_
Down! Uei_
Treatment L egend
Number Treatment
1 Alternaria brassicicola
2 chitin
3 drought / dehydration / wilt
4 ethylene
5 jasmonate (methyl)
6 light
7 salicylic acid
Figure 4 2 : Evaluation Experiment 3 . Researcher Comment: “Another small set to consider. Not sure if this is a 
good one or not. Maybe this is a set where one could make some predictions to test in the lab.
This experim ent show n in Figure 42  sh ow s tw o groupings o f  gen es that respond in the 
opposite manner to each other w hen induced by ethylene or jasm on ate(m eth yl). This is 
ind icative o f  cross-talk in the pathway. It is b e lieved  that crosstalk betw een  jasm onate and 
ethylene pathw ays enables plants to optim ize their d efence strategies m ore effic ien tly  and 
eco n o m ica lly  (Zhao, 20 0 4 ). The b io log ist may be interested to find how  these gen es respond  
to other treatm ents that the tw o plant horm ones are know n to react to in order to further 
investigate this gene grouping.
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The number of matching records 160
G en e  N am e /  T re a tm e n t 11 2 s  S  S 6 7 8 9 10 u 12 13 14 15 16 17 18 19
A tlg01140  (SNF1 -related kinase) D M P M P M
A tlg01720  (no apical meristem /  transcription activator, MAC I B M  
domain, ATAF1)
A tlg07040  (unknown) P M
A tlg l3 9 9 0  (unknown) P I
A tlg32640  (protein kinase; RD22BP1; transcription factor, 
bHLH putative)
A tlg45249  (ABA-responsive cis-acting element) P M em m
A tlg52980  (GTP-binding protein puta tive) WTO? WTO? WTO?
A tlg61890  (MATE efflux family) WTOHD^M E M B M
A tlg66760  (MATE efflux family protein, putative) WTO? DIM P M
A tlg68440  (unknown) em P M
A tlg72800  (unknown, nudeolin like? (N uM l-re la ted)) mm
A tlg7 5 50 0  (nodulin MtN21 family) WW? WTO? WTO? WTO?
At2g02710 (receptor-like serine/threonine protein kinase) DM D M P M
At2g05540 (glycine-rich protein puta tive) P M E M
At2g06050 (12-oxophytodienoate reductase) WTOBDl?® [ H m m P M
At2g30550 (lipase putative) P m
At2g42890 (Mei2) E M
At2g46680 (transcription factor, homeobox leucine zipper) P m [PI EM urn WTO?
At2g47190 (transcription factor, Myb) [HP
At3g02480 (ABA-responsive protein-related) P M e m
At3g 17000 (ubiguitin conjugating enzyme like) DM P m PM
At3g 19290 (transcription factor, bZIP (AREB2, ABF4)) mm s a WTO?
At3g20300 (unknown) P m P M
At3g22830 (heat shock transcription factor-like protein) P M
At3g29575 (unknown) p a W f f lS D ^ H
At3g53710 (zinc finger-containing protein ARF GAP-like 
ZIGA2)
At3g55530 (zinc finger (C3HC4-type RING finger) family) P M
At3g59930 (unknown) P M I n
At3g62030 (peptidyl-prolyl cis-trans isomerase, chloroplast / J N H  
cyclophilin /  rotamase)
At4g01020 (pentatricopeptide (PPR) repeat-containing 
protein)
At4g20830 (reticuline oxidase homolog) B M p i p a
At4g23050 (protein kinase, serine/threonine putative) P M P M P M
At4g37510 (ribonudease I I I  family) WTO?
At5g01520 (zinc finger (C3HC4-type RING-HCa)) DM P m
At5g09440 (phosphate-responsive protein, putative) S U P S P M p a P M
A t5 g l 1420 (unknown)
At5g23060 (unknown) WTO? wro? WTO?
At5g25460 (unknown) WTO? w?w? WM?
At5g39610 (NAC, NAM (no apical meristem) like) P M P M P m
At5g42010 (WD-40 repeat protein family) WTO? WTO?
At5g48180 (jasmonate inducible (myrosinase binding)) P m P m
At5g52300 (responsive to dessication RD29B) P M
At5g61820 (MtN19like) PM PM [PI m E M
Treatment Legend
Number Treatment
1 ABA (abscisic acid)
2 Alternaria brassicicola
3 cucumber mosaic virus (CMV)
4 drought / dehydration / wilt
5 ethylene
B flagellin 22 (flg22)7 hydrogen peroxide
B jasmonate (methyl)
9 low oxygen
10 malondialdehyde (MDA)
11 methanol
12 nitric oxide (NO donor NOR-3)
13 ozone
14 phosphate starvation
15 salicylic acid
16 senescence
17 sodium chloride
18 wound
19 Yariv phenylglycoside (beta-D-Glc)3
Figure 4 3 : Evaluation Experiment 4 . Researcher Comment: "'May be the genes that are down-regulated in this 
list are linked whilst those that are up-regulated are linked together. The genes down-regulated by treatment 3 
also look linked.”
132
The experim ent exam ple depicted in Figure 43  has been created from  gen es that the 
researcher k now s respond to A B A  w hich  were found using a search function from  the 
database. It clearly  sh ow s groups o f  gen es that are up-regulated by three treatm ents and 
another group that are dow n regulated. This indicates cross-talk  in the pathw ay and enables 
the researcher to h ypothesise that these results m ay m ean that there are tw o or m ore gene  
groups that are interlinked in tw o separate pathw ays. The treatm ents in vo lved  are also 
interesting to the research such as drought and sodium  chloride seem  to share the sam e gene  
group w hich m akes sen se as drought w ould  increase the salt lev e ls  in soil.
Figure 4 4 : Evaluation Experiment 5 . Pathway result enabling researcher to hypothesis about the involvement of 
calreticulin 1 and calreticulin 2 in signalling.
The result show n in Figure 44 w as found by a researcher w ho w as interested at look in g  for 
groups o f  gen es that are co-regulated in response to different treatm ents su ggestin g  that they  
are likely  to occur in the sam e signal transduction pathway. Here the up-regulation o f  
calreticulin  3 (A t lg 0 8 4 5 0 )  in A rabidopsis is associated w ith the up-regulation o f  a number o f  
potential sign allin g  gen es including kinases w hich  do not occur if  calreticulin  1 (A tlg 5 6 3 4 0 )  
and calreticulin  2 (A tlg 0 9 2 1 0 )  are dow n-regulated.
In addition to results found from  using the pathw ay too ls, the database too lset has also been  
used for gain ing new  know ledge o f  gen es that have been described in publications as 
unknow n. For exam ple 12% o f entries in the database are described as 'unknown' function. 
The toolset is useful for linking together inform ation on E ST s described as gen es o f  unknown  
function. For exam ple, by converting accession  num bers into A G I num bers w e have show n  
that the fo llo w in g  E ST s that are dow n-regulated  by chitin  (H 3 7 2 3 1 , R 90 1 4 0 , T 41806), 
drought (A V 8 2 3 7 4 4 ), ethylene (R 9 0 1 4 0 ), low  oxygen  (A t2g  10940), or sod ium  chloride  
(A V 8 2 3 7 4 4 ), or up-regulated by sa licy lic  acid (R 9 0 1 4 0 , H 3 7 2 3 1 ) are all the sam e gene i.e. 
A t2g  10940.
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T he to o ls  have a lso  been  used  b y  researchers to gain  an insight into the interaction b etw een  
b iotic  and abiotic stress responses by  look in g  at gen e exp ression  data w ith in  this database 
u sin g  the search or V enn diagram  tools. For exam p le, the A rabidopsis gen es A t2 g l4 5 6 0  and  
A t5 g  1 4920  o f  unknow n function are dow n-regulated  by  co ld  and drought resp ective ly  but are 
both up-regulated by  B T H  and b y  in fection  w ith  an incom patib le iso la te  o f  Peronospora 
parasitica, thus su ggestin g  how  resistance cou ld  b e a ffected  detrim entally  by  environm ental 
con d ition s.
T h ese results dem onstrate that D R A ST IC  has m et its aim  o f  enabling researchers to create  
n ew  h yp oth eses for signal transduction. There are several interesting results; one result has  
prom pted the researcher to consider exp loring  h yp oth esised  results in a laboratory setting and  
all have g iven  the researcher n ew  insight and enabled  new  thoughts about p ossib le  gen e  
grouping and p lacem ent in pathw ays.
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Chapter 8 Summary and Future Work
8.1. Summary
The aim of the project was to create a generic toolset for scientists to assist with investigating 
gene expression for defence signal transduction mechanisms in plants. Anecdotal evidence 
from web statistics of visitors to the DRASTIC-INSIGHTS website have shown a steady 
increase in both number and location base o f users (Pers Comm. Lyon, 2007). DRASTIC- 
INSIGHTS has been used by biologists at SCRI in their research towards induced resistance 
for plant defence (Walters e t a l ., 2007 and Button e t al., 2005). The DRASTIC-INSIGHTS 
website was described in the book “The Epidemiology of Plant Diseases” (Cooke e t a l, 2006) 
as a useful tool for epidemiologists:
“For exam ple, an im p o rta n t a sp e c t o f  u n derstan d in g  the ep id em io lo g y  o f  p la n t-m ic ro b e  
in teraction s is to  u n d ersta n d  h ow  a b io tic  s tre ss  ca u sed  b y  c lim ate , e.g . d ro u g h t a n d  h ea t  
stresses, can a ffec t the su sc e p tib ility  o f  a  p la n t to  infection. A  w eb  reso u rce  c a lle d  D R A S T IC  
(D a ta b a se  R esou rce  f o r  the A n a lys is  o f  S ig n a l T ran sdu ction  in C ells) m a y  n o t a t  f i r s t  seem  
like an e p id e m io lo g is t’s  fa v o u r ite  site. L ikew ise , one o f  its  m ain  resou rces, a  d a ta b a se  o f  
p la n t gen e expression  d a ta  w hich p r o v id e s  va lu a b le  in form ation  on the p o te n tia l in tera c tio n  
b e tw een  b io tic  a n d  a b io tic  s tresses, m ay b e  d ifficu lt a t f i r s t  to  re la te  to  ep id em io lo g y . 
H ow ever, D R A ST IC  d o e s  n o t s im p ly  p ro v id e  d a ta  fro m  m icro a rra ys. The d a ta b a se  co n ta in s  
in form ation  fro m  a w id e  ran ge o f  p u b lish e d  p a p e r s  on w h eth er p la n t g en es  a re  up- o r  d ow n -  
reg u la ted  in resp o n se  to  variou s b io tic  a n d  a b io tic  s tresses. M uch o f  the in form ation  is b a se d  
on experim en ts w ith  the m o d e l p la n t A ra b id o p s is  th a lian a  a n d  b eca u se  the d a ta b a se  u ses  
A ra b id o p s is  G enom e In itia tive  (A G I) n u m bers it is  p o ss ib le  to  be  con fiden t a b o u t w h ich  g en e  
w ith in  a fa m ily  o f  g en es  is a c tu a lly  b e in g  re g u la te d .”
Furthermore, DRASTIC has been used by the ONDEX project (Kohler e t a l., 2006) which is 
a tool for biological network analysis. ONDEX provides 2D representations o f directed, 
undirected and weighted networks. It can handle large scale networks of hundred thousands 
of nodes and edges. Data for integration is modelled as a suitable framework of concepts 
(such as gene, pathway, and protein) and relations (such as 'belongs_to', 'is_a') describe the 
mapping between them. In addition, a powerful filter is available to import microarray 
expression level data to globally analyze the relations between the different genes being
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expressed. ONDEX uses data from DRASTIC-INSIGHTS AMONG other sources as 
described by Pavlopoulos (2008).
Independent use of DRASTIC-INSIGHTS was most recently illustrated in a paper published 
by Sundar et al., (2008) who have developed a computer algorithm to identify key 
transcription factor binding sites upstream of a gene of interest. They used the DRASTIC- 
INSIGHT toolset to identify stress responsive genes based on their consistent up-regulation in 
response to abiotic stress signals. They found that several genes could be up-regulated during 
multiple stresses, such as cold, salinity, drought etc. Experimental biochemical validations 
have proved the involvement of several transcription factors could be involved in the up- 
regulation of these stress responsive genes. In order to follow the intricate and complicated 
networks of transcription factors and genes that respond to stress situations in plants, they 
developed the Stress up-regulated Transcription Factor (STIF) algorithm. This demonstrates 
the wide and generic application possibilities for the DRASTIC-INSIGHT tool.
8.2. Future Work
The database and toolset have met its original objectives and testing has demonstrated that it 
meets its requirement specification. DRASTIC-INSIGHTS is built on a structured design 
that stores, and importantly facilitates the maintenance and updating of data from peer 
reviewed journals and databases that relate to stress response genes that have been shown to 
be active in early signal transduction events. During this study, there have been many 
nomenclature issues with the data as described in Chapter 4 and thus the database has been 
developed to be a generic data container which should be adaptable to what ever the next 
generation of experimental protocols are.
While there are progressive movements towards unified ontologies and nomenclatures such
as GO and the AGI, there is more work required in this field. The data inaccuracy problems
encountered during the work on this thesis appears to emanate from the rapid advances that
are made in the technologies and knowledge in the field and the staticness of journals.
Microarray technologies are constantly evolving and there are still updates being made on
gene sequences but these updates do not seem to filter through to the older public data that is
being processed and mined by many different enterprises. Findings from observing biologists
showed that they were willing to accept the results from computing tools without delving
further into the background data which as demonstrated can be flawed or out of date. More
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knowledge is lost from journals by the fact that old publications cannot be updated in 
instances where a gene that at time of publication had an unknown function and as a result 
knowledge is lost or not recognised. It seems that in the rush to evaluate new data, the older 
data is ignored and allowed to degenerate. Although unexpected at the start of the project, 
there has been a focus on evaluating how to maintain and store both new and legacy data in 
this thesis and DRASTIC is a way forward in an attempt to bridge the gap between journals 
and microarray databases.
The DRASTIC knowledge base enables these genes to be updated by revised annotation / 
nomenclature / function as knowledge improves while preserving traceable links to all 
previous annotation and references. Scientists can access multiple references for the majority 
of genes and accession numbers that are held in DRASTIC. Searches in pubmed, science 
direct and ingenta when using accession numbers or AGI numbers do not return these results 
and as chapter 4 shows, there is no consistent submission format to address this in journals. 
Drastic uniquely enables scientist to search for genes which are co-expressed by multiple 
stimuli therefore enabling researchers to establish a start group of genes that they may be 
interested in (Biilow et al. 2007). Drastic has already been used as a basis by ONDEX 
(Koehler et al. 2006) and as many data mining techniques require “bait genes” for example 
network analysis and learning sets for Soms and neural nets and DRASTIC can easily 
provide these as it does not have the overhead of hundreds of thousands of data sets that need 
to be calculated (pair-wise comparison) in order to create a starting group.
Although many of the results presented in section 7.3 to evaluate the tools are based on one 
species which is A.thaliana the system is designed to be able to process multi-species data. 
The database does hold information on multiple species and the tools are designed to retrieve 
data from multiple species. For some of the searches (Venn diagram and pathway), a unique 
identifier is required which in the case of Arabidopsis is the AGI number. The unique locus 
identifier is needed as it is important to be able to distinguish between genes and not 
mistakenly report multiple responses for many genes which later turn out to be one gene with 
many accession numbers. As more progress is made in sequencing different species, more 
focus is paid to naming conventions as discussed in section 4.2.6. The Oryza sativa (rice) 
nomenclature for locus id are similar in design to the AGI numbers (McCouch, 2008) and 
analogous naming conventions are being adopted for tomato (Mueller, 2005) and maize
(MaizeGDB, 2002). The use of A G I’ s in DRASTIC-INSIGHTS is proof of concept and the
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system is set up to enable the user to select any gene that has a unique identifier of this type 
of nomenclature to compare genes across multiple species.
An interesting development from NCBI is the HomoloGene database which enables the user 
to enter a gene of interest and the database retrieves homologs among the annotated genes of 
several completely sequenced eukaryotic genomes using an automated procedure (Wheeler et 
al, 2006). This has more recently included A.thaliana and O.sativa and future work could 
include making use of this facility to compare potentially related genes in different species 
and examining their gene expression as the data levels increase.
The biologists ultimate aim would be to create an interactive chart containing all the 
hypothesised pathways and the biologists issues with current systems that were not fully met 
from Chapter 2 are:
1. It is not possible to draw separate diagrams for each agonist/response as it would be too time consuming.
2. It may include varying degrees of uncertainty (‘informed guesses’) that other scientists may find 
inappropriate or are wrong (by virtue of having not taken into account some other published information).
3. It is not possible to interrogate a diagram.
4. It is not possible to add to the diagram ones own personal or unpublished data.
DRASTIC-INSIGHTS has developed the infrastructure to store and query gene expression 
data but this could be improved by focussing on the visualisation aspect in the future. A  
version of the database which included the facility for a single biologist to input hypothesised 
results and store pathways for further investigation has been developed to prototype level and 
this partially covers some of these requests but it would be useful to have the ability to view 
and manipulate these newly found hypothesised pathways.
Pathoplant is a database project which aims to give a comprehensive overview about specific 
plant-pathogen interactions and to link this information to signal perception and transduction 
components. This may allow identification of missing links in signal transduction pathways, 
deduction of the function of novel proteins by comparison with known signal transduction 
pathways. It stores sequences of known molecules and corresponding reactions and it 
facilitates easy access to published data. The problem that they have encountered is lack of 
protein interaction data which it relies on to create the signal transduction pathways. In 2004 
the database contains one signalling pathway (ethylene) available with 104 interaction records
and 26 reaction records over 47 plant species. In 2008 the database contains 1 signalling
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pathway, 350 interaction records and 26 reaction records over 96 species although this 
approach may be very successful when more data becomes available. The database does 
however have a small scale visualisation of a single pathway (ethylene). Collaboration 
between this database, DRASTIC-INSIGHT and potentially ONDEX or some similar 
pathway viewing software could move us nearer to the ultimate goal of being able to visually 
represent the whole of the data as an interrogative chart.
Appendix I-IV contain conference posters and a published paper for this thesis along with an 
review from The Biochemist which reviews the work as “ an excellent example of a database, 
probably constructed on a limited budget, that, once it is complete, will prove invaluable to 
one specialist research community and be of great interest to those outside it. With the ‘data 
swamp’ described by the authors showing few signs of becoming more tractable, it is an 
approach that other specialist research communities might do well to copy.”
Drastic-Insights will in the future be extended by linking both public and private domain data 
to enable scientists to hypothesize using personal and published data. Optional access to 
Nottingham Arabidopsis Stock Centre (NASC) microarray data will also be made available 
via individual user domains. Development of text mining and data capture tools in a separate 
Carnegie project to automatically identify suitable publications and datasets for inclusion in 
DRASTIC have been undertaken.
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ABSTRACT
DRASTIC— Database Resource for the Analysis of 
Signal Transduction In Celts (http://www.drastic. 
org.uk/) has been created as a first step towards a 
data-based approach for constructing signal trans­
duction pathways. DRASTIC is a relational database 
of plant expressed sequence tags and genes up- or 
down-regulated in response to various pathogens, 
chemical exposure or other treatments such as 
drought, salt and low temperature. More than 17700 
records have been obtained from 306 treatments 
affecting 73 plant species from 512 peer-reviewed 
publications with most emphasis being placed on 
data from A rab ido ps is  thaliana. DRASTIC has been 
developed by the Scottish Crop Research Institute 
and the University of Abertay Dundee and allows 
rapid identification of plant genes that are up- or 
down-regulated by multiple treatments and those 
that are regulated by a very limited (or perhaps a 
single) treatment. The INSIGHTS (INference of cell 
SIGnaling HypoTheseS) suite of web-based tools 
allows intelligent data mining and extraction of 
information from the DRASTIC database. Potential 
response pathways can be visualized and comparis­
ons made between gene expression patterns in 
response to various treatments. The knowledge 
gained informs plant signalling pathways and sys­
tems biology investigations.
INTRODUCTION
Recovering value from the burgeoning mass of genomics and 
gene expression data now being accumulated is a major task 
for biologists and computer scientists (1). Increasing amounts
of gene sequence, expressed sequence tag (EST). northern blot and microarray data provide fertile ground for the mining of expression data extracting information and adding value by 
evaluating how gene expression is regulated and biochemical pathways function (2). DRASTIC (Database Resource for the Analysis of Signal Transduction in Cells) and the INSIGHTS 
(INference of cell SIGnaling HypoTheseS) web-based suite of tools bring together data on plant responses to pathogens, environmental stresses and chemicals (treatments) from ref­ereed journal publications. Presenting these data in a unified, 
searchable format allows the user to extract information beyond single genes, or clusters of similar expression patterns 
by browsing multiple treatments at once, identifying poten­tial regulatory relationships between multiple treatments and 
genes. DRASTIC-INSIGHTS overcomes the limitations of 
other plant expression databases by allowing for updating of information from previous publications, by directly link­
ing to publications and through the tracking of genes with 
unknown junction that have the same accession or AGI 
(A ra b id o p s is  genome initiative) number, which would other­wise be difficult to link between publications (3.4). Addition­
ally. genomic, EST. northern data and information derived 
from microarrays from multiple plant species arc included, after human curation. to ensure accuracy and to standardize the nomenclature of data (5). The INSIGHTS tools encourage 
comparison of gene expression patterns, intelligent mining of 
information, testing and formulation of novel hypotheses on the complex signal transduction and response pathways used 
by plants (6). Identifying common elements in pathways 
affected by different treatments permits the formation of 
hypotheses previously opaque to the user (7).
Database content
DRASTIC Is a gene expression relational database developed 
by SCRI (Scottish Crop Research Institute) and UAD (Uni­
versity of Abertay Dundee) to record responses to treatments, 
which are defined as exposure to experimental conditions such
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as pathogens, chemicals and other environmental stresses. 
More than 17 7(X) records are included with information on 
73 species and 306 treatments obtained from 512 references. 
Each record contains expression data for a single gene, from a 
single host, subjected to a treatment obtained from a single 
refereed journal publication. Manually curated records include 
data from plant northern blots, ESTs, cDNA-AFLPs. quantit­
ative RT-PCR, massively parallel signature sequencing and 
information derived from microarrays. These expression data 
are recorded as up- or down-regulated compared with control 
values, and. where applicable, the time and magnitude of 
expression arc also recorded. DRASTIC makes it possible, 
for example, to rapidly identify plant genes that are up- 
regulated by multiple treatments and those that are up- 
regulated by a single treatment (see http://www.scri.sari.ac. 
uk/TiPP/PPS/DRASTIC/mpage/countoftrcatment.asp for 
numbers of records per treatment). Such information repres­
ents important knowledge to assist in constructing putative 
signalling pathways for systems biology research (8). Data­
base requirements were elicited using semi-structured inter­
views with computer scientists and bioscientists. The complex 
ERM (entity relationship model ) consists of over 20 tables (see 
explanatory tables and ERM diagram in Supplementary Data). 
The ERM is implemented in Microsoft RDBMS (relational 
database management system) and is searched using the public 
web-based interface hosted by SCRI on Microsoft 2000 
Advanced Server. The web toolkit was developed using 
SQL (structured query language) embedded in ASP (active 
server pages) to dynamically create HTML result pages based 
on user queries. All records in the DRASTIC-INSIGHTS 
database are accessible through the publieally available web­
site http://www.drastic.org.uk or can be freely downloaded in 
a comma delimited text tile from the website download page 
(http://www.scri.sari.ac.uk/TiPP/PPS/DRASTIC/mpage/ 
downloads.asp).
Data quality
Several methods have been implemented to ensure that the 
data stored in DRASTIC arc of high quality. Inclusion in the 
database is solely following expert human curation of expres­
sion data from refereed publications. No expression data have 
been included by direct submission from laboratories. Acces­
sion numbers for ESTs are preferred, as the nomenclature of 
such sequences can be updated in the future. Information from 
some papers has not been included because accession numbers 
were not provided. The need to standardize nomenclature is 
important (5), thus the names used in the database correspond 
with current Unigene classification (9) rather than those cited 
in the original publication, unless a more recent primary pub­
lication indicates otherwise. Sometimes changes in gene iden­
tification are small but in other cases they can be dramatic and 
critical if signal transduction pathways are to be correctly 
understood. For example, one plant gene originally described 
as senescence-associated is now described as inositol-1.4,5- 
triphosphate 5-phosphatase, and another gene originally 
described as 'no homology' is now known to be a protein 
kinase. In addition, with genes from A r a b id o p s is , the Unigene 
system has been used to provide AGI ( A r a b id o p s i s  genome 
initiative) numbers where known. This has proven particularly 
useful for genes classified as ‘unknown’, as ‘unknowns’ from
different publications and with different accession numbers 
can be shown to be the same gene. For example. At2g36220 is 
classified as a gene of unknown Junction but by using informa­
tion from many references we can sec that it is up-regulated by 
abseisic acid, brassinosteroid, benzothiadiazol (BTH). cold. 
tlagellin-22, hydrogen peroxide, low oxygen, P e r o n o s p o r a  
p a r a s i t i c a  and sodium nitroprusside treatments. A backtrack­
ing facility has been included for historical gene names as all 
updates are stored in a data dictionary. In addition, a software 
routine called AGIDetect has been developed to check for 
mismatches between AGI, gene names and accession numbers 
to assist in maintaining data accuracy.
INSIGHTS data tools
At a simple level the web interface (http://ww w.drastic.org.uk) 
permits users to find published information on expression data 
for plant genes of interest. More importantly, INSIGHTS 
offers a number of tools to mine further information and create 
new knowledge. Some mining tools use AGI numbers where 
expression data correctly identify a specific member of a gene 
family. Through the INSIGHTS integrated toolkit users may 
investigate data in the following ways:
(i) G e n e r a l  d a ta b a s e  s e a r c h  prov ides a basic query function 
for the database. The user can select the following para­
meters: treatments, species, gene, regulation and date. 
The search returns the results in tabular format which 
can be sorted on all parameters and provides links to 
the primary references.
(ii) D R A S T I C  s t a t i s t i c s  provides an up-to-date list of statis­
tics for the database including the total number of records, 
species and treatments. It also provides a breakdown of 
both records per species and records per treatment, which 
can be ordered alphabetically or numerically. To gain a 
more in-depth view, a table of data providing statistics on 
the number of records by species or treatment can be 
obtained. These can be further mined to view individual 
records with bibliographic references.
(iii) A c c e s s io n  n u m b e r  s e a r c h  provides a query function spe­
cifically for the accession numbers in the DRASTIC 
database. Selectable parameters include accession 
number, treatment, regulation type and date. The results 
arc displayed in tabular format which can be sorted, 
providing links to references.
(iv) A r a b id o p s is  g e n o m e  in i t ia t iv e  s e a r c h  provides a query 
function specifically for AGI numbers in the DRASTIC 
database. The user can select from AGI number, treat­
ment, regulation and date.
(v) V en n  d ia g r a m s  enables the creation of Venn diagrams 
using the A r a b id o p s is  th a l ia n a  data from the DRASTIC 
database. The user can select two or three treatments and 
the tool will process the selections and output the results 
as a Venn diagram. The Venn diagram tool displays the 
number of genes regulated by each individual treatment 
or by multiple treatments based on the DRASTIC data. 
Records where genes have been up-regulated, down- 
regulated or both (up or down) can be included. The 
diagrams can be mined further by clicking on a segment 
of the diagram to view the individual records and relevant 
bibliographies.
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Figure 1. Web interface for the Pathway tool. (A) The search page fora set of AGI numbers. The pathway result is shown in t B ). Up regulated genes are shown in red. 
Down regulated genes are shown in blue. Green cells indicate that both up and down regulation record! s) are held in DRASTIC. The pathway can be further muted 
by choosing any coloured cell which will display all the records for the AGIAreatment combination as shown in ((’). The references for each record can be selected as 
shown in (I)).
(vi) TAIR AG I search enables the user to search records that include the AGI number and directly use them with the TAIR (the Arahidopsis information resource) chromo­some mapping and fonctional categorization tools, 
which are specifically designed to analyse AGI data (10). The user can select a subset of records from DRAS­TIC using a search on a treatment, multiple treatment or gene group (such as kinases) and regulation type. The 
selected data are then formatted for use with the TAIR tools.(vii) Pathway tool enables the user to extract and visualize knowledge from the database to hypothesize potential 
relationships between signalling elements. It includes 
a search facility to allow selection of a number of 
A.thaliana  genes by AGI numbers. A 'pathway' is pro­
duced to display the regulation of selected genes in 
response to different treatments (Figure I). Any groups 
of genes that are always co-regulated are identified, sug­gesting that they are likely to occur in the same signal 
transduction pathway. The pathway tool can be used to indicate die relatedness of induction patterns for selected 
genes. For instance, it can be shown that up-regulation of calreticulin 3 (Allg08450) in Arabidopsis has been 
shown to be associated with the up-regulation of a number of potential signalling genes (including kinases).
which does not occur if calreticulin 1 (Atlg56340) and calreticulin 2 (Atlg()9210) are down-regulated. The path­way tool can also be used in a hypothesis testing manner or as aquality control check tool for data in known signal 
transduction pathways (11).
(viii) Roadmap tool creates lookup tables to find genes that are co-regulated by different treatments. The user can 'drill 
down’ through the map to investigate individual genes 
and view all references that support each data point pro­viding a level of con fide nee for each result To ope rate the roadmap, the userselectsan AGI number and a regulation (up-, down- or both) to include in the search. The tool 
establishes which treatments regulate expression of the selected gene and then displays in a map all the genes in DRASTIC that are regulated by these treatments (Figure 2). This tool demonstrates that it is possible to 
identity groups of treatments that appear to produce simi­lar regulatory results in A.thaliana. Roadmap results can be used in conjunction with the Pathway tool.
(ix) Unique genes tool identifies all the A.thaliana  genes that are regulated by a single treatment. Full details including references for each gene are linked to each record.
Genes for proteins involved in the same signal transduction pathway are likely to be co-regulated and show the same
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DRASTIC INSIGHTS
caiycunn cr»lir drvufhr / Js-h*1rat on l wft
salicylic acidUVUV ♦ aacoftac
YmWp-*r>ylglycc*<dofbma-C-Glcp
drou.cafycuir-rhrr rj* hydra! ion f flsgoiln fc/deegsn ate panvira (rrrhyl, 7 ♦Lf/Mcotbic•cid «2 s i a 2 2 i i a i3 TV 4 1z 6 a 2 E 3 2 in i2 1 N 22 £ ao 29 a z ani LL £ A4 & 22 21 Ififi1 6 22 as 7 ID us is !a 12 as 2 12 L SB a a az
2 2 a 22 z a snmu 2 2 -2 .i 2k 3Z oa as -  ttbo111 2Si a a a  i 2 i rtl9 z :k I 9 a a 2 1 I""- S i k ja Ol LA 12 It 12 2S Z p
“4 2D 2S2 r  r 10 t h r *
The number of ra te  hing records 7 tor treatnen’ naoundtkflC ttM-K Nul<i Region9kN copper CmtJmq prcljn stolacyamnol owilsHo *i«zy UoACYP96C? 4AOB19 Uocytadoonw Pl5_ *CYPeiri UbSt*1 3 AtMRO W6U4 UoYcwty <m»3 Matanly K not avaiiot ie AAC86171 Uotrsntcaplicn '*ctcr, API/tPEBP *OPSB2A H77041 Uotram copter C2H2 *Z*'2< PHL41CAAC7232 Uo
The number d mating records. 7 for teatneit UVHarm limit Mam KUMUMI Mur !*<dIuo copper bind* j potem sJolacyannnot maiUfclo T4C51 Uozytxhrom* P45C *CYP7EC2 Uo:ytx*rom» P453 /HCYPB1F4 Aj4gj74!0 Uo
'A*P kinase 3 AtMP-3 K»-60 Uo'ocapfor-tike v mw tobfaraty W nol H7CM Upnanocoptan f*ctcr. AP1/EREBP *DREB2A K7704I Uovar«CTpt«r -actor. C2H2 *ZaT2> RHL41T41722 Uo
Wtmv Mtmim Y h*f JIM M.SwiU >*♦ :*< M, Eijj A S>*nozm KTW» Cmtuh n »* la »»ac ami b
P*C*»! JZ'
Figure 2. Web interface for the Roadmap tool. In this example, treatments up regulating At3g45640 (MAP Kinase 3) were selected for investigation. (A) The 
resulting roadmap. From tlx- DRASTIC data. 12 treatments up regulate Atg45640. Using these treatments as the 'lookupco-ordinates', the map displays the total 
number of unique AGIsup regulated by these treatments. The shaded squares hold the total number of genes up regulated by a single treatment, and the numbers in 
the unshaded squares showthe number of genesco regulated by treatments. This map can he further mined by clicking on any of the squares to display the supporting 
records (see (II) where the co ordinates wound and UV have been select'd) Each rocotd has a link to the reference it was curated ftum as shown in (O .
response to a range of treatments. Thus, to find e.g. kinases, transcription factors and calcium-binding proteins that are in the same signal transduction pathway expression patterns should be compared. Verification that identified genes are truly associated within signal transduction or metabolic pathways reijuia's experimental confirmation, but the database and associated diagrams promote more targeted hypothesis formation. This type of analysis is useful in providing a frame­work for understanding signal transduction responses and to assist with identifying regulatory gene networks. It is also useful for finding genes associated with plant pathogen infec­tion that are also affected by environmental stresses such as drought and cold in differing ways (12. 13). A downloadable guide to using DRASTIC INSIGHTS has been developed to assist users and is available at http://www.scri.sari.ac.uk/TiPP/ PPS/DRASTIC/helpfiles/i ndex.html.
f uture work
DRASTIC- INSIGHTS will in the future be extended by link ing both public and private domain data to enable scientists to hypothesize using personal and published data. Optional access to Nottingham Arabidopsis Stock Centre (NASC)
mieroarray data will also be made available via individual user domains. Development of text mining and data capture tools to automatically identity suitable publications and datasets for inclusion in DRASTIC is currently being under­taken .
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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Appendix II (pp. 156-157) - Independent Review of DRASTIC by Clare Sansom, Birkbeck 
College, London, has been removed from this e-thesis due to copyright restrictions.  
The review was published in The Biochemist, August 2005 , pp 47-48.
Appendix III - Conference Poster
Button D. K., Heilbronn J., Ball L., Natanson L., Gartland J., Gartland K. M. A., Marshall B., 
Newton A. and Lyon G. (2005). D ra stic : A  D a ta b a se  R eso u rce  f o r  the A n a ly s is  o f  S ign a l 
T ran sdu ction  In C ells, (w w w .d ra s tic .o rg .u k ). XII International Congress on Molecular Plant- 
Microbe Interactions 2005 in Cancun, Mexico
Poster Abstract
In recent years there has been an explosion in data acquisition regarding the molecular 
biology of plant-microbe interactions. Unfortunately much of it is ignored or lost as it cannot 
readily be searched, gene names have changed with time, and many genes of unknown 
function are being ignored. Consequently our understanding of the implications of that data 
has not been fully exploited. We have therefore set up a relational database containing stress- 
responsive gene expression data derived from Northerns and microarrays that have been 
published in refereed papers. The database currently contains approximately 14,000 entries 
covering 67 plant species and 289 stress treatments, both abiotic and biotic, and can be 
queried from our web site at www.drastic.org.uk. This database has enabled us to up-date the 
nomenclature of genes cited in ‘old papers’ and to link publications on genes classified as 
unknown function. Querying the database can rapidly identify treatments that regulate 
expression of selected genes. For example, the database has enabled us to identify genes that 
are down-regulated by cold and drought but which are up-regulated in response to infection 
by a pathogen thus providing a molecular insight into how environmental factors may affect 
disease resistance. Importantly, we are developing a suite of software tools to extract and 
visualise knowledge from the database to hypothesise possible relationships between 
signalling genes that can then be tested experimentally. For instance, up-regulation of a 
number of signalling genes in response to virus infection correlates with up-regulation of 
calreticulin 3 (Atlg08450) but not with the other calreticulins.
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Although there has been an explosion in data acquisition regarding the molecular biology of plant-microbe interactions in recent years our understanding of the implications of that data has not been fully exploited. As a consequence of this data swamp much published information is ignored or 'lost'
Whilst we have been able to draw static' cell signalling diagrams containing a limited amount of (sometimes speculative) information such diagrams are of limifed value when trying to interpret large amounts of data from microarray experiments Thus in future, we expect such diagrams to be drawn dynamically in response to a query and to be driven by a combination of public and private domain databases
As a first step in this process we have set up a relational database of stress-responsive' gene expression data populated with information from published refereed papers containing gene expression data (Northerns and Microarrays) This database can be searched from our web site at www.drastic.org.uk.
The database
The database currently contains apDrox 15,300 entries covenng 70 plant species and 297 treatments.The database can be searched for published information on these 'stress- responsive' genes.
d r a s t ic S3
We are developing a suite of software tools to extract and visualise knowledge from the database to hypothesise possible relationships between potential signalling genes. Looking at the regulation ot genes in response to different treatments it is possible to see that certain groups of genes are always co-regulated suggesting that they are likely to occur in the same signal transduction pathway. For instance, using a prototype of a PATHWAY' software we have developed we can show that up-regulation of calreticulin 3 (At1g08450) in Arabidopsis is associated with the up-regulation of a number of potential signalling genes (inc kinases) which does not occur If calreticulin 1 (At1g56340) and calreticulin 2 (At1g09210) are down-regulated
Venn diagrams
Unknown genes Biotic and abiotic interactions12% of entries in the database are described as unknown’ function 
The database is useful for linking together information on ESTs described as genes of unknown function. For example, by converting accession numbers into AGI numbers we have shown that the following ESTs that are down-regulated by chitm (H37231, R90140, T41806). drought (AV823744). ethylene (R90140). low oxygen (At2gi0940), or sodium chloride (AV823744), or up-regulated by salicylic acid (R90140, H37231) are all the same gene i.e. At2gl0940
Lyor G2. Msv/tc- AC and Ma-anaB 3 2002 ~-s nsec for a randarfl no-e-daue *cr pane cb&ifcsacr. 
(a *Juc^ 3tce r jncuon Ccce anc an a-tOTialec oata-bosec so l»  assist - uncs-star'cng the -ncecular 
assoc atona - o» aignai ng in 3-am-MJhcger tnteracrons Moecuia ■ Pant =‘ar*>ogy 3.103-100
It is possible to gain an insight into the interaction between biotic and abiotic stress responses by looking at gene expression data within this database. For example, the Arabidopsis genes At2g14560 and At5g14920 of unknown function are down-regulated by cold and drought respectively but are both up-regulated by BTH and by infection with an incompatible isolate of Peronospora parasitica. thus suggesting how resistance could be affected detrimentally by environmental conditions
159
Appendix IV - Conference Poster
Button D. K., Gartland K. M. A., Ball L. D., Natanson L., Gartland J. S., Ghazal P., Duncan 
I., Newton A. C., Marshall B. and Lyon G. D. (2004). Mining Value From Gene Expression 
Data. 12th International conference on intelligent systems for molecular biology (ISMB
2004) and 3rd European conference on computational biology (ECCB 2004). July 31st - 
August 4th , Glasgow. Abstract A-70
Poster Abstract
DRASTIC is a relational database for gene expression developed by University of Abertay 
Dundee and Scottish Crop Research Institute to record molecular plant responses to 
treatments. The INSIGHT Project is focused on developing a suite of tools to intelligently 
mine the database. Techniques used include Data Mining , clustering and visualisation. 
INSIGHT tools are available at http://www.drastic.org.uk.
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Database Resource for Analysis of Signal Transduction In Cells Inference of Cell Signalling Hypotheses
D R A S T I C  I N S I G H T SMining Value from Gene expression DataDavina K. Buttons Kevan M, A. GartlandX Leslie D. BaHS Louis NatansonS Jill S. GartlandX Peter GhazalS Ishoel Duncanx Aonan C. Newton , Bruce Marshall and Gary 0 Lyon
Making senseof the enormous quantities of gene expression data now becoming available is a central problem for all hioscientisLs Developing easy to use tools to enable valuable information to be extracted from complex datasets is crucial to achieving this aim■ The DRASTIC INSIGHTS project builds an intelligent and generic system for new hypothesis formulation from complex biochemical pathway databases■ DRASTIC contains a relational database for gene expression developed by Scottish Crop Research Institute iSCRIj and University of Abertay Dundee (UAD) to record molecular plant responses to pathogen and other environmental stress treatments e g drought, sodium chlonde, high and low temperatures• INSIGHT develops a suite of tools to intelligently mine the database allowing novel hypotheses for response regulation to he created
2. Gene Expression Database
• www.drastic.org.uk offers web-based access to the providing tools to search the database• Incorporates publ ished mi croarray and Northern data of stress responsive plant genes• Tracks Arubidopsis Genome Initiative (AGI) numbers through NCBI• Permits updating of gene names• Quality control software• Currently contains information on❖ 300 references❖  270 treatments ❖ 65 plant species❖  1160 responses
Roadmap is a suite of search tools that• Lists all genes that are only regulated by one treatment• Displays a 'Roadmap' of all genes that are co-regulated by corresponding treatments• Groups Common Genes
Proteins involved in the same signal transduction pathway are likely to be co-regulated and show the same response to a range of treatments To find kinases, transcription factors, and calcium-binding proteins that are in the same signal transduction pathway one should compare expression patterns between these diagrams
i 3 Pathway BuilderGenes with similar expression patterns are likely to be in the same signal transduction pathway• The Pathway Search allows the user to build up "pathways" of genes• lhe results display the gene regulation for each treatment that the database holds results for.• The user can identify genes that have similar response patterns which permits hypotheses postulation which can be tested expenmentally
3 4 Chromosome Mapping For Arabidopsts genes regulated by a specific treatment can be mapped on the chromosome using software available at TAIR (www Arabidopsis.otg) as shown below or in the TAIR GO program that provides pie charts show’ing the functional categorization
3.5 Venn Diagrams
The Venn Tool shows us which genes are involved in overlapping signal transduction pathways
4 Summary
• Enables one to retneve published information on gene expression data for stress responsive plant genes
• INSIGHTs interface has produced visualisations giving rise to novel hypotheses which where previously opaque to the user of the database and include identification of common elements in pathways affected by different treatments
• Hypotheses can he used to inform further experimentation by bioscientists whose findings could enrich the database
Acknowledgements: Carnegie Tnist and SEERAD for funding
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Appendix V -  Experiment Results (13 Experiments)
R esu lt 1
The number of matching records: 78
Gene Name i T reatment 1 2 3 |4 5 6 7 8 9 10 11 12 |l3 |14 15 |i6 17 18 19 20 21 22 23 24
Ai1 g08450 (calreticulin) m m m tm m m m m
Ai1 g09210 (calreticulin)
At1g24140 (metalloproteinase, zinc, like) 13 b h El pieibu m
At1 gS6340 (calreticulin)
At2g31800 (ankyrin protein kinase, putative) Bn PI Bn E3
At2g32680 (disease resistance protein putative) m m m
Ai2g32800 (protein kinase) uimugig m  El m
Ai2g41110 (calmodulin) m M m n i b h mm
At3g08760 (protein kinase putative) E3 m m PI
At4g03450 (ankyrin repeat family) m m
At4g08260 (phosphatase 2C Ser/thr) IMBm E3 m pi 13 El
At4g34390 (G protein, extra large like) m m m n m  Bn
Number Treatment1 Altemaria brassicicola2 BTH
3 cold
4 cucumber mosaic virus (CMV)
5 ethylene6 flagellin 22 (flg22)
7 heat stress8 hydrogen peroxide
9 jasmonate (methyl)10 light11 malondialdehyde (MDA)12 mannitol (0.2M)
13 methanol
14 oilseed rape tobamovirus (ORMV)
15 ozone
16 Peronospora parasitica
17 potato virus X potexvirus (PVX)
18 salicylic acid
19 sodium chloride20 sodium nitropruside (an NO donor)21 turnip mosaic potyvirus (TuMV)22 turnip vein clearing tobamovirus (TVCV)
23 wound
24 Yariv phenylglycoside (beta-D-Glc)3
Researcher Com m ent:
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Result 2 The number of matching records: 90
Treatment Legend
Number Treatment
1 ABA (abscisic acid)
2 Alternaria brassicicola
3 cold
4 cucumber mosaic virus (CMV)
5 drought / dehydration / wilt
6 ethylene
7 jasmonate (methyl)
8 light
9 mannitol (0.2M)
10 ozone
11 salicylic acid
12 senescence
13 sodium chloride
14 wound
15 Yariv phenylglycoside (beta-D-Glc)3
R esearcher C om m ent: “Put these into pathw ay search. Lots o f possibly interesting stuff. 
M ore to follow  later probably”
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Result 3 The number of matching records: 52
Gene Name /  Treatment 1 2 3 6 7 8 9 10 11 12 13 14 15 16 17
At4g34000 (bZIP absdsic acid responsive elements- 
binding factor)
At5g05410 (DRE-binding protein (DREB2A))
At5g 15850 (zinc finger protein CONSTAN5 like 1)
At5g 15960 (kinl) Bi
At5g 15970 (kin2 (cold regulated cor6.6)) BI
At5g 17300 (transcription factor, Myb)
At5gl7460 (unknown)
At5gl7465 (unknown)
At5g53140 (protein phosphatase 2C putative)
Treatment Legend
Number Treatment
1 ABA (abscisic acid)
2 cold
3 cucumber mosaic virus (CMV)
4 drought / dehydration / wilt
5 ethylene
6 flagellin 22 (flg22)
7 harpin
8 hydrogen peroxide
9 malondialdehyde (MDA)
10 mannitol (0 2M)
11 ozone
12 Peronospora parasitica
13 Pseudomonas syringae pv tomato
14 sodium chloride
15 UV
16 UV + ascorbic acid
17 wound
R esearcher Com m ent: ‘T h e y  should be related to the last set (Pathw ay 2) I sent but there are 
too m any to keep tog ther”
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Result 4
T h e num ber of m atch ing records: 13
Gene Name /  T re a tm e n t 2 3
Atlg69490 (transcription factor, NAC family, NAP like putative)
At2g01010 (unknown)
At2gul030 (unknown)
m  E3
Treatrnent Legend
Number Treatment
1 ABA (abscisic acid)
2 brassinosteroid
3 cold
4 drought / dehydration / wilt
5 Pseudomonas fluorescens
6 sodium chloride
R esearcher Com m ent: “A small group”
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Result 5
Treatment Legend
Number Treatment
1 ABA (abscisic acid)
2 Alternaria brassicicola
3 chitin
4 cold
5 cucumber mosaic virus (CMV)
6 drought / dehydration / wilt
7 ethylene
8 hydrogen peroxide
9 jasmonate (methyl)
10 light
11 low oxygen
12 nitric oxide (NO donor NOR-3)
13 oilseed rape tobamovirus (ORMV)
14 phosphate starvation
15 Phytophthora infestans
16 potato virus X potexvirus (PVX)
17 Pseudomonas fluorescens
18 Pseudomonas syringae pv tomato
19 salicylic acid
20 senescence
21 sodium chloride
22 turnip mosaic potyvirus (TuMV)
23 turnip vein clearing tobamovirus (TVCV)
R esearcher C om m ent: "This is one to rave about Print this one out and show it to K evan”
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Result 6
T he n u m ber of m atching records: 15
Gene Nam e /  T re a tm e n t 5  6  7
Atlg20350 (protease, cysteine, papain-like (CIA-3 family))
At3gl2610 (DNA darnage-repair/toleration protein)
Up I Down
Up I Down
At3g53460 (R.NA binding protein cp29) Down I Ug_ I Down
At4g04460 (protease, aspartic, pepsin-like (A 1-4 family))
At4g 13660 (pinoresinol-lariciresinol reductase, putative)
Down! Up
Down I LJfj_
Treatment Legend
Number Treatment
1 Alternaria brassicicola
2 chitin
3 drought / dehydration / wilt
4 ethylene
5 jasmonate (methyl)
6 light
7 salicylic acid
R esearcher Com m ent: “A nother sm all set to consider. Not sure if this is a good one or not. 
M aybe this is a set w here one could make som e predictions to test in the lab.”
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Result 7
i n e  nu m oer or rnatcrnng recoras: i y
Gene Name /  T re a tm e n t 1 2 3
Atlg09210 (calreticulin) Down
Atlg21550 (calcium-binding protein)
Atlg62480 (calcium-binding protein, vacuolar, putative) Uel B i Down
At3g57530 (calcium-dependent protein kinase)
At4g04720 (calcium-dependent protein kinase)
Down Down
Down B IB i
Ue_ Ue_
Down Down
UiL UEL
Treatment Legend
Number Treatment
1 Alternaria brassicicola
2 BTH
3 cucumber mosaic virus (CMV)
4 ethylene
5 hydrogen peroxide
6 jasmonate (methyl)
7 salicylic acid
8 sodium nitropruside (an NO donor)
9 Yariv phenylglycoside (beta-D-Glc)3
R esearcher Com m ent: “M ore AGI for pathw ays”
Result 8
T h e num ber of m atch ing records: 16
Gene Name /  T re a tm e n t I 2
Atlg09210 (calreticulin) Down
Atlg62480 (calcium-binding prote in vacuolar, putative) UEL m \
6 1 8
Down DownDown
Down I U£_
At3g57530 (calcium-dependent protein kinase)
At4g04720 (calcium-dependent protein kinase)
UCL UiL
Down Down H
Uel UEL
Treatment Legend
Number Treatment
1 Alternaria brassicicola
2 BTH
3 cucumber mosaic virus (CMV)
4 ethylene
5 hydrogen peroxide
6 jasmonate (methyl)
7 salicylic acid
8 Yariv phenylglycoside (beta-D-Glc)3
Researcher Com m ent:
Result 9
The number of matching records: 35
Treatment Legend
N u m b e r T re a tm e n t
1 Alternaria brassicicola
2 chitin
3 cold
4 drought /  dehydration /  wilt
5 ethylene
6 hydrogen peroxide
7 jasmonate (methyl)
8 light
9 low oxygen
10 Phytophthora infestans
11 Pseudomonas fluorescens
12 salicylic acid
13 Yariv phenylglycoside (beta-D-Glc)3
R esearcher Com m ent: “This list contains som e existing num bers but is slightly different and 
perhaps better than som e earlier ones.”
170
Result 10
The number of matching records: 37
Gene Name / Treatment 1 2 3 4 5 6 7 8 9 10 11 12 13 14
At2g4G000 (nematode resistance protein putative / Hslpro-1 like) mmm tw im mama
At3g50930 (ATPase family AAA-type) m m  ma m na
At4g 12720 (growth factor-like) mana na
At4g20780 (calcium-binding protein putative) m m m naAt4g39640 (glutamyltransferase, gamma, putative) naira cm na
At5g25930 (leucine-rich repeat family protein / protein kinase family RLK5 like) naira na
At5g57560 (xyloglucan endotransglycosylase related) [rirrirriCTmirain in na nana
Treatment Legend
N u m b e r T re a tm e n t1 ABA (abscisic acid)2 brassinosteroid
3 cold
4 cucumber mosaic virus (CMV)
5 drought /  dehydration i  wilt
3 flagellin 22 (flg22)
7 gamma irradiation8 hydrogen peroxide
b IAA10 low oxygen11 malondialdehyde (MDA)12 methanol
13 wound
14 Yariv phenylglycoside (beta-D-Glc)3
R esearcher Com m ent: “A nother set o f genes possibly  in the sam e pathw ay. I have ju st put 
som e inform ation into the database on genes regulated by gam m a irradiation and noticed that 
som e were also regulated by Y ariv phenylglycosides. I therefore had a closer look at 
everything that was regulated by both o f those treatm ents and noticed that the follow ing 
subset o f genes are also all up-regulated by flagellin. T hese m ust therefore be likely 
candidates for being involved in the sam e pathw ay, (possibly the last gene i.e. A t5g57560 
m ay be regulated by too m any different treatm ents and m ay therefore not be that close in 
term s o f signalling distance to the other genes)”
R esu lt 11
T h e  n u m b e r  o f  m a tc h in g  re c o rd s :  15
Gene Name /  Treatment 1 2 3 4 5 6 7Atlgl9670 (chlorophyllase 1, coronatine-induced protein 1) ■JHHlim "STBPSini
At2g21210 (auxin-induced putative) 5E5HS11EB53
At2g46690 (auxin-responsive family) BSWTI
At4g38840 (auxin induced 3AUR-13 like) •5PHS iTHBfffl tTHfllffl in a
___________ T re  a tm  e n t  L e  g e n d___________
■ N u m b e r  T r e a t m e n t  h cold2 cucumber mosaic virus (CMV)3 flagellin 22 (flg22)4 qarnma irradiation
5 IA A6 jasmonate (methyl)
7  ___  wound
R esearcher Com m ent: “This small group looks interesting w hen put into the pathw ay 
search.”
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Result 12
The number of matching records: 133
Gene Name /  Treatment 1 2 3 4 5 6 7 8 9 10 H 12 13 14 15 16 17 18
Atlg09340 (RNA binding protein putative g5bf) ■HEW ■HEW n ■HEW
Atlgl6850 (unknown) M B * ■ B M
Atlg43160 (AP2 domain containing protein RAP2.6, ERF 
family)
Atlg49450 (transposon like protein, En/5pm-like) W d M B M ■EffETI
Atlg78070 (WD-40 repeat family)
At2g01010 (unknown)
At2g 15970 (low temperature-regulated membrane protein 
putative)
At2g23120 (unknown)
At2g26980 (SNF1-related kinase) BMDra
At2g30360 (protein kinase 11 CBL-interacting (CIPK11) / 
5NF1-related kinase)
At2g33380 (calcium-binding EF-hand protein) ora P I
At2g46270 (transcription factor, bZIP G box binding factor 
GBF3)
At3g61890 (transcription factor, homeobox leucine zipper) I W H W i lW I M B M ira s ra r
At4g26080 (protein phosphatase 2C ABI1 / PP2C ABI1 / 
abscisic acid-insensitive 1 (ABI1))
At4g27410 (NAC family) B M Bra B M
At4g34000 (bZIP abscisic acid responsive elements-binding 
factor)
At5g 15960 (kinl) BMESB Bra ■Brorpra n n
At5g 15970 (kin2 (cold regulated cor6.6)) B M D M (ra B M
At5g 17300 (transcription factor, Myb) n m 33S9S
At5gl7460 (unknown) B M B M
At5g 17465 (unknown) I IM U M B M
At5g52310 (responsive to dessication RD29A, cor78, Itil40, 
LTI78)
El1
At5g53140 (protein phosphatase 2C putative) ■JiWWI »HEW ■HEWED ■ETOT
Treatment Legend
Number Treatment
1 ABA (abscisic acid)2 cold
3 cucumber mosaic virus (CMV)4 drought / dehydration / wilt5 ethylene
B gamma irradiation7 jasmonate (methyl)B mannitol (0 2M)
9 mannitol (0.4M)10 mannitol (0.6M)11 ozone
12 Peronospora parasitica
13 Pseudomonas syringae pv tomato14 salicylic acid15 senescence
16 sodium chloride17 wound18 Yariv phenylglycoside (beta-D-Glc)3
R esearcher Com m ent: “I have had a closer look at genes involved in A B A -associated 
signalling. Lots of them . I think there are sub-groups in this list eg look at responses to 
treatm ent 8”
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Result 13
TheGene Name / Treatment
AtlgOl 140 (SNF1 -related kinase)
Atlg01720 (no apical meristem / transcription activator, NAC 
domain, ATAF1)
Atlg07040 (unknown)
Atlgl3990 (unknown)
Atlg32640 (protein kinase; RD22BP1; transcription factor, 
bHLH putative)
Atlg45249 (ABA-responsive cis-acting element)
Atlg52980 (GTP-binding protein putative)
number of matching records 1 60l 3 S IS 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Atlg61890 (MATE efflux family)
Atlg66760 (MATE efflux family protein, putative) 
Atlg68440 (unknown)
Atlg72800 (unknown, nucleolin like? (NuMl-related)) 
Atlg75500 (nodulin MtN21 family)
At2g02710 (receptor-like serine/threonine protein kinase) 
At2g05540 (glycine-rich protein putative)
At2g06050 (12-oxophytodienoate reductase)
At2g3055Q (lipase putative)
At2g42890 (Mei2)
At2g46680 (transcription factor, homeobox leucine zipper) 
At2g47190 (transcription factor, Myb)
At3g02480 (ABA-responsive protein-related)
At3g 17000 (ubiquitin conjugating enzyme like)
At3gl9290 (transcription factor, bZIP (AREB2, ABF4)) 
At3g20300 (unknown)
At3g22830 (heat shock transcription factor-like protein) 
At3g29575 (unknown)
At3g53710 (zinc finger-containing protein ARF GAP-like 
ZIGA2)
At3g55530 (zinc finger (C3HC4-type RING finger) family) 
At3g59930 (unknown)
DM CM
IIM
CM CM
At3g62030 (peptidyl-prolyl cis-trans isomerase, chloroplast / j|j|||j| 
cydophilin / rotamase) ■ ■
At4g01020 (pentatricopeptide (PPR) repeat-containing RHH 
protein)
At4g20830 (reticuline oxidase homolog) H M F I F I
At4g23050 (protein kinase, serine/threonine putative)
At4g37510 (ribonuclease III family)
At5g01520 (zinc finger (C3HC4-type RING-HCa)) P M F M
At5g09440 (phosphate-responsive protein, putative) F I
At5gl 1420 (unknown) BHf
At5g23060 (unknown) 335?
At5g25460 (unknown) ■SB?
At5g39610 (NAC, NAM (no apical meristem) like) F M
At5g42010 (WD-40 repeat protein family)
At5g48180 (jasmonate inducible (myrosinase binding)) C M F M
At5g52300 (responsive to dessication RD29B)
At5g61820 (MtN19like) D M F I f i F M
Treatment Legend
Number Treatment1 ABA (abscisic acid)2 Alternaria brassicicola3 cucumber mosaic virus (CMV)4 drought / dehydration / wilt5 ethyleneB flagellin 22 (flg22)
7 hydrogen peroxideB jasmonate (methyl)9 low oxygen10 malondialdehyde (MDA)11 methanol12 nitric oxide (NO donor NOR-3)13 ozone14 phosphate starvation15 salicylic acid16 senescence17 sodium chloride18 wound19 Yariv phenylglycoside (beta-D-Glc)3
R esearcher Com m ent: “M ay be the genes that are dow n-regulated  in this last are linked 
whilst those that are up-regulated are linked together. The genes dow n-regulated by treatm ent 
3 also look linked.”
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A p p e n d ix  V I  -  D r a s t i c  I n s ig h t  U s e r  G u id e
W elc o m e  to  D R A S T IC  I N S I G H T S  H elp P a g e s
D rastic In s ig h ts  is a su ite  o f  w e b  to o ls  th a t e n a b le  yo u  to  m in e  th e  g e n e  e x p r e ss io n  d a ta  in th e  
DRASTIC d a ta b a se .
T h e  to o ls  a re  listed  b e lo w . Click on  th e  links to  v ie w  h o w  to  u s e  th em :
G eneral D a ta b a se  S earch  
D rastic S ta tistics
T h e  fo llow in g  to o ls  w ork  w ith  on ly  th e  A r a b id o p s is  th a lia n a  d a ta :
AGI S earch
C h rom o so m e M apping
GO F unctional C a tegor isa tion
V enn D iagram s
P ath w a y  Finder
R oad m ap
U niq ue G e n es
D R A S T IC  D a t a b a s e
T h e  D rastic D a ta b a se  is a relational d a ta b a se  d e v e lo p e d  by SCRI (S c o ttish  C rop R ese a r c h  In s t itu te )  
a n d  UAD ( U n iversity  o f  A b ertay  D u n d e e ) . It in co rp o ra tes  d a ta  from  p u b lish ed  re fereed  p a p ers  
co n ta in in g  p lan t m o lecu lar  r e s p o n s e s , m icroarrays, N orth ern s an d  ESTs reg u la ted  by a w id e  ra n g e  o f  
ch em ic a ls , en v iro n m en ta l s t r e s s e s ,  p a th o g e n s  a n d  e lic ito rs  referred  to  h e re  a s  tr e a tm e n ts . T h e  e f fe c t s  
o f  e a c h  tr e a tm e n t on  th e  up - or d o w n - regu la tion  o f  g e n e  ex p r e ss io n  h a v e  b e e n  u se d  to  p o p u la te  th e  
d a ta b a se . At th e  t im e  o f  w riting th ere  a r e  m o re  th a n  1 6 ,0 0 0  g e n e  a c c e s s io n s  relatin g  to  o v er  2 9 5  
d ifferen t tr e a tm e n ts  in o v e r  6 0  plant s p e c ie s  ta k e n  from  o v er  4 0 0  r e fe r e n c e s .
T h is d a ta  ca n  b e  se a r c h e d  an d  m an ip u la ted  u sin g  th e  w e b  to o ls  provided  by th e  D rastic In s ig h t  
p roject av a ila b le  from  w w w .d ra stic .o rq .u k . T h e  D rastic  d a ta b a se  is u p d a ted  w ith  n e w  d a ta  o n  a daily  
b a sis .
D r a s t ic  S t a t i s t i c s
D rastic S ta tis tic s  p rov id es an  u p -to -d a te  list o f  s ta t is t ic s  for th e  d a ta b a se  includ ing  th e  to ta l n u m b er  
o f  rea c tio n s , s p e c ie s  a n d  tr e a tm e n ts . It a lso  p rov id es  a b reak d ow n  o f  both  rea c tio n s  per s p e c ie s  an d  
rea ctio n s p er tr e a tm e n t. You can  ord er th e  lists a lp h a b etica lly  or nu m erica lly . T h e r e  a re  sev era l w a y s  
to  v ie w  th e  d ata :
Sort R ea ctio n s  
In d e p th  v ie w  o f  R ea ctio n s  
V iew  Individual R eaction  R esu lts  
V iew  Journal R e fer en ce s
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Order Stats Numerically Order Stats Alphabetically
Tota l n u m b e r o f R eac tio n s : 1 3 8 2 4  
T ota l n u m b e r o f S p e c ies : 67  
Tota l n u m b e r o f T re a tm e n ts : 287
|llumber of Reactions per Species: (lumber of Reactions per Treatment:{Arabidoosis thaliana 10510 |sodium chloride 1050{Orvza sativa 683 jdrouctht / dehydration / wilt 1037|l_vcooersicon esculentum 641 |cold 913Hordeum vulaare 473 {cucumber mosaic virus (CMVI 635Nicotiana tabacum 363 |wound 609Solanum tuberosum 297 {Pseudomonas svrinaae ov tomato 561Caosicum annuum 113 |iasmonate fmethvn 513Medicaao truncatula 103 salicvlic acid 511{Glycine max 69 ABA (abscisic acid) 496Pisum sativum 49 Yariv chenvlalvcoside (beta-D-Glc'13 475>ie AA Q
S o r t  F u n c t io n
T h e  D rastic  S tatistic  p a g e  p rov id es an  e a s y  w a y  o f  b row sin g  th e  d a ta . T h e  n u m b er o f  rea c tio n s  
r e p r e se n ts  th e  n u m b er o f  record s held  in th e  D rastic d a ta b a s e  for e a c h  ca te g o r y .
You ca n  click on  th e  'O rder S ta ts  N um erically' b u tto n  if y o u  w a n t to  s e e  th e  ta b le (s )  n u m erica lly  
o rd ered . T h is op tio n  so r ts  th e  d a ta  acco rd in g  to  th e  n u m b er  o f  r ea c tio n s  p er c a te g o r y  in a sc e n d in g  
order.
You ca n  click  on  th e  'O rder S ta ts  A lphabetically ' b u tton  w h ich  will so rt th e  d a ta  into  a lp h a b etica lly  
a sc e n d in g  order.
V i e w  R e a c t i o n s  b y  S p e c i e s  f o r  a  s e l e c t e d  T r e a t m e n t
T o  g a in  a  m o re  in d e p th  v ie w  on  a  particu lar tr e a tm e n t, click o n  th e  tr e a tm e n t th a t yo u  a re  in ter e s ted  
in. T h is will p rod u ce  a  n e w  ta b le  o f  d a ta  provid ing s ta t is t ic s  o n  th e  n u m b er  o f  rea c tio n s by s p e c ie s  for  
th e  tr e a tm e n t you  s e le c te d . T h e  rea c tio n s ca n  b e  so r te d  N um erically  or A lp h ab etica lly . T h is ca n  b e  
m in ed  fu rth er by clicking o n  a  s p e c ie s  from  th e  n e w  list - s e e  V iew  Individual R ea ctio n s
V i e w  R e a c t i o n s  b y  T r e a t m e n t  f o r  a  s e l e c t e d  S p e c i e s
T o  v ie w  fu rth er in form ation  on  a particu lar s p e c ie s ,  click  on  th e  s p e c ie s  th a t y o u  a re  in ter e sted  in. 
T h is will n a v ig a te  yo u  to  a  n e w  p a g e  w h ich  will p rov id e  s ta tis t ic s  o n  th e  n u m b er o f  rea c tio n s by  
tr e a tm e n t for th e  s p e c ie s  y o u  s e le c te d  a s  s h o w n  b e lo w :
Order Stats Numerically Order Stats Alphabetically
Total number of Reactions: 683 Total number of Treatments: 40
Humber of Reactions per Treatmerrt for Oryza sativa:MaanaDorthe arises 166i sodium chloride 120drouaht / dehvdrartion f wilt 58| ABA (abscisic acid! 48 |iasmonic acid 47Icold 42BTH 24iellcitor. cell wall from M arises 20 [•* — —1 A O
For A r a b id o p s is  th a lia n a  on ly , in ad d ition  to  th e  n u m b er  o f  rea c tio n s per tr e a tm e n t, th e r e  is an  
ad d ition al ta b le  w h ich  d isp la y s  th e  n u m b er  o f  u n iq u e  AGI n u m b ers per tr e a tm e n t. T h is ta b le  ca n  b e  
fo u n d  by scrolling d o w n  th e  p a g e  p a s t  th e  first ta b le  a s  sh o w n  b e low :
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cvcloheximide 1
liaht+sucrose+MeJa 1
Number of Unique AGI Numbers per Treatment
N u m b er o f R eactions p e r  T re a tm e n t fo r  A rab ido ps is  thaliana: !
1-aminocvclopropane-1 -carboxvlate fA C Q  0
[2.4-D 2
13AT (catalase inhibitor^ 4
3-O-methvlalucose 1
6-deoxvalucose 7
ABA fabscisic acidl 252
Alternaria alternata 6
Alternaria brassicicola 161
aluminium 1
j ascorbic acid 1
I BAP {'6-benzoaminopurinel___________________________________ 1
T h e  rea c tio n s can  b e  so r te d  N um erically  or A lp h ab etica lly  or m in ed  fu rth er  by clicking o n  a tr e a tm e n t  
from  th e  n e w  list - s e e  V iew  Individual R eactio n s
V i e w  I n d iv id u a l  R e a c t i o n  R e s u l t s
T h is s c r e e n  e n a b le s  y o u  to  v ie w  all th e  individual rea c tio n s  h eld  o n  d rastic  fo r  th e  tr e a tm e n t a n d  
s p e c ie s  th a t  y o u  s e le c te d  from  th e  D rastic S ta tistic  p a g e s  a s  sh o w n  in th e  d ia gra m  b elow :
T h e  n u m b er o f  resu lts  an d  th e  s p e c ie s /tr e a tm e n t  c h o s e n  a re  d isp la y ed  a t  th e  to p  o f  th e  p a g e .
Each ta b le  o f  record s ca n  b e  so r ted  a lp h a b etica lly  (a sc e n d in g  or d e sc e n d in g )  by clicking o n  th e  
co lu m n  h ea d in g  th a t  y o u  w a n t to  so r t th e  d a ta  by. T h e  first t im e  y o u  click , it will so rt th e  c o n te n ts  in 
a sc e n d in g  order. T h e  s e c o n d  tim e  yo u  click it will so r t th e  ta b le  c o n te n ts  in d e sc e n d in g  ord er. T h is is 
in d icated  by a black  arrow  th a t  will a p p ea r  in th e  so r te d  co lu m n  h e a d in g .
T o  v ie w  th e  full journal r e fe ren c e  d a ta , click  o n  th e  R efer en ce  ID n u m b er o f  th e  record  y o u  a re  
in ter e sted  in. T h is will o p e n  a  n ew  w in d o w  w h ich  d isp la y s  th e  full r e fe r e n c e  in form ation  includ ing th e  
jou rn a l it w a s  p u b lish ed  in.
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The Number of results for Arabidopsis thaliana and sodium chloride are 786
Name Gene Name Accession Regulation 
Number
AGMumber [Treatment Compatibility 
Name
Genus and
Species
(CuMvar)
Reference
12-oxophytodienoate
reductase AtOPR3
AVB24251; 
AV785462; Up 
AF410322
At2 g06050
isodium
[chloride
Arabidopsis 
[non pathogen jthaliana (cv 
iColumbia) jlflZ
12-oxophytodienoate 
reductase AtOPR3
AV824251; .. 
AV785462 Up At2 g06050
sodium
chloride non pathogen
Arabidopsis 
thaliana (cv 
Columbia)
234
1-aminocyclopropane-1- 
carboxylate (ACC) 
oxidase putative
not known At2 g19590 Down At2 g19590 sodiumichloride non pathogen
Arabidopsis 
thaliana (cv 
Columbia)
472
1-aminocyclopropane-1- 
carboxylate (ACC) 
oxidase putative
not known At1g12010 Down At1 g12010 sodiumchloride
Arabidopsis 
non pathogen thaliana (cv 
Columbia)
422
1-aminocyclopropane-1- 
carboxylate (ACC) 
synthase
AtACS2 not ,, available p not available
sodium
chloride non pathogen
Arabidopsis 
thaliana (cv 
Columbia)
4Q4
1-aminocyclopropane-1- 
carboxylate (ACC) 
synthase like
not known At4 g26200 Down At4g26200 sodiumchloride
Arabidopsis 
non pathogen thaliana (cv 
Columbia)
422
2-isopropylmalate 
synthase-like; 
homocitrate synthase like
not available AV821148 Down At5 g23010 sodiumchloride non pathogen
Arabidopsis 
thaliana (cv 
Columbia)
334
2-isopropylmalate 
synthase-like; 
homocitrate synthase like
not available AVB21148 Down At5 g23010 sodiumichloride non pathogen
Arabidopsis 
thaliana (cv 
Columbia)
107
2-oxoglutarate 
dehydrogenase, E1 not available BE844998 Up At3 g55410 sodiumrhlnrirlp
Arabidopsis 
non pathogen thaliana (cv 15
V i e w  J o u r n a l  R e f e r e n c e s
T o  v ie w  th e  full jou rn a l r e fe ren c e  d a ta , click  o n  th e  R e fer en ce  ID n u m b er o f  th e  record  yo u  a re  
in ter e sted  in. T his will o p e n  a n e w  w in d o w  w h ich  d isp la y s  th e  full r e fe r e n c e  inform ation  includ ing th e  
journal it w a s  p u b lish ed  in a s  sh o w n  b e low :
T h e  N u m b e r  o f  r e su lts  fo r  O r y z a  s a t i v a  a n d  M a g n a p o r t h e  g r i s e a  a r e  1 6 6
Name
peroxidase
Gene Accession Regulation AGINumber Ti eat met it Compatibility Genus and Refeience
Name t Number Name Species
(CiiRrvar |
Oryza sativa
POX22.3 Bt348527 Up not available Magnaporthe nQt specified (ssp laponica-grisea cv t
PRlb D R A S T I COn( * k «H  R* f * « n *  «*r •* V lfw l  T im « 4 « c4l*n l> C« M*  tfl H  13 If l
48R eferenceD;
Author*: FtauyareeP.CholW. Fang E. Bacfcmon B. Dean RA
TM«: Genes expressed during earty stages of rice infection w ih  the rice falasl fungus Magpaporihe y ise a
Journals Mote cuter Plant Pathology
Volume: 2
347-3542001
Northerns
Page*: 
Year: llot re:
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D a t a b a s e  S e a r c h
T h is p ro v id es  a  b a sic  q u ery  fu n ction  for th e  d a ta b a se . You ca n  s e le c t  th e  fo llow in g  p a ra m eters:  
T r e a tm e n ts , S p e c ie s , G e n e , R egu la tion  a n d  D a te . T h e  sea rch  retu rn s th e  resu lts  in tab u lar  fo rm a t  
w h ich  ca n  b e  so r te d , providing links to  th e  r e fe r e n c e s .
D a ta b a se  S earch  P a g e  
D a ta b a se  S earch  R esu lts
G e n e r a l  S e a r c h  P a g e
T o  s e le c t  a s u b s e t  o f  rea c tio n s to  v ie w  from  th e  D rastic D a ta b a se , s e le c t  you r sea rch  criteria from  th e  
S earch  P a g e  a s  sh o w n  b e low : Click th e  'Subm it Search' bu tton  to  v ie w  y ou r  resu lts .
Treatment:
Species:
Gene:
Regulation:
Date:
2.5-norbornadiene 3AT (catalase inhibitor)5-chlorosalicylic acidAAPH (2.2-azobis (2-amidinopropane) dihydrochloride (free radical generator)
acetylsalicyfic acid Agrobacterium tumefaciens Alternaria alternata Alternaria brassicae Alternaria brassidcola
Arabidopsis th all an a
All (or select...)
UP
All (or select)
[ Submit Query ] [Records entered in last 30 days I Records entered in last 60 days
f  yo u  w o u ld  like to  u s e  th e  AND o p er a to r  w ith  tr e a tm e n ts , u s e  th e  V en n  D iagram  to o l.
G e n e r a l  S e a r c h  R e s u l t s
T his s c r e e n  e n a b le s  y o u  to  v ie w  all th e  individual r ea c tio n s  held  o n  th e  d rastic  d a ta b a s e  acco rd in g  to  
you r se a r c h  criteria a s  sh o w n  in th e  d iagram  b elow :
T h e  n u m b er  o f  r esu lts  a re  d isp layed  a t  th e  to p  o f  th e  p a g e .
T h e  w h o le  ta b le  o f  record s ca n  b e  so r ted  a lp h ab etica lly  (a sc e n d in g  or d e sc e n d in g )  by click ing o n  th e  
co lu m n  h e a d in g  th a t  y o u  w a n t to  so r t th e  d a ta  by. T h e  first t im e  y o u  click , it will so r t  th e  c o n te n ts  in 
a sc e n d in g  ord er. T h e  s e c o n d  tim e  y o u  click  it will so r t th e  ta b le  c o n te n ts  in d e sc e n d in g  order. T h is is 
in d icated  by a  b lack  arrow  th a t will a p p e a r  in th e  so r te d  co lu m n  h ea d in g .
T o  v ie w  th e  full journal re fe ren c e  d a ta , click  o n  th e  R e fer en ce  ID n u m b er o f  th e  record  y o u  a re  
in ter e s ted  in. T h is will o p e n  a n ew  w in d o w  w h ich  d isp la y s  th e  full r e fe r e n c e  in form ation  including th e  
journal it w a s  p u b lish ed  in.
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The number of matching records: 207
H o m e  a n t i  ( G e n e  N a m e )  4 A c c e s s io n A G I R e g u la t io n T r e a t m e n t C o m p a t ib i l i t y S p e c ie s
M n m b e f N u m b e r N a m e
2 -o«c iisovalerate  d e h y d ro g e n a s e , 
putative  (h o t k n o w n ) A t5g 0S 3O0 A1SgO9300 U p
cucum ber  
m o saic  v iru s  
(C M V )
inccmpafcbfe A rab id o p s is  th a lian a
C 24
4 -co itr> are te ;C o A  lig a s e  (A 14-C L1 ) A Y 133S82 A11gS1630 U p a z  one n on  p a thogen A rab id o p s is  th a iia n a  c v  C d u r b ia
4 -c o im a rs te :C o A  lig a s e  (A 14-C L2 ) B X 0039S8 A13g 21230 U p o zo n e n c n  p a th o g en A ra b id o p s is  th a lian a  c v  C c tu rb ia
a m h o  a c id  p e rm e a s e  3 (n o t a v a fa b le )
'
A i 1g 77380 A t t g 77330 U p cucum ber m o saic  v irus  
(C M V )
inccmpsfefofe A ra b id o p s is  th a lian a  
C 24
am m onium  t ra n s p o rte r  (A tA M T I .1) A M g 13510 A14g 13510 U p cucum ber m osaic  v irus incctrpatobfe A ra b id o p s is  th a iian a  C 24
(C M '/ )
a ra b h o g a la c la n  p ro te in  fa s c ic ln - lk e  
(A tF L A I 2) A tS g 60490 A1Sg60490 U p
cucum ber 
m o saic  v irus  
(C M '/ )
in c c rrp a tb ie A rab id o p s is  th a lian a  
C 24
a s c o rb a te  o x id a s e  p ita t iv e  (n o t k n o w n ) A t5g 21100 A 1Sg21100 U p cucum ber m o saic  v irus  
(C M '/ )
irc c rrp a tb fe A rab id o p s is  th a iian a  
C 24
R e f  |
i d  j
1SS '--  IiS. '
*§& ;
±es i
±85.
is
is
A c c e s s i o n  N u m b e r  S e a r c h
T his p rov id es a q u ery  fu n ction  sp ec ifica lly  for th e  A ccess io n  n u m b ers in th e  D rastic d a ta b a se . Y ou can  
s e le c t  th e  fo llo w in g  p a ra m eters: A c c e ss io n  n u m b er , T r ea tm en t R egu la tion  a n d  D a te . T h e  sea rch  
returns th e  resu lts  in tab u lar  form at w h ich  ca n  b e  so r te d , provid ing links to  th e  r e fe r e n c e s .
A ccess ion  N um b er S earch  P a g e  
A ccession  N um b er S earch  R esu lts
A c c e s s i o n  N u m b e r  S e a r c h  P a g e
T o s e le c t  a s u b s e t  o f  r ea c tio n s  to  v ie w  from  th e  D rastic D a ta b a se , s e le c t  yo u r sea rch  criteria from  th e  
A ccess io n  N u m b er S earch  P a g e
A c c e s s i o n  N u m b e r :  T h is  b o x  can  b e  le ft b lank to  in clu d e all A ccess io n  n u m b ers or y o u  ca n  input 
o n e  A ccess io n  n u m b er  to  th e  sea rch .
T r e a t m e n t :  You ca n  s e le c t  o n e  tr e a tm e n t from  th e  list or c h o o s e  th e m  all.
R e g u la t io n :  You ca n  c h o o s e  to  in c lu d e  o n ly  u p -reg u la tio n  rea c tio n s  or d o w n -reg u la tio n  rea c tio n s  or  
b oth .
D a t e :  You ca n  v ie w  all rea c tio n s in p u tted  to  th e  d a ta b a se , or s e le c t  to  o n ly  v iew  th o s e  in p u tted  in th e  
la st 6 0  or 3 0  d a y s .
Click th e  'Su bm it Search ' b u tton  to  v ie w  you r  resu lts________________________________________________________
Accession Number Search
There are 7675 Accession numbers in the DRASTIC database 
Enter Accession Number:
Treatment:
e g. D13044
All (or select . . . )1.2- dioctanoyl phosphatidic acid (8:0 PA)1.2- dioctanoylglycerol (8:0 DG)1 -aminocyclopropane-1 -carboxylate (ACC) 2, A, 6-tri n itroto I u e n e2.4- D2.5- norbornadiene3AT (catalase inhibitor)3-O-m ethyl g I u co s e 5-chlorosalicylic acid
Regulation:
Date:
[ Submit Query
UP
All (or select)
Reset
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V ie w  A c c e s s i o n  N u m b e r  R e s u l t s
T h is s c r e e n  e n a b le s  y o u  to  v ie w  all th e  individual rea c tio n s  h eld  o n  th e  d rastic  d a ta b a s e  a cco rd in g  to  
you r  sea rch  criteria a s  sh o w n  in th e  d iagram  b elow :
T h e  n u m b er o f  r esu lts  a re  d isp layed  a t  th e  to p  o f  th e  p a g e .
T h e  w h o le  ta b le  o f  record s can  b e  so r ted  a lp h a b etica lly  (a sc e n d in g  or d e sc e n d in g )  by clicking on  th e  
co lu m n  h ea d in g  th a t  y o u  w a n t to  so r t th e  d a ta  by. T h e  first t im e  y o u  click, it will so r t th e  c o n te n ts  in 
a sc e n d in g  order. T h e  s e c o n d  tim e  y o u  click  it will so r t  th e  ta b le  c o n te n ts  in d e sc e n d in g  order. T h is is 
in d icated  by a  b lack  arrow  th a t will a p p e a r  in th e  so r ted  co lu m n  h ead in g .
T o  v ie w  th e  full journal r e fe ren c e  d a ta , click o n  th e  R e fe r e n c e  ID n u m b er o f  th e  record  yo u  a re  
in ter e s ted  in. T h is will o p e n  a n e w  w in d o w  w h ich  d isp la y s  th e  full r e fe r e n c e  in form ation  including th e  
journal it w a s  p u b lish ed  in.
The number of matching records: 2 3
Name and (Gene Name) A ccession
Number
AGI Regulation 
Nrmber
Treatment
iName
CompatibWy S p ec ies Ref
Id
responsive to 
dessication RD29A, 
cor7 8 , Iti14 0 , LTI78 
(Aird29A)
D13044
|
i|At5 g52310  Upi
drought /
! dehydration /  
! wilt
Arabidopsis thaliana cvnon pathogen 2Z2
!
responsive to 
dessication RD29A, 
cor7 8 , tti1 4 0 , LTI78 
(Atrd29A)
I!
D13044 At5 g52310  Up sodium chloride
Arabidopsis thaliana
.. C24  expressing  i non Pathogen R D A 2 9 A . L U C
transgene
255
.responsive to 
dessication RD29A, 
cor7 8 , tti1 4 0 , LTI78 
(Alrd29A)
D13044 At5g52310  Up ABA (abscisic  acid)
Arabidopsis thaliana
.. C24  expressing  non pathogen RDA2gA.|_u c
transgene
255
responsive to 
dessication RD29A, 
cor7 8 , Iti1 4 0 , LTI78 
(Atrd29A)
D13044 At5 g52310  Up sodium chloride Arabidopsis thaliana cv !non pathogen Co|uIrJ a 214
responsive to 
dessication RD29A, irH'an/i t____ i i- ----________________ ..... ..........  Arabidopsis thaliana cv 'inn
A r a b id o o s is  th a lia n a  O n ly  T o o l s  
A G I S e a r c h
T his p rov id es  a q u ery  fu n ction  sp ec ifica lly  for AGI n u m b e rs  in th e  D rastic d a ta b a se . You ca n  s e le c t  
th e  fo llo w in g  p a ra m eters: AGI n u m b er , T r ea tm en t R eg u la tion  an d  D a te . T h e  sea rch  retu rn s th e  
resu lts  in tab u lar  fo rm a t w hich  can  b e  so r te d , provid ing links to  th e  re fe r e n c e s .
AGI S earch  P a g e  
AGI S earch  R esu lts
A G I S e a r c h  P a g e
T o  s e le c t  a s u b s e t  o f  rea c tio n s to  v ie w  from  th e  D rastic D a ta b a se , s e le c t  yo u r sea rch  criteria from  th e  
AGI S earch  P a g e
A G I N u m b e r :  T h is b o x  can  b e  left b lank to  in c lu d e  all AGI n u m b ers or y o u  ca n  inp ut o n e  AGI 
n u m b er to  th e  sea rch .
T r e a t m e n t :  You can  s e le c t  o n e  tr e a tm e n t from  th e  list or c h o o s e  th e m  all.
R e g u l a t i o n :  You can  c h o o s e  to  in clu d e o n ly  u p -reg u la tio n  rea c tio n s  or d o w n -reg u la tio n  rea c tio n s  or  
both .
D a t e :  Y ou ca n  v ie w  all reaction s in p u tted  to  th e  d a ta b a se , or s e le c t  to  on ly  v ie w  t h o s e  in p u tted  in th e  
la s t 6 0  or  3 0  d a y s .
Click th e  'Su bm it S earch ' bu tton  to  v ie w  you r resu lts
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A r a b id o p s is  G e n o m e  In i t ia t iv e  (A G I)  S e a r c h
E n te r  A G I N u m b e r : ] e  g. A t5 g 1 0 4 5 0
T r «  a tm  e  n t:
1 -am ino cydo prop ane-1  -carboxylats  (ACC) 
2,4-D
3A T  (ca ta lase  inhibitor)
A B A  (abscisic  acid)
A lternaria b ra s s id c o la
aluminium
ascorb ic  acid
B A P  (G-benzoam inopurine)
benoxacor
|
R e g u la t io n : U P  or
D a ta : All (or select) v
[ Subm it Query1 1 R e s e t ]
V ie w  A G I R e s u l t s
T his s c r e e n  e n a b le s  y o u  to  v ie w  all th e  individual r ea c tio n s  held  o n  th e  d rastic  d a ta b a s e  acco rd in g  to  
you r sea rch  criteria a s  sh o w n  in th e  d iagram  below :
T h e  n u m b er  o f  resu lts  a re  d isp la y ed  a t  th e  to p  o f  th e  p a g e .
T h e  w h o le  ta b le  o f  record s ca n  b e  so r ted  a lp h a b etica lly  (a sc e n d in g  or d e sc e n d in g )  by clicking on  th e  
co lu m n  h ea d in g  th a t  y o u  w a n t to  so r t th e  d a ta  by. T h e  first t im e  y o u  click, it will so r t  th e  c o n te n ts  in 
a sc e n d in g  order. T h e  s e c o n d  t im e  y o u  click  it will so r t  th e  ta b le  c o n te n ts  in d e sc e n d in g  order. T h is is 
in d icated  by a  black  arrow  th a t  will a p p e a r  in th e  so r te d  co lu m n  h ea d in g .
T o  v ie w  th e  full journal r e fe ren c e  d a ta , click  o n  th e  R e fe r e n c e  ID n u m b er o f  th e  record  yo u  a re  
in ter e s ted  in. T his will o p e n  a  n e w  w in d o w  w hich  d isp la y s  th e  full r e fe r e n c e  in form ation  includ ing th e  
ournal it w a s  p u b lish ed  in._________________________________________________________________
The number of matching records: 10
Name ami (Gene 
Name)
Accession
Numbei
AGI Niimbei Regulation ITieatment 
Name A
Compatibility Species Ref j 
ID i
14-3-3 (RCI1B  
homolog ATF1 
(GF14 
lambda))
T75872 At5g10450 Up
i
Alternaria
brassicicola compatible
lArabidopsis 
i thaliana cv 
Columbia
2
14-3-3 (RCI1B  
homolog ATF1 
(GF14 
lambda))
H36693 At5g 10450 Up Alternariabrassicicola
compatible
Arabidopsis 
thaliana cv 
Columbia
2
14-3-3 (RCI1B  
homolog ATF1 
(GF14 
lambda))
X74141 At5g 10450 Up cold
non
pathogen
Arabidopsis 
thaliana cv 
Columbia
370
14-3-3 (RCI1B A rohirlAnrir
T A IR  A G I S e a r c h
T h e  D rastic  d a ta b a se  h a s  a  large  n u m b er  o f  record s for rea c tio n s  on  A r a b id o p s is  th a lia n a  . T h e  
m ajority o f  t h e s e  record s in clu d e th e  AGI (A ra b id op sis  G e n o m e  In itia tiv e ) n u m b er  for th e  g e n e  
in vo lved .
T h e  TAIR (T h e  A rab id op sis  In fo rm a tio n  R e so u r c e )  s it e  h a s  a n u m b er o f  to o ls  sp ec ifica lly  d e s ig n e d  to  
a n a ly sis  AGI d a ta . W e e n a b le  y o u  to  m a k e  u s e  o f  t h e s e  to o ls  by se le c tin g  a s u b s e t  o f  record s from  
D rastic , a n d  fo rm attin g  th e  d a ta  s o  th a t  it ca n  b e  u se d  w ith  th e  TAIR to o ls . T h e  to o ls  th a t  a re  
a v a ila b le  to  u s e  are:
C h r o m o s o m e  M a p p in g  an d  
F u n c t io n a l  C a t e g o r i s a t i o n
H ow  to  u s e  th e  C h r o m o s o m e  M a p  T o o l
T h is s e a r c h  e n a b le s  y o u  to  p rod u ce  an  im a g e  o f  th e  p osition  o f  yo u r s e le c te d  g e n e s  o n  TAIR's 
A rab id op sis C h ro m o so m e M ap.
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Step 1 : Use the search options to select genes. Click 'Submit Query
Step 2 : A list of the genes resulting from your search will be displayed. Select 'TAIR Chromosome 
Map' button.
Step 3 : A pop up window should appear for the TAIR fwww.arabidopsis.oro I site. Right Click in list 
box and select paste. Click 'Display on Chromosome' button to view Chromosome map of your 
selected genes. A sample output is shown below.
U 1g02920  A t1g02930  _A t1 g u7 8 90  _At1g03450 A t1g08830  
U 1g 1 58 10
U 1g20620  _At1g2 1270
U 1g27730A t1g28330A t1g29395
t1 g6 9 70 0
t1 g7 2 91 0A t1g73540
U 2g02930U2g05Q70-A t2g05380
U 2g14560  __At2g15890
U 2g22500
Vt2g26190
U 2g33830  _ A t2 g 3 6 1 0 0  -A t2g36220  A t2g38530  
M 2g43970
U 3g01290
M 3g10410
U 3g15353-.A t3g15450
Vt3g22 120 A t3g22220  A t3g22240  -A t3g26170
kt3g44260
I.t3g47340 A t3 g 4 91 2 0  
V13g52400 A t3g52800  - ___A t3g56880
kt3g61260 -_ A t3 g 6 2 6 8 0
U 4g02380A t4g02520
M 4g14400
U 4g18010_ A t4g19200
Vt4g24570
M 4g32670_ A t4 g 3 4 0 3 0-A t4 g 3 5 7 5 0A t4 g 3 57 7 0A 14g36040
U 5g14920 
U Sg18170 _A15g19230 -A t5g20230
U 5g37600
Vt5g42200-A t6g42530
USg5987 0  —_ A 15g61600
V i  a i r
Search Page
Step 1 : Use search option to select genes. Click 'Submit Query'
The screen shot below details each search option. This enables you to select a treatment or 
treatment type or gene group (such as kinases) and regulation. The search produces a group of 
genes from the Drastic database whose positions can be viewed on the Arabidopsis chromosome.
Search Results
Step 2 : Click 'TAIR Chromosome Map' button
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This is your selected list of genes from DRASTIC based from your selected search options. Click on 
the 'TAIR Chromosome Map' button which will produce a pop up window to TAIR 
f www.arabidopsis.org) site.________________________________________________________________
f T A IR  C h ro m o s o m e  M a p  | [ T A J R  Fun ctiona l C a te g o riza tio n
T h e  to ta l n u m b e r  o f re c o rd s  re tr ie v e d  is 2 0 6
J
AcIgO1140 Ac lcrOl-970 Ac 1^01720 Ac lg02 2 05 Aclg05340 AclgOSSSO AclgOS6SO Aclg06570 AClg07O4O Aclg07720 Aclg08920 AClcr09S00 AClg!0070
S.\')'l-rela'ed_fcinase1 3tce_cmli r yogenes i undone LIA14tcancer ipc ion_ocC ivator,_HAC_domain,_ATAF1CESl_pcoceinur.Jcn.ounUDP-giucosylcran=re:aaemdo lc - 3 - acetace_beca-glucosylti:an3ferase_like4 -hydroxyphenylpyruvaCe_dioxygcnoseunknownfa tty  acid elongasa 3 -Jcetoacy i—Co A synt Jiase 1 like  3ugar_craa3f orter_p'it ac ive cinnainvl_airohol_deh7drogcr.aac_l ike amino Cranafctasc branchcd-chain
View Chromosome M a p
Step 3 : Input results to TAIR Chromosome Mapping tool
A pop up window will have appeared looking like the one below. Place the mouse pointer in the list 
box as shown in image. Right click on the mouse and select Paste from the menu. This will copy the 
results from the search into the TAIR tool to be processed. Click the 'Display on Chromosomes' button 
to view map.
C h r o m o s o m e  M a p  T o o l
This utility al lows you to draw m a p s  of the Arabi dopsi s  q e n o m e  usinq a list of l oc u s  n a m e s  (i.e. At 1g 0 1 0 1 0 ) .  The list should contain o ne  l o c us  n a m e  per line.
You can add an alternate display n a m e  after the  l o c u s  n a m e  if you prefer another n a m e  for the l oc us  to be di spl ayed (i.e,  entering: A t 1 g 0 1 0 1 0  hello'will  display 'hello' on the c h r o m o s o m e ) .  Entering a dot a s  the alternate n a m e  s u p p r e s s e s  display of the n a m e  (i.e. ' At 1g01010 ."), only a little tick mark on the  c h r o m o s o m e  will be drawn. This is useful  if you have  m a n y  loci and would like to get a s e n s e  of their distribution on t he  c h r o m o s o m e s .
The Z o om Factor  al lows you to m a k e  the  c h r o m o s o m e  smal ler  (<100)  or larger (>100).  A  z o o m  of 10 0 % c o r r es p on d s  to 5 0 , 0 0 0  b p / s cr e en  pixel
Do not enter more than a f ew hundred loci at a t ime.
Z o om  Factor: 100  
P a g e  title: (optional)
C h r o m o s o m e  color: s a u s a g e  v
Right Clic k m o u s e  to s h o w  menu and select  P as te
Tickmark color: white
| D IS P LA Y O N  C H R O M O S O M E S  | V #  a i r
How to use the Functional Categorisation Tool
This search enables you to generate pie charts of the GO slim/Functional Classification set using TAIR 
GO tool.
Step 1 : Use the search options to select genes. Click 'Submit Query'
Step 2 : A list of the genes resulting from your search will be displayed. Select 'TAIR Functional 
Categorization' button.
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Step 3 : A pop up window should appear for the TAIR www.arabidopsis.org) site. Right Click in list box 
and select paste. Click 'Functional Categorization' button to obtain a list of functional categories for 
your selected of genes.
Step 4 : Click 'Create Pie Charts' button to display the graphs. The results will be displayed as three 
separate graphs, each representing the functional classification according to keyword category (GO 
Molecular Function, GO Biological Process and GO Cellular Component). - an example output is shown 
below:
Functional Categorization for : GO Cellular Component
o t h e r  m e m b r a n e s :  2 9 . 9 %  (  r a w  v a l u e  =  8 2  )  
c e l lu la r  c o m p o n e n t  u n k n o w n  2 0  8 %  (  r a w  v a lu e  =  5 7  )  
c h lo r o p la s l  9 . 5 %  (  r a w  v a lu e  =  2 6  )  
n u c le u s  7 . 3 %  (  r a w  v a l u e  =  2 0  )  
m it o c h o n d r ia : 7 . 3 %  (  r a w  v a lu e  = 2 0  )o t h e r  c y t o p la s m ic  c o m p o n e n t s : 7 . 3 %  (  r a w  v a lu e  =  2 0  )  
o t h e '  c e l lu la r  c o m p o n e n t s : 5  5 %  (  r a w  v a lu e  =  1 5  )  
o t h e r  in tr a c e l lu la r  c o m p o n e n t s : 4 %  < r a w  v a lu e  =  1 1  )  
p la s m a  m e m b r a n e  1 8 %  (  r a w  v a lu e  =  5  )  
c y t o s o l  1 5 %  {  r a w  v a lu e  =  4  )  
p la s t i c  1 . 5 %  (  r a w  v a lu e  =  4  )  
e x t r a c e l lu la r : 1 . 5 %  (  r a w  v a lu e  =  4 - )  
r ib o s o m e  1 . 1 %  (  r a w  v a lu e  =  3  )  
c e ll  w aII  1 . 1 %  (  r a w  v a lu e  =  3  )Functional Categorization for : GO Biological Process
o th e r  p h y s io lo g ic a l  p r o c e s s e s  2 2  8 %  (  r a w  v a lu e  =  1 9 6  )  
o th e r  m e t a b o l i c  p r o c e s s e s  1 7  6 %  (  ra w  v a lu e  -  1 5 1  )
o th e r  c e l lu la r  p r o c e s s e s  1 6  4 %  (  r a w  v a lu e  -  1 4 1  )  
r e s p o n s e  to  s t r e s s  7  9 %  (  r a w  v a lu e  —  6 8  )  
t r a n s p o r t  7  9 %  (  r a w  v a lu e  =  6 7  )
r e s p o n s e  to  a b io t ic  or  b io t ic  s t im u lu s  7  7 %  (  r a w  v a lu e  =  6 6  )  
b io lo g ic a l  p r o c e s s  u n k n o w n  4  3 %  (  r a w  v a lu e  =  3 7  )  
p r o te in  m e t a b o l i s m  3  3 %  (  r a w  v a l u e  =  2 8  )  
d e v e lo p m e n t a l  p r o c e s s e s  2  4 %  (  ra w  v a l u e  =  2 1  )
I r a n s c r ip t io n  2  3 %  (  r a w  v a lu e  =  2 0  )  
o th e r  b io lo g ic a l  p r o c e s s e s  2  2 %  (  r a w  v a lu e  =  1 9  )  s ig n a l  t r a n s d u c t io n  1 7 %  (  ra w  v a lu e  -  1 5  )
e le c t r o n  t r a n s p o r t  or  e n e r g y  p a t h w a y s  1 7 %  (  ra w  v a lu e  = 1 5  
c e l l  o r g a n iz a t io n  a n d  b i o g e n e s i s  O 9 %  (  ra w  v a lu e  =  B )
D N A  o r  R N  A  m e t a b o l i s m '  O 7 %  (  r a w  v a lu e  =  6  )
Functional Categorization for : GO Molecular Function
o t h e r  e n z y m e  a c t iv ity  1 9  9 %  < r a w  v a lu e  =  7 6  )  
t r a n s f e r a s e  a c t iv it y  1 3  1 %  (  r a w  v a lu e  =  5 0  )  
m o le c u la r  fu n c t io n  u n k n o w n  1 1  5 %  (  r a w  v a lu e  =  4 4  )  
h y d r o la s e  a c t  iv ity  1 1 %  (  r a w  v a lu e  =  4 2  )  
t r a n s p o r te r  a c t iv ity  8  1 %  (  r a w  v a lu e  =  3 1  )  
o th e r  b in d in g  7  6 %  < r a w  v a lu e  =  2 9  )  
o th e r  m o le c u la r  f u n c t io n s  6  3 %  (  r a w  v a lu e  =  2 4  )  
t r a n s c r ip t io n  fa c t o r  a c t iv ity  5 %  (  r a w  v a lu e  =  1 9  )
D N A  or  R N A  b in d in g  4  7 %  ( r a w  v a lu e  =  1 8  )  
k in a s e  a c t iv it y  4  5 %  (  r a w  v a lu e  =  1 7  )  
n u c le o t id e  b in d in g  3  9 %  (  r a w  v a lu e  —  1 5  )  p r o te in  b in d in g  1  8 %  (  r a w  v a lu e  — 7  ) 
s tr u c tu r a l  m o l e c u l e  a c t iv ity  1 3 %  (  r a w  v a lu e  =  5  )  
n u c le i c  a c id  b in d in g  O 8 %  (  r a w  v a lu e  =  3  )  
r e c e p t o r  b in d in g  or  a c t iv ity  O 3 %  (  r a w  v a lu e  =  1 )
For Step 1 and Step 2 see instructions for Chromosome Map 
Process Results
Step 3 : Input results to TAIR Functional Categorisation tool.
A pop up window should appear for the TAIR www.arabidopsis.org) site. Right Click in the empty list 
box and select paste as illustrated in the screen shot below. This will copy your results into the TAIR 
tool. You should see text appear in the list box. Click the 'Functional Categorisation' button to obtain a 
list of functional categories for your selected of genes.
View Functional Categorisation Pie Charts
Step 4 : Click 'Create Pie Charts' button to display the graphs.
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! TAIR Database v> Quit
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|  n ew  search  |
D is p la y  rig  4 3  re c o rd s .  
K o y w o i i t  C .w e ijo iy
G O  C e llu la r  C o m p o n e n t  
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The results will be displayed as three separate graphs, each representing the functional classification 
according to the keyword category (GO Molecular Function, GO Biological Process and GO Cellular 
Component). The created graphs are in GIF format and can be saved to your PC by right clicking on 
the image and selecting "Save Picture As.." option.
V e n n  D ia g r a m s
This tool enables you to create Venn Diagrams using the A r a b id o p s i s  th a l ia n a  data from the DRASTIC 
database. You can select two or three treatments and the tool will process the selections and output 
the results as a Venn Diagram. The Venn Diagram displays the number of genes regulated by each 
individual treatment or by multiple treatments based on the Drastic data. You can choose to include 
records where genes have been up regulated, down regulated or both. The diagrams can be mined 
further by clicking on a segment of the diagram to view the individual reactions.
Select Treatments 
View Venn Diagram 
View Individual Reaction Results 
View Journal References
T re a tm e n t 1: T re a tm e n t 2:
ABA (altscisic  aci»l>: 202  salicylic acid:  192
T re a tm e n t 3: 
sodium  cNoiide :  254
Venn Diagram with three Treatments
Treatm ent 1: Treatm ent 2:
sodium  chloride: 254 sen escen c e: 59
Venn Diagram with twoTreatments
S e a r c h  P a g e
Use search option to select treatments. Click 'Submit Query'
You can create a Venn diagram by selecting either two or three treatments. To select a treatment, 
double click on the treatment from the list box and it will appear in the 'Selected Treatment' box. To 
select the regulation of the included genes, select up, down or both from the list. Click 'Submit Query' 
to create the Venn diagram. To change your selection click 'Clear Selected'. Due to the large amount 
of data processed, this search may take a few minutes, but a progress bar will be displayed.
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Treatment:
S e l e c t e d  T r e a t m e n t s :
1 -a m  i n o cyc l o p ro p an  e-1 -c a rb  oxy l a te  (A C C )  
2 .4 -D
3A T  (c a ta la s e  inhibitor)
i l l
A lte rn a r ia  b ra s s ic ic o la
a lu m in iu m
a s c o rb ic  a c id
B A P  (6 -b e n z o a m in o p u rin e ) V
A lte rn a r ia  b ra s s ic ic o la  
A B A  (a b s c is ic  a c id )
Regulation: U P
S u b m it Q u e ry C le a r  S e le c te d
The search does not include any results in the database that do not have an AGI number associated 
with them.
View Venn Diagram
A Venn diagram is used to display the results of your search. Each segment of the Venn diagram has 
a number, which represents the number of genes that are regulated by the treatment combinations. 
The reactions for each segment of the Venn diagram can be viewed by clicking on underlined 
number.
T re a tm e n t 1: T re a tm e n t 2:
A B A  (obscisic acitb: 2 0 2 salicylic acid: 192
sodium chloride: 2 5 4
View Individual Reaction Results
This screen enables you to view all the individual reactions held on drastic for the treatment(s) and 
regulation that you selected from the Venn diagram search as shown in the diagram below:
The number of unique AGI numbers and the treatments chosen are displayed at the top of the page. 
The AGI numbers are displayed in a table on the left hand side of the screen to enable you easily 
navigate between the reactions.
Each table of records can be sorted alphabetically (ascending or descending) by clicking on the 
column heading that you want to sort the data by. The first time you click, it will sort the contents in 
ascending order. The second time you click it will sort the table contents in descending order. This is 
indicated by a black arrow that will appear in the sorted column heading.
To view the full journal reference data, click on the Reference ID number of the record you are 
interested in. This will open a new window which displays the full reference information including the 
journal it was published in.
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The total AG I Numbers from Drastic for treatment drought dehydration wilt AND salicylic acid AND sodium
chloride is 1 0  _, , . . . . _. .Total number of unique AG I numbers 
found in the Drastic Database for the 
chosen venn segment
AGI
Numb
At2ar 8
List of AGI num bers from the venn 
diagram search. Click on the .AGI 
number to view a I the reactions.
At2a3157C
At2a3315C
At2a46270l 
8170
At5a09440
/n
Ate
At5a52310
54310
The number of matching records for At2g18700 is 5
.Name and (Gene 
Name)
Accession
Number t
Regulation Tieatment
Name
Compatibility Species Ref
ID
trehalose-6- 
phosphate 
synthase 
putative (not 
available)
\
T21173
Clicktable headingsto order 
table contents alphabetirally 
(ascending or descending). id
non
pathogen
Arabidopsis 
thaliana cv 
Columbia
2
trehalose-6- 
phosphate 
synthase 
putative (not
AV822913;
A V 7 8 3 7 8 4
Up
drought/
dehydration/
wilt
non
pathogen
Arabidopsis 
thaliana cv 
Columbia
334
available) List of reactions for a particular 
AGI number based on the 
treatments selected for the venn 
diaaram.
trehalose-6-
rvlhAPK\ri /-if/A A y/■1Ki rJAr\pi
Pathway Tool
The pathway tool enables you to extract and visualise knowledge from the database to hypothesise 
possible relationships between potential signalling genes.
It has a search facility that allows you to select a number of A r a b id o p s i s  t h a / ia n a  genes using the AGI 
numbers. This produces a 'pathway' which enables you to look at the regulation of genes in response 
to different treatments.
It is possible to see that certain groups of genes are always co-regulated suggesting that they are 
likely to occur in the same signal transduction pathway. An example of this is shown below:
The nurreer of matching records 7B
0*f\e Name TrwaHmepril 1 2 3 ~]S [s 6 7 6 9 10 i- 10 13 14 15 16 17 18 19 20 21 22 23 24
M1 jC6453 (catefcdJn) E 3  E l E 3 E 3 1 E 1 E 1 e i E i
«ia092io (eafretaJiro
M1 30-4140 (IMtelOprOteinM4, lire. Ike) E l m H E l m m m  e i
M1aSf3*0 (cakefteUtl) TO M
£00 (ar*ryrfi p^ Jteri kriase, putative) E l H E l e g
W2a32630 (disease resistance fvcteri putative) E l E S E 3 m B 3 E 3
M2b329O0 (prdeO kirase.i n m m E l  E l m m  w i n
A£2fl41110 (cattcduln) m e g e g  e g e g W I B I I B I
W3a06780 (crctei'i ptlsbvp E l E l E l E l E l
M*b£5*50 far*:yrfi retreat lamtvi E l E l E l e i e i
*t*aCe260 (ptuMpfetase 2C Ser/TtT I E 9 E 3 E l
W*a^SQ (0 pterter, extra larae Ike) E l E 3 E l E l w i n  P I
Pathway Search Page
The Pathway Search enables you to select genes by AGI number or gene name (only includes genes 
which have an AGI number in the Drastic database can be selected to ensure accuracy of results). 
Selecting genes: Double click on the gene in the Gene Name and it will be copied to the lower box 
and included in your search. Click 'Submit Query' when you have completed your selection.
R em ove g en es  from search: To remove one gene from your search, click on the gene in the lower 
box and then click the 'Clear Selected AGI'. To clear all your current selection click 'Clear AH'
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Sorting gen e list: To make finding your selection easier, you can choose to sort the gene list by 
name or AGI number. NOTE: Sort the list prior to selecting the genes to include in the search or you 
may have to re-select your genes.
Bulk Upload: If you know the AGI numbers of the genes you want to include in your search, select 
the 'AGI Bulk Upload' link and you can paste the AGI numbers into the text box.
Order AGI's numerically Order AGI's by gene name
G e n e  N a m e :
D o u b le  click on a g en e from  
the G e n e  N a m e  list to  add to  
your se lected  g e n e s  list.
S e le c te d  G e n e  N a m e s :
Submit Query
At4g34210 (SKPHike 11)
At4g34230 (cinnamyl alcohol dehydrogenase putative) 
At4g34240 (aldehyde dehydrogenase)
At4g34250 (fatty acid elongase putative)
At^g34270 (cysteine protease)
At‘;lg3‘1320 (unknown)AMqS^O (G protein, extra large like)
T h e  G e n e  N am  e list can  b e  
ordered  nu m erica lly  (b y  AG I 
num b e r) or b y ge ne n am e .
At4g34400 (unknown)
At4g34410 (ethylene-responsive element binding protein homolog) 
At4g34460 (GTP binding protein beta subunit (AGE31))
At1 g08450 At1 g09210 At1 g241 AO At1g56340 At2g31800 At2g32680 At2g32800 At2g41110 At3g08760 At4qO3450
(calreticulin)(calreticulin)(metalloproteinase, zinc, like) (calreticulin)(ankyrin protein kinase, putative) (disease resistance protein putative) (protein kinase)(calmodulin)(protein kinase putative)(ankyrin repeat famil Click on a  s ingle gen e from your  se lected  list and click o n  th e  'C lea r  
S e le c te d  .AGI button' to  re m o v e  it.
Clear All Clear Selected AGI
Pathway Results
The diagram below shows a sample pathway result.
The column headers represent the treatments (see treatment legend) for which the database holds 
records.
The rows hold your selected genes and the corresponding results.
The blue highlight denotes down-regulation, red highlight denotes up-regulation and the green 
highlight denotes that reactions for both up- and down- regulation are held.
The number of reactions used to create the pathway diagram is displayed at the top.
Amend Search: The 'Amend Search' button enables you to return to the search page with the genes 
you previously selected saved to enable you to add to your current search.
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Amend Search
Click the An end Search to return to 
the search page wth your current 
gene selection saved.
The number of matching records 70
Displays the number of 
reactions used to create 
the pathv\ay diagram
Be M Marie ' . ! 1 ) 2 3 4 5 6 7 3 9 10 11 12 13 14 15 16 17 [18 19 [2D ;• 2: 23 24
WMJC&45D (cafretctiro -4| E l P i t W P i W E 3 E 3
M1809210 (catneiaJn) /
’■11 j2-1‘ C rir/.al-f tUtr in. I*fi / E l  1 3 1 3 m  1 3 1 3  E l E 3
M1056340 /
At?-j r-1930 l ar t rr n GnJ’.ri nr • - - ' m E 3 E l  _ m ____________ E 3 E 3 _
At2s32630 (tfteesse redstart 
W2 a 32930 I pru)tin kjf«ssj 
A£2g41l10 (ca*-<
W3aC67S0 (prcter kit pt 
AJt4gC:3450 (snkyrfi rtf.*? at 18 
W*bC©260 Cprosor-(4as« 2C 
W4(j3433D (L*p’LCeii, extralsr
The treatments are represented as 
colum ns on the pathv\ay diagram. The 
treatment can be looked up in the 
treatrn ent legend from the colum n header 
num ber.
m
I  E 3 E 1  
E l  E 3
m
e s
mr a
Each row represents the 
results found for each of 
your selected genes
P I  IP!
re atm ent Legend
Treatm ent
Alternaria brassicicola
2 BTH
3 cold
A 1-1 in imhpr mn<?j=»ir s/iri w  ('C'lWlVi
c a
m
c a r . aDQK3 |0 E
m ___3 3
Up highlight denotes Up regulation 
Blue highlight denotes Down regulation 
Green highlight denotes Both 
Click on the highlighted box to viewthe 
individual reaction records.
e a
Pathway Individual Reactions
This screen enables you to view all the individual reactions held on the drastic database for the 
specific pathway element selected as shown in the diagram below:
The number of results are displayed at the top of the page.
The whole table of records can be sorted alphabetically (ascending or descending) by clicking on the 
column heading that you want to sort the data by. The first time you click, it will sort the contents in 
ascending order. The second time you click it will sort the table contents in descending order. This is 
indicated by a black arrow that will appear in the sorted column heading.
To view the full journal reference data, click on the Reference ID number of the record you are 
interested in. This will open a new window which displays the full reference information including the 
journal it was published in.
The number of matching records 70
Gene Treatment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
«1jC6450 (MfreioJn) Q E l E S E S Q Q E S Q
At 1 jC9210 (c aketcdn)
W1324140 (metataprctemerj?. line, toe) E l Q
uick on patnway element to view E 3 G 3 E 3  ES
«13503*0 (eetekeiJln) muiviuuai reauiun re suns. r
W2a31800 (wkyrfi protein kinase, pwtstrve) E l ------- E ! m -n a — \ E S Q
M2b32630 (dteease resistance proton putative) E l E S Q ES \ Q Q
M2g32BOO (protein kirarse.i E S S E 3  ES ES E 3 ^ Q Q
AL2a41110 E l c a ES ES ® Q Q
M3jC6780 1: 1 — ■ ■ — --------------- — ------------ ™ —
M4gC3450(i 
M*3C6260 (| 
«4j:439C (i
T he number of matching records: 2
Nome <ni<l i
iGene Name!
Accession
Number
AGI
Numbei
Regulation Treatment Name Compatibility Species RefID
calmodulin 
(AtCaMS (TCH3)) D45848 At2g41110
turnip vein clearing 
tobamovirus (TVCV) compatible
Arabidopsis thaliana 
cv Columbia 391
calmodulin (not 
available) M88307 At2g41110
turnip vein clearing 
 ^ tobamovirus (TVCV) compatible
Arabidopsis thaliana 
cv Columbia 391
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The Roadmap Tool enables the user to create look-up tables to find genes that are co-regulated by 
treatments (only includes genes which have an AGI number in the Drastic database can be selected 
to ensure accuracy of results).
It has a search facility that allows you to select one A r a b id o p s i s  t h a / ia n a  gene using the AGI numbers. 
This produces a 'roadmap' that enables you to look at the regulation of genes in response to different 
treatments. This can assist in identifying groups of treatments that appear to produce similar 
regulatory results.
The search operates by identifying all treatments that regulated the selected AGI number. These 
treatments are then used to create the roadmap, and all AGIs that are regulated by these treatments 
are included in the map (see example below):
Roadmap Search Page 
Roadmap Results 
View Individual Results
R o a d m a p  T oo l
At4 g 1 1 3 3 0  (Map K inase) - Up R egulation
(chitin
flagellin 22 (flg22)
Yariv phenylglycoside (beta-D-Glc)3 8 252
chitin flagellin 22 (flg22) Yariv phenylglycoside (beta-D-Glc)3 
H H 17 8
25217
Roadmap Search Page
The Roadmap search enables you to select an AGI number and a regulation.
Select Gene: The list of genes can be ordered by AGI or name. Click on the AGI number to select it. 
Select Regulation: Select a regulation from the drop down list.
Click 'Submit Query' when you have completed your selection.__________________________
G e n e  N am e:
R eg u la tio n :
Subm it Query
Order AGI's numeric ally Order API's bv gene name
At5g14850 (mannosyltransferase. putative) 
At1g01560 (MAP kinase)
At2g18170 (MAP kinase)
At2g43790 (MAP kinase)
At4g11330 (MAP kinase)
At1g05100 (MAP kinase (NPK1 related))
At3g45640 (MAP kinase 3)
At2g18170 (MAP kinase 7)
Atlgl 8150 (MAP kinase 8?)
At5g565S0 (MAP kinase kinase (MAPKK), putative)
Clidr to orcer list by AGI or rame
Select ore AGI number by clicking or the chcsen value
U P
UP
D O W N
B O T H
Select a regulation from the drop down let
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R o a d m a p  R e s u lt s
The diagram below shows a sample pathway result.
The column and row headers represent the treatments for which the database holds records and are 
used as a look-up table.
The red highlight indicates cells showing the total AGIs that are regulated by a single treatment. E.g. 
in the roadmap below, there are 5 8  genes that are regulated by chitin.
The underlined results in the white cells show the number of genes that are regulated by both 
treatments. E.g. in the roadmap below, it can be seen that there are 1 4  genes that are co-regulated 
by chitin and wound.
A t3 g 4 5 6 4 0  (M a p  K in a s e  3 ) -  U p  o r  D o w n  R e g u la t io n  (B o th )
calycuiin 
(chitin 
drought / 
dehydration / wilt 
flagellin 22 (flg22) 
hydrogen peroxide 1 
jasmonate _
(methyl) ~
ozone
salicylic acid 
|UV
UV  + ascorbic 
acid
drought /
calycuiin chitin dehydration 
j [wilt
i 2 
H H b
hydrogen jasmonate
8
19
’[T-
23
1 rUs
3
salicylic . , ozone ., ■ U V  acid
Ths w b its boxes s h ow the tctal number cf AGIs that ars regulates Dy BOTH treatments
wound 2 ( M ) 83 125 21 45
Yariv t
phenylglycoside
(beta-D-Glc)3
4 26 254 2 1 15
Treatments are sis played in rows anc columns ars are used as a lock up table e.g. there are 14 AGIs that are cc- regulated by wound and chitir
2
19
'[TIT
3
U V  + Yariv
ascorbic wound phenylglycoside 
acid (beta-D-Glc)3
~~h E T
2 14 8
Clio on a numc-er and the supporting records for both treatments will te sis clayed I alcng with references )
2
24
165 4 3
|l8 2 2
3I£ 4 1
(4 ifi 8
1 8 |  |
[36 7
/- The bores in res s hexv the total number of records (unique AGIs) for asirgle treatment.
View Individual Roadmap Results
This screen enables you to view all the individual reactions held on the drastic database from BOTH 
treatments and the supporting references
The number of results is displayed at the top of each table. (You may have to scroll down the page 
for the second treatment results. The number of results may be different for each treatment as this 
depends how many supporting records are held by Drastic.
Each table of records can be sorted alphabetically (ascending or descending) by clicking on the 
column heading that you want to sort the data by. The first time you click, it will sort the contents in 
ascending order. The second time you click it will sort the table contents in descending order. This is 
indicated by a black arrow that will appear in the sorted column heading.
To view the full journal reference data, click on the Reference ID number of the record you are 
interested in. This will open a new window that displays the full reference information including the 
journal it was published in.
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The number of matching records: 39 for treatment drought / dehydration / wilt
Name Gene Name Accession Number Regulation AGI Ref Number ID
calmodulin related putative not available ;AV824175; AV785354 j Up At5g42380 |334
calmodulin related putative not available R30557 Up At5g42380 !l
cytochrome P450 AtCYP707A1 AV825284; AV790857 Up At4g 19230 \ m
cytochrome P450i
AtCYP707A1 AV825284 AV790857;MK.Yr/U/AI AYQ5Q980 u p At4g19230 107
cytochrome P450 
dehydrin like
late embryogenesis abundant LEA D113 type 1
AICYP707A3 Ai5g45340 ! Up At5g45340 482
Iti30 Z18121 Up At3g50970 26
not available AV826209 AV794009 Up At5g06760 2M
The number of matching records: 26 for treatment Yariv phenylglycoside (beta-D-Glc)3
Name Gene Name AccessionNumber Regulation AGINumber RefID
calmodulin related putative not known At5g42380 Up At5g42380 455
i cytochrome P450 AtCYP707A1 At4g19230 Up At4g 19230 455
cytochrome P450 
dehydrin like
late embryogenesis abundant LEA D113 type 1
AtCYP707A3
Iti30
not available
At5g45340
At3g50970
At5g06760
Up
Up
; Down
At5g45340
At3g50970
At5g06760
455
455
455
late embryoqenesis abundant LEA SAG21 homoloq not available At4q02380 Up At4q02380 455
U n i q u e  G e n e  T o o l
The Unique Genes Tool identifies all of the A r a b id o p s i s  th a l ia n a  genes that are regulated by a single 
treatment based on the Drastic data. Full details (including the reference) of each gene are available 
by selecting a result. The results will dynamically change with time as more data is added to the 
database.
Unique Gene Results 
View Individual Results
U n i q u e  G e n e  R e s u l t s
This screen displays all the A r a b id o p s i s  t h a l i a n a  genes that Drastic has identified as being regulated 
by a single treatment.
The number of unique AGI numbers is displayed at the top of the page.
To make viewing your results easier, you can choose to sort the list by name, AGI number or 
treatment.
This data can be mined further by viewing the Individual Results by clicking on the AGI number.
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O rd e r  A G I's  num erica lly  O rd e r A G I's  bv g e n e  n a m e  O rd e r  T re a tm e n ts  a lp h ab e tica lly
The number of matching records: 3117
A G I  N u m b e r  ( N a m e ) T r e a t m e n t
A t1 a 0 1 0 1 0  fno aDical m eris tem ) A B A  (a b sc is ic  ac id )
A t1 g 0 1 0 7 0  (nodulin M tN 2 1  fa m ilv l P seu d o m o n as  fluorescens
A t1 a 0 1 1 2 0  (fattv  acid e lo n a ase  3 -k e to a c v l-C o A  s v n th a s e  11 cu cu m b er m o sa ic  virus (C M V )
A t1 a 0 1 1 3 0  (unknow n! A B A  (a b sc is ic  ac id )
A t1 a 0 1 3 0 0  (asD artvl D ro teasel z e a tin  (cyto kin in )
A t 1 a 0 1 3 7 0  (h is to ne H 3 H TR121 A B A  (a b sc is ic  ac id )
A t1 g 0 1 4 8 0  (1 -am ino cvc loD roD an e-1 -carbo xv la te  (ACC1 svn th asg ) cu cu m b er m o sa ic  virus (C M V )
A t1 a 0 1 4 9 0  (h e a w -m e ta l-a s s o c ia te d  dom ain -con ta in ing  protein) | P s eu d o m o n as  flu orescens
V i e w  I n d i v i d u a l  R e s u l t s
This screen enables you to view all the individual reactions held on the drastic database according to 
your search criteria as shown in the diagram below:
The number of results is displayed at the top of the page.
The whole table of records can be sorted alphabetically (ascending or descending) by clicking on the 
column heading that you want to sort the data by. The first time you click, it will sort the contents in 
ascending order. The second time you click it will sort the table contents in descending order. This is 
indicated by a black arrow that will appear in the sorted column heading.
To view the full journal reference data, click on the Reference ID number of the record you are 
interested in. This will open a new window that displays the full reference information including the 
journal it was published in.
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Appendix VII -  Contents of CD
1. Website Files (These will need an ASP Server to view the site) 
Folder Drastic_Website:
AccNumResponse.asp
AGIResponse.asp
BasicQueryReference.asp
DatabaseStats.asp
Pathway, asp
PathwayCheck.asp
PathwayP.asp
Pathway Result, asp
PathwayResultp.asp
Search, asp
searchAccNum.asp
SearchAGI.asp
S tatsReactions. asp
StatsResult.asp
Tairagi.asp
T air AGIResponse.asp
VennDetails.asp
VennQuery.asp
VennQueryResponse.asp
Folder Drastic_Website/Files
DatabaseDetails.inc
Footer, inc
headerA.inc
headerB.inc
insight.css
List.js
Sorttable.js
Treearr.js
2. Drastic Database including User Entry Forms 
DrasticV6.mdb
3. Unigene Search Program
U nigeneSearch. vbp 
UnigeneSearchIngo.doc
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